the O O
majority O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
the O O
breast-ovarian B-Dis B-Dis
cancer I-Dis I-Dis
families O O
were O O
due O O
to O O
brca1 O O
, O O
with O O
most O O
others O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
due O O
to O O
brca2 O O
. O O

the O O
tau O O
level O O
in O O
the O O
cerebrospinal O O
fluid O O
-lrb- O O
csf O O
-rrb- O O
in O O
patient O O
_num1 O O
was O O
as O O
high O O
as O O
that O O
of O O
patients O O
with O O
alzheimers B-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
ad B-Dis O
-rrb- O O
. O O

the O O
common O O
mutation O O
at O O
codon O O
_num2 O O
in O O
exon O O
_num1 O O
might O O
be O O
responsible O O
for O O
most O O
japanese O O
c9 B-Dis B-Dis
deficiency I-Dis I-Dis
. O O
. O O

to O O
date O O
, O O
however O O
, O O
linkage O O
studies O O
have O O
attempted O O
only O O
to O O
identify O O
chromosomal O O
loci O O
that O O
cause O O
or O O
increase O O
the O O
risk O O
of O O
developing O O
bpad B-Dis B-Dis
. O O

while O O
very O O
few O O
patients O O
with O O
agu B-Dis B-Dis
have O O
been O O
reported O O
from O O
non-finnish O O
origin O O
, O O
we O O
diagnosed O O
the O O
disorder O O
in O O
_num1 O O
patients O O
originating O O
from O O
_num1 O O
unrelated O O
families O O
, O O
all O O
palestinian O O
arabs O O
from O O
the O O
region O O
of O O
jerusalem O O
. O O

carriers O O
of O O
the O O
same O O
mutation O O
, O O
from O O
different O O
families O O
, O O
shared O O
similar O O
haplotypes O O
, O O
indicating O O
that O O
the O O
mutant O O
alleles O O
were O O
likely O O
to O O
be O O
identical O O
by O O
descent O O
for O O
a O O
mutation O O
in O O
the O O
founder O O
population O O
. O O

maternal B-Dis O
disomy I-Dis O
and O O
prader-willi B-Dis B-Dis
syndrome I-Dis I-Dis
consistent O O
with O O
gamete O O
complementation O O
in O O
a O O
case O O
of O O
familial O O
translocation O O
-lrb- O O
_num1 O O
; O O
_num2 O O
-rrb- O O
-lrb- O O
_an O O
; O O
_an O O
.2 O O
-rrb- O O
. O O

three O O
went O O
from O O
a O O
decreased O O
risk O O
to O O
an O O
increased O O
risk O O
, O O
while O O
in O O
another O O
three O O
the O O
risk O O
was O O
decreased O O
. O O

we O O
generated O O
a O O
mouse O O
model O O
for O O
this O O
disease O O
by O O
using O O
gene O O
targeting O O
. O O

a O O
panel O O
of O O
_num2 O O
monoclonal O O
antibodies O O
-lrb- O O
mabs O O
-rrb- O O
has O O
been O O
mapped O O
to O O
six O O
specific O O
sites O O
throughout O O
the O O
emerin O O
molecule O O
using O O
phage-displayed O O
peptide O O
libraries O O
and O O
has O O
been O O
used O O
to O O
localize O O
emerin O O
in O O
human O O
and O O
rabbit O O
heart O O
. O O

less O O
severe O O
, O O
subacute O O
-lrb- O O
juvenile-onset O O
-rrb- O O
and O O
chronic O O
-lrb- O O
adult-onset O O
-rrb- O O
variants O O
are O O
characterized O O
by O O
a O O
broad O O
spectrum O O
of O O
clinical O O
manifestations O O
and O O
are O O
associated O O
with O O
residual O O
levels O O
of O O
hex O O
a O O
enzyme O O
activity O O
. O O

are O O
dp71 O O
and O O
dp140 O O
brain O O
dystrophin O O
isoforms O O
related O O
to O O
cognitive B-Dis O
impairment I-Dis O
in O O
duchenne B-Dis B-Dis
muscular I-Dis I-Dis
dystrophy I-Dis I-Dis
? O O

_num1 O O
% O O
of O O
mutations O O
, O O
respectively O O
, O O
whereas O O
the O O
remaining O O
f69v O O
is O O
limited O O
to O O
a O O
single O O
allele O O
. O O

the O O
dmpk O O
gene O O
of O O
severely O O
affected O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
patients O O
is O O
hypermethylated O O
proximal O O
to O O
the O O
largely O O
expanded O O
_ds O O
repeat O O
. O O

we O O
identified O O
both O O
causative O O
mutations O O
in O O
_num3 O O
patients O O
from O O
seven O O
european O O
centers O O
. O O

his O O
brain O O
magnetic O O
resonance O O
image O O
-lrb- O O
mri O O
-rrb- O O
showed O O
abnormalities B-Dis B-Dis
in I-Dis I-Dis
the I-Dis I-Dis
bilateral I-Dis I-Dis
cerebellar I-Dis I-Dis
hemispheres I-Dis I-Dis
and O O
brain O O
stem O O
, O O
but O O
not O O
in O O
the O O
cerebral O O
white O O
matter O O
, O O
where O O
marked O O
reductions O O
of O O
the O O
cerebral O O
blood O O
flow O O
and O O
oxygen O O
metabolism O O
were O O
clearly O O
demonstrated O O
by O O
positron O O
emission O O
tomography O O
-lrb- O O
pet O O
-rrb- O O
. O O

it O O
is O O
crucial O O
to O O
diagnose O O
hemochromatosis B-Dis B-Dis
before O O
hepatic B-Dis B-Dis
cirrhosis I-Dis I-Dis
develops O O
because O O
phlebotomy O O
therapy O O
can O O
avert O O
serious O O
chronic O B-Dis
disease O I-Dis
and O O
can O O
even O O
lead O O
to O O
normal O O
life O O
expectancy O O
. O O
. O O

patients O O
reported O O
as O O
having O O
either O O
neonatal O O
sjs B-Dis O
or O O
sws B-Dis O
presented O O
a O O
combination O O
of O O
a O O
severe O O
, O O
prenatal-onset O O
neuromuscular B-Dis B-Dis
disorder I-Dis I-Dis
-lrb- O O
with O O
congenital B-Dis B-Dis
joint I-Dis I-Dis
contractures I-Dis I-Dis
, O O
respiratory O O
and O O
feeding O O
difficulties O O
, O O
tendency O O
to O O
hyperthermia B-Dis O
, O O
and O O
frequent O O
death O O
in O O
infancy O O
-rrb- O O
with O O
a O O
distinct O O
campomelic-metaphyseal B-Dis B-Dis
skeletal I-Dis I-Dis
dysplasia I-Dis I-Dis
. O O

compared O O
with O O
the O O
frequency O O
in O O
two O O
separate O O
population O O
control O O
groups O O
, O O
the O O
apc O O
i1307k O O
allele O O
is O O
associated O O
with O O
an O O
estimated O O
relative O O
risk O O
of O O
_num1 O O
. O O

when O O
the O O
w474c-containing O O
alpha-subunit O O
was O O
transiently O O
co-expressed O O
with O O
the O O
beta-subunit O O
to O O
produce O O
hex O O
a O O
-lrb- O O
alphabeta O O
-rrb- O O
in O O
cos-7 O O
cells O O
, O O
the O O
mature O O
alpha-subunit O O
was O O
present O O
, O O
but O O
its O O
level O O
was O O
much O O
lower O O
than O O
that O O
from O O
normal O O
alpha-subunit O O
transfections O O
, O O
although O O
higher O O
than O O
in O O
those O O
cells O O
transfected O O
with O O
an O O
alpha-subunit O O
associated O O
with O O
infantile O O
tsd B-Dis B-Dis
. O O

in O O
a O O
survey O O
of O O
dm B-Dis B-Dis
in O O
northern O O
ireland O O
, O O
_num2 O O
pedigrees O O
were O O
ascertained O O
. O O

angelman B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
as B-Dis B-Dis
-rrb- O O
is O O
caused O O
by O O
chromosome O O
15q11-q13 O O
deletions O O
of O O
maternal O O
origin O O
, O O
by O O
paternal O O
uniparental B-Dis B-Dis
disomy I-Dis I-Dis
-lrb- O O
upd B-Dis B-Dis
-rrb- O O
_num2 O O
, O O
by O O
imprinting O O
defects O O
, O O
and O O
by O O
mutations O O
in O O
the O O
ube3a O O
gene O O
. O O

a O O
variant O O
of O O
fap B-Dis B-Dis
is O O
attenuated B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
coli I-Dis I-Dis
, O O
which O O
results O O
from O O
germ-line O O
mutations O O
in O O
the O O
_num1 O O
and O O
_num1 O O
regions O O
of O O
the O O
apc B-Dis B-Dis
gene O O
. O O

the O O
breast B-Dis B-Dis
and I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
susceptibility O O
gene O O
brca1 O O
encodes O O
a O O
zinc O O
finger O O
protein O O
of O O
unknown O O
function O O
. O O

_num3 O O
mg O O
/ O O
ml O O
; O O
n O O
= O O
_num1 O O
-rrb- O O
, O O
compared O O
with O O
the O O
level O O
-lrb- O O
_num1 O O
. O O

oral O O
contraceptives O O
protect O O
against O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
in O O
general O O
, O O
but O O
it O O
is O O
not O O
known O O
whether O O
they O O
also O O
protect O O
against O O
hereditary B-Dis B-Dis
forms I-Dis I-Dis
of I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
. O O

both O O
vhl-positive O O
and O O
vhl-negative O B-Dis
rcc B-Dis I-Dis
cells O O
exit O O
the O O
cell O O
cycle O O
by O O
contact O O
inhibition O O
. O O

families O O
were O O
included O O
without O O
regard O O
to O O
the O O
occurrence O O
of O O
ovarian B-Dis B-Dis
or I-Dis I-Dis
other I-Dis I-Dis
cancers I-Dis I-Dis
. O O

major O O
instability O O
, O O
with O O
very O O
large O O
expansions O O
between O O
generations O O
and O O
high O O
levels O O
of O O
somatic O O
mosaicism O O
, O O
is O O
observed O O
in O O
patients O O
. O O

our O O
previous O O
study O O
showed O O
that O O
this O O
ashkenazi O O
mutation O O
also O O
occurs O O
in O O
iraqi O O
jews O O
with O O
a O O
similar O O
allelic O O
pattern O O
. O O

microsatellite O O
genotyping O O
around O O
the O O
atm O O
locus O O
also O O
indicated O O
that O O
a O O
common O O
haplotype O O
was O O
shared O O
by O O
the O O
mutant O O
alleles O O
in O O
both O O
mutations O O
. O O

we O O
assessed O O
the O O
i1307k O O
prevalence O O
in O O
israeli O O
jews O O
of O O
differing O O
ethnic O O
origin O O
and O O
risk O O
for O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
. O O

maei O O
restriction O O
analysis O O
showed O O
two O O
other O O
carriers O O
in O O
the O O
family O O
. O O

human B-Dis O
complement I-Dis B-Dis
factor I-Dis I-Dis
h I-Dis I-Dis
deficiency I-Dis I-Dis
associated O O
with O O
hemolytic B-Dis B-Dis
uremic I-Dis I-Dis
syndrome I-Dis I-Dis
. O O

her O O
ventricular O O
hypertrophy O O
resolved O O
significantly O O
over O O
_num1 O O
year O O
, O O
and O O
cognitively O O
, O O
she O O
is O O
in O O
the O O
superior O O
range O O
for O O
age O O
. O O

patient O O
_num1 O O
was O O
homozygous O O
for O O
a O O
mutation O O
in O O
exon O O
_num1 O O
-lrb- O O
c3804a O O
-rrb- O O
which O O
abolishes O O
pomc O O
translation O O
. O O

thus O O
, O O
a O O
homozygous O O
germ-line O O
mlh1 O O
mutation O O
and O O
consequent O O
mismatch O O
repair O B-Dis
deficiency O I-Dis
results O O
in O O
a O O
mutator O O
phenotype O O
characterized O O
by O O
leukemia B-Dis B-Dis
and O O
/ O O
or O O
lymphoma B-Dis O
associated O O
with O O
neurofibromatosis B-Dis B-Dis
type I-Dis I-Dis
_num1 I-Dis I-Dis
. O O
. O O

deficiency B-Dis B-Dis
of I-Dis I-Dis
the I-Dis I-Dis
ninth I-Dis I-Dis
component I-Dis I-Dis
of I-Dis I-Dis
human I-Dis I-Dis
complement I-Dis I-Dis
-lrb- O O
c9 O O
-rrb- O O
is O O
the O O
most O O
common O O
complement B-Dis B-Dis
deficiency I-Dis I-Dis
in O O
japan O O
but O O
is O O
rare O O
in O O
other O O
countries O O
. O O

the O O
risk O O
of O O
cancer B-Dis B-Dis
, O O
especially O O
lymphoid B-Dis O
neoplasias I-Dis O
, O O
is O O
substantially O O
elevated O O
in O O
a-t B-Dis B-Dis
patients O O
and O O
has O O
long O O
been O O
associated O O
with O O
chromosomal O O
instability O O
. O O

cycloheximide O O
facilitates O O
the O O
identification O O
of O O
aberrant O O
transcripts O O
resulting O O
from O O
a O O
novel O O
splice-site O O
mutation O O
in O O
col17a1 O O
in O O
a O O
patient O O
with O O
generalized O O
atrophic B-Dis B-Dis
benign I-Dis I-Dis
epidermolysis I-Dis I-Dis
bullosa I-Dis I-Dis
. O O

pax6 O O
regulates O O
eye O O
development O O
in O O
animals O O
ranging O O
from O O
jellyfish O O
to O O
drosophila O O
to O O
humans O O
. O O

however O O
, O O
several O O
truncation O O
mutations O O
have O O
been O O
found O O
to O O
occur O O
in O O
the O O
c-terminal O O
half O O
of O O
pax6 O O
in O O
patients O O
with O O
aniridia B-Dis B-Dis
resulting O O
in O O
mutant O O
proteins O O
that O O
retain O O
the O O
dna-binding O O
domains O O
but O O
have O O
lost O O
most O O
of O O
the O O
transactivation O O
domain O O
. O O

data O O
presented O O
here O O
indicate O O
that O O
the O O
conserved O O
heterogeneous O O
nuclear O O
ribonucleoprotein O O
, O O
cug-binding O O
protein O O
-lrb- O O
cug-bp O O
-rrb- O O
, O O
may O O
mediate O O
the O O
trans-dominant O O
effect O O
of O O
the O O
rna O O
. O O

four O O
mutations O O
-- O O
r778l O O
, O O
a874v O O
, O O
l1083f O O
, O O
and O O
2304delc O O
-- O O
in O O
the O O
copper-transporting O O
enzyme O O
, O O
p-type O O
atpase O O
-lrb- O O
atp7b O O
-rrb- O O
, O O
were O O
identified O O
in O O
korean O O
patients O O
with O O
wilson B-Dis B-Dis
disease I-Dis I-Dis
. O O

in O O
patients O O
_num1 O O
and O O
_num1 O O
, O O
the O O
autopsy O O
findings O O
showed O O
massive O O
demyelination B-Dis B-Dis
of I-Dis O
the I-Dis O
cerebral I-Dis O
white I-Dis O
matter I-Dis O
with O O
sparing O O
of O O
the O O
u-fibers O O
, O O
compatible O O
with O O
the O O
findings O O
of O O
childhood O O
ald B-Dis B-Dis
. O O

identification O O
and O O
quantitation O O
of O O
hex O O
a O O
, O O
amounting O O
to O O
_num1 O O
. O O

it O O
is O O
therefore O O
concluded O O
that O O
the O O
r496h O O
mutation O O
of O O
arsa O O
does O O
not O O
negatively O O
influence O O
the O O
activity O O
of O O
arsa O O
and O O
is O O
not O O
a O O
cause O O
of O O
mld B-Dis B-Dis
piebaldism I-Dis B-Dis
with O O
deafness B-Dis B-Dis
: O O
molecular O O
evidence O O
for O O
an O O
expanded O O
syndrome O O
. O O

cell O O
cycle-dependent O O
colocalization O O
of O O
bard1 O O
and O O
brca1 O O
proteins O O
in O O
discrete O O
nuclear O O
domains O O
. O O

thus O O
, O O
brca1 O O
and O O
brca2 O O
participate O O
, O O
together O O
, O O
in O O
a O O
pathway O O
-lrb- O O
s O O
-rrb- O O
associated O O
with O O
the O O
activation O O
of O O
double-strand O O
break O O
repair O O
and O O
/ O O
or O O
homologous O O
recombination O O
. O O

in O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
_num2 O O
tumors B-Dis B-Dis
without O O
loh O O
, O O
one O O
mutation O O
was O O
detected O O
, O O
and O O
in O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
the O O
tumors B-Dis B-Dis
without O O
loh O O
, O O
both O O
mutations O O
were O O
found O O
. O O

the O O
dual O O
role O O
of O O
alpha-msh O O
in O O
regulating O O
food O O
intake O O
and O O
influencing O O
hair O O
pigmentation O O
predicts O O
that O O
the O O
phenotype O O
associated O O
with O O
a O O
defect O O
in O O
pomc O O
function O O
would O O
include O O
obesity B-Dis B-Dis
, O O
alteration O O
in O O
pigmentation O B-Dis
and O O
acth B-Dis B-Dis
deficiency I-Dis I-Dis
. O O

there O O
is O O
a O O
noticeably O O
elevated O O
level O O
of O O
mutation O O
in O O
the O O
paired O O
domain O O
compared O O
with O O
the O O
rest O O
of O O
the O O
gene O O
. O O

_num2 O O
families O O
with O O
_num2 O O
matings O O
informative O O
for O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
were O O
found O O
. O O

in O O
males O O
, O O
sf-1 O O
participates O O
in O O
sexual O O
development O O
by O O
regulating O O
expression O O
of O O
the O O
polypeptide O O
hormone O O
mullerian O O
inhibiting O O
substance O O
-lrb- O O
mis O O
-rrb- O O
. O O

hla-b27 O O
accounts O O
for O O
a O O
minority O O
of O O
the O O
overall O O
genetic O O
susceptibility O O
to O O
as B-Dis B-Dis
. O O

limits O O
to O O
accuracy O O
included O O
recombination O O
between O O
the O O
dna O O
markers O O
and O O
the O O
mutation O O
, O O
pedigree O O
structure O O
, O O
and O O
whether O O
dna O O
samples O O
were O O
available O O
from O O
family O O
members O O
. O O

the O O
evidence O O
of O O
a O O
significant O O
proportion O O
of O O
loss-of-function O O
mutations O O
and O O
a O O
complete O O
absence O O
of O O
the O O
normal O O
copy O O
of O O
atm O O
in O O
the O O
majority O O
of O O
mutated O B-Dis
tumours B-Dis I-Dis
establishes O O
somatic O O
inactivation O O
of O O
this O O
gene O O
in O O
the O O
pathogenesis O O
of O O
sporadic B-Dis O
t-pll I-Dis O
and O O
suggests O O
that O O
atm O O
acts O O
as O O
a O O
tumour B-Dis B-Dis
suppressor O O
. O O

7-kb O O
genomic O O
deletion O O
of O O
the O O
_num1 O O
end O O
of O O
the O O
gene O O
, O O
most O O
likely O O
a O O
result O O
of O O
recombination O O
between O O
two O O
line O O
elements O O
, O O
was O O
identified O O
. O O

cug-bp O O
was O O
found O O
to O O
bind O O
to O O
the O O
human O O
cardiac O O
troponin O O
t O O
-lrb- O O
ctnt O O
-rrb- O O
pre-messenger O O
rna O O
and O O
regulate O O
its O O
alternative O O
splicing O O
. O O

molecular O O
defects O O
leading O O
to O O
human O B-Dis
complement B-Dis I-Dis
component I-Dis I-Dis
c6 I-Dis I-Dis
deficiency I-Dis I-Dis
in O O
an O O
african-american O O
family O O
. O O

apc B-Dis O
is O O
a O O
tumour-suppressor O O
gene O O
, O O
and O O
somatic O O
loss O O
occurs O O
in O O
tumours B-Dis B-Dis
. O O

to O O
determine O O
whether O O
there O O
could O O
be O O
protective O O
alleles O O
that O O
prevent O O
or O O
reduce O O
the O O
risk O O
of O O
developing O O
bpad B-Dis B-Dis
, O O
similar O O
to O O
what O O
is O O
observed O O
in O O
other O O
genetic B-Dis B-Dis
disorders I-Dis I-Dis
, O O
we O O
used O O
mental O O
health O O
wellness O O
-lrb- O O
absence O B-Dis
of O I-Dis
any O I-Dis
psychiatric B-Dis I-Dis
disorder I-Dis I-Dis
-rrb- O O
as O O
the O O
phenotype O O
in O O
our O O
genome-wide O O
linkage O O
scan O O
of O O
several O O
large O O
multigeneration O O
old O O
order O O
amish O O
pedigrees O O
exhibiting O O
an O O
extremely O O
high O O
incidence O O
of O O
bpad B-Dis B-Dis
. O O

we O O
identified O O
four O O
germline O O
mutations O O
in O O
three O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
families O O
and O O
in O O
one O O
breast-ovarian B-Dis B-Dis
cancer I-Dis I-Dis
family O O
. O O

in O O
sca3 B-Dis O
, O O
gaze-evoked B-Dis O
nystagmus I-Dis O
was O O
often O O
present O O
as O O
was O O
saccade O O
hypometria O O
and O O
smooth O O
pursuit O O
gain O O
was O O
markedly O O
decreased O O
. O O

we O O
have O O
identified O O
three O O
offspring O O
in O O
a O O
hereditary B-Dis B-Dis
nonpolyposis I-Dis I-Dis
colorectal I-Dis I-Dis
cancer I-Dis I-Dis
family O O
who O O
developed O O
hematological B-Dis B-Dis
malignancy I-Dis I-Dis
at O O
a O O
very O O
early O O
age O O
, O O
and O O
at O O
least O O
two O O
of O O
them O O
displayed O O
signs O O
of O O
neurofibromatosis B-Dis B-Dis
type I-Dis I-Dis
_num1 I-Dis I-Dis
-lrb- O O
nf1 B-Dis O
-rrb- O O
. O O

in O O
the O O
present O O
study O O
, O O
the O O
classification O O
of O O
_num3 O O
pah O O
mutations O O
may O O
allow O O
the O O
prediction O O
of O O
the O O
biochemical O O
phenotype O O
in O O
> O O
_num2 O O
, O O
_num3 O O
genotypes O O
, O O
which O O
may O O
be O O
useful O O
for O O
the O O
management O O
of O O
hyperphenylalaninemia B-Dis B-Dis
in O O
newborns O O
. O O

_num1 O O
years O O
, O O
whereas O O
the O O
family O O
harbouring O O
the O O
missense O O
mutation O O
had O O
an O O
average O O
age O O
of O O
onset O O
of O O
_num2 O O
. O O

because O O
of O O
the O O
small O O
size O O
of O O
most O O
pedigrees O O
and O O
the O O
high O O
incidence O O
of O O
sudden B-Dis B-Dis
death I-Dis I-Dis
, O O
however O O
, O O
molecular O O
genetic O O
studies O O
of O O
ivf B-Dis B-Dis
have O O
not O O
yet O O
been O O
done O O
. O O

three O O
novel O O
missense O O
mutations O O
never O O
identified O O
previously O O
in O O
other O O
populations O O
and O O
found O O
in O O
_num2 O O
out O O
of O O
_num2 O O
colombian O O
mps B-Dis B-Dis
iva I-Dis I-Dis
unrelated O O
alleles O O
account O O
for O O
_num2 O O
. O O

we O O
also O O
show O O
that O O
_num2 O O
% O O
of O O
all O O
a-t B-Dis B-Dis
patients O O
carried O O
in-frame O O
deletions O O
or O O
missense O O
mutations O O
, O O
many O O
of O O
which O O
were O O
also O O
associated O O
with O O
expression O O
of O O
mutant O O
atm O O
protein O O
. O O

these O O
data O O
support O O
multistep O O
models O O
of O O
triplet O O
repeat O O
expansion O O
that O O
have O O
been O O
proposed O O
for O O
both O O
dm B-Dis B-Dis
and O O
friedreichs B-Dis B-Dis
ataxia I-Dis I-Dis
. O O
. O O

arg778leu O O
, O O
the O O
most O O
frequently O O
reported O O
mutation O O
of O O
this O O
enzyme O O
, O O
was O O
found O O
in O O
six O O
of O O
eight O O
unrelated O O
patients O O
studied O O
, O O
an O O
allele O O
frequency O O
of O O
_num2 O O
. O O

_num1 O O
% O O
-rrb- O O
had O O
significantly O O
lower O O
frequencies O O
of O O
the O O
tyr O O
allele O O
. O O

_num1 O O
of O O
embryogenesis O O
. O O

_num2 O O
mg O O
/ O O
ml O O
, O O
which O O
was O O
approximately O O
half O O
the O O
level O O
of O O
hp O O
in O O
control O O
sera O O
from O O
the O O
hp1 O O
phenotype O O
-lrb- O O
_num1 O O
. O O

mutations O O
in O O
the O O
smad4 O O
/ O O
dpc4 O O
tumor B-Dis B-Dis
suppressor O O
gene O O
, O O
a O O
key O O
signal O O
transducer O O
in O O
most O O
tgfbeta-related O O
pathways O O
, O O
are O O
involved O O
in O O
_num2 O O
% O O
of O O
pancreatic B-Dis B-Dis
cancers I-Dis I-Dis
. O O

his O O
affected O O
son O O
has O O
repeat O O
sizes O O
of O O
_num4 O O
and O O
_num3 O O
. O O

vwf-deficient B-Dis O
mice O O
appeared O O
normal O O
at O O
birth O O
; O O
they O O
were O O
viable O O
and O O
fertile O O
. O O

a O O
novel O O
common O O
missense O O
mutation O O
g301c O O
in O O
the O O
n-acetylgalactosamine-6-sulfate O O
sulfatase O O
gene O O
in O O
mucopolysaccharidosis B-Dis B-Dis
iva I-Dis I-Dis
. O O

background O O
& O O
aims O O
israeli O O
jews O O
of O O
european O O
birth O O
, O O
i. O O
e. O O
, O O
ashkenazim O O
, O O
have O O
the O O
highest O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
incidence O O
of O O
any O O
israeli O O
ethnic O O
group O O
. O O

our O O
results O O
support O O
the O O
hypothesis O O
that O O
the O O
under-representation O O
of O O
missense O O
mutations O O
is O O
caused O O
by O O
ascertainment O O
bias O O
and O O
suggest O O
that O O
a O O
substantial O O
burden O O
of O O
pax6 B-Dis O
related I-Dis O
disease I-Dis O
remains O O
to O O
be O O
uncovered O O
. O O
. O O

the O O
patient O O
-lrb- O O
j. O O
b. O O
-rrb- O O
, O O
a O O
17-year-old O O
white O O
male O O
with O O
pws B-Dis B-Dis
, O O
was O O
found O O
to O O
have O O
_num2 O O
chromosomes O O
with O O
a O O
supernumerary O O
, O O
paternal O O
der O O
-lrb- O O
_num2 O O
-rrb- O O
consisting O O
of O O
the O O
short O O
arm O O
and O O
the O O
proximal O O
long O O
arm O O
of O O
chromosome O O
_num2 O O
, O O
and O O
distal O O
chromosome O O
arm O O
3p O O
. O O

friedreich B-Dis B-Dis
ataxia I-Dis I-Dis
is O O
usually O O
caused O O
by O O
an O O
expansion O O
of O O
a O O
_ds O O
trinucleotide O O
repeat O O
in O O
intron O O
_num1 O O
of O O
the O O
frda B-Dis B-Dis
gene O O
. O O

the O O
overlap O O
in O O
clinical O O
features O O
and O O
the O O
presence O O
, O O
in O O
the O O
same O O
genes O O
, O O
of O O
mutations O O
for O O
more O O
than O O
one O O
craniosynostotic B-Dis O
condition I-Dis O
such O O
as O O
saethre-chotzen B-Dis O
, I-Dis O
crouzon I-Dis O
, I-Dis O
and I-Dis O
pfeiffer I-Dis O
syndromes I-Dis O
support O O
the O O
hypothesis O O
that O O
twist O O
and O O
fgfrs O O
are O O
components O O
of O O
the O O
same O O
molecular O O
pathway O O
involved O O
in O O
the O O
modulation O O
of O O
craniofacial O O
and O O
limb O O
development O O
in O O
humans O O
. O O
. O O

we O O
found O O
that O O
the O O
dominant-negative O O
effects O O
result O O
from O O
the O O
enhanced O O
dna O O
binding O O
ability O O
of O O
these O O
mutants O O
. O O

another O O
group O O
of O O
patients O O
with O O
multiple O B-Dis
adenomas B-Dis I-Dis
has O O
no O O
mutations O O
in O O
the O O
apc B-Dis B-Dis
gene O O
, O O
and O O
their O O
phenotype O O
probably O O
results O O
from O O
variation O O
at O O
a O O
locus O O
, O O
or O O
loci O O
, O O
elsewhere O O
in O O
the O O
genome O O
. O O

three O O
of O O
_num2 O O
uninformative O O
patients O O
had O O
constitutional O O
deletions O O
. O O

in O O
a O O
family O O
with O O
three O O
siblings O O
, O O
one O O
developed O O
classical O O
late O O
infantile O O
metachromatic B-Dis B-Dis
leukodystrophy I-Dis I-Dis
-lrb- O O
mld B-Dis B-Dis
-rrb- O O
, O O
fatal O O
at O O
age O O
_num1 O O
years O O
, O O
with O O
deficient O O
arylsulfatase O O
a O O
-lrb- O O
arsa O O
-rrb- O O
activity O O
and O O
increased O O
galactosylsulfatide O O
-lrb- O O
gs O B-Dis
-rrb- O O
excretion O O
. O O

_num2 O O
mg O O
/ O O
ml O O
-rrb- O O
obtained O O
from O O
_num2 O O
healthy O O
volunteers O O
having O O
phenotype O O
hp2 O O
, O O
whereas O O
the O O
serum O O
hp O O
level O O
of O O
an O O
individual O O
with O O
hp1 O O
/ O O
hpdel O O
was O O
_num1 O O
. O O

these O O
results O O
indicate O O
that O O
4003deltc O O
occurs O O
on O O
a O O
single O O
ancestral O O
allele O O
. O O
. O O

to O O
determine O O
the O O
frequency O O
and O O
nature O O
of O O
constitutional O O
rb1-gene O O
mutations O O
in O O
patients O O
with O O
isolated O O
unilateral B-Dis B-Dis
retinoblastoma I-Dis I-Dis
, O O
we O O
analyzed O O
dna O O
from O O
peripheral O O
blood O O
and O O
from O O
tumor B-Dis B-Dis
tissue O O
. O O

a O O
nonsense O O
mutation O O
in O O
exon O O
_num2 O O
-lrb- O O
codon O O
_num3 O O
-rrb- O O
of O O
the O O
rb1 O O
gene O O
was O O
found O O
to O O
be O O
present O O
homozygously O O
in O O
both O O
the O O
retinal B-Dis B-Dis
and I-Dis I-Dis
the I-Dis I-Dis
pineal I-Dis I-Dis
tumours I-Dis I-Dis
. O O

we O O
analyzed O O
genotype O O
/ O O
phenotype O O
correlations O O
, O O
on O O
the O O
basis O O
of O O
the O O
constitution O O
of O O
a O O
wt1 O O
mutation O O
database O O
of O O
_num2 O O
germ-line O O
mutations O O
, O O
to O O
compare O O
the O O
distribution O O
and O O
type O O
of O O
mutations O O
, O O
according O O
to O O
the O O
different O O
symptoms O O
. O O

_num1 O O
. O O

normal O O
hemolytic O O
titers O O
were O O
restored O O
to O O
both O O
homozygous O O
c5-deficient B-Dis B-Dis
-lrb- O O
c5d B-Dis B-Dis
-rrb- O O
sera O O
by O O
addition O O
of O O
highly O O
purified O O
human O O
c5 O O
. O O

a O O
lod O O
score O O
of O O
_num2 O O
between O O
hla-b O O
and O O
factor O O
b O O
allotypes O O
was O O
calculated O O
at O O
a O O
maximum O O
likelihood O O
value O O
of O O
the O O
recombinant O O
fraction O O
of O O
_num1 O O
. O O

liver O O
biopsy O O
is O O
also O O
used O O
to O O
establish O O
the O O
presence O O
or O O
absence O O
of O O
cirrhosis B-Dis B-Dis
, O O
which O O
can O O
affect O O
prognosis O O
and O O
management O O
. O O

moreover O O
, O O
although O O
the O O
scale O O
of O O
the O O
study O O
is O O
limited O O
, O O
there O O
is O O
a O O
possibility O O
that O O
pet O O
can O O
detect O O
an O O
insidious B-Dis O
lesion I-Dis O
which O O
is O O
undetectable O O
by O O
computed O O
tomogram O O
-lrb- O O
_ds O O
-rrb- O O
or O O
mri O O
analysis O O
, O O
and O O
that O O
the O O
higher O O
level O O
of O O
tau O O
reflects O O
the O O
process O O
of O O
neuronal B-Dis B-Dis
degeneration I-Dis I-Dis
in O O
ald B-Dis B-Dis
. O O

however O O
, O O
these O O
observations O O
would O O
need O O
to O O
be O O
confirmed O O
by O O
studying O O
a O O
larger O O
number O O
of O O
cd B-Dis O
families O O
. O O

where O O
the O O
transmitting O O
parent O O
was O O
male O O
, O O
_num2 O O
. O O

we O O
performed O O
mutation O O
analysis O O
of O O
the O O
pds O B-Dis
gene O O
in O O
patients O O
from O O
_num2 O O
pendred B-Dis B-Dis
families O O
originating O O
from O O
seven O O
countries O O
and O O
identified O O
all O O
mutations O O
. O O

_num1 O O
; O O
p O O
= O O
. O O

the O O
mutation O O
was O O
confirmed O O
by O O
restriction O O
endonuclease O O
analysis O O
. O O

genotype-phenotype O O
correlations O O
identified O O
significant O O
differences O O
in O O
the O O
nature O O
of O O
certain O O
extracolonic O O
manifestations O O
in O O
fap B-Dis B-Dis
patients O O
belonging O O
to O O
three O O
mutation O O
subgroups O O
. O O

based O O
on O O
its O O
chromosomal O O
position O O
, O O
this O O
gene O O
is O O
a O O
candidate O O
for O O
conferring O O
susceptibility O O
to O O
diabetes B-Dis B-Dis
. O O

of O O
clinical O O
interest O O
are O O
-lrb- O O
a O O
-rrb- O O
the O O
documentation O O
of O O
membranous O B-Dis
glomerulonephritis B-Dis I-Dis
, O O
vasculitis B-Dis B-Dis
, O O
and O O
arthritis B-Dis B-Dis
in O O
an O O
individual O O
lacking O O
c5 O O
-lrb- O O
and O O
its O O
biologic O O
functions O O
-rrb- O O
, O O
and O O
-lrb- O O
b O O
-rrb- O O
a O O
remarkable O O
propensity O O
to O O
bacterial B-Dis B-Dis
infections I-Dis I-Dis
in O O
the O O
proband O O
, O O
even O O
during O O
periods O O
of O O
low-dose O O
or O O
alternate-day O O
corticosteroid O O
therapy O O
. O O

oleic O O
and O O
erucic O O
acids O O
-lrb- O O
lorenzos O O
oil O O
-rrb- O O
were O O
administered O O
to O O
patients O O
_num1 O O
and O O
_num1 O O
, O O
but O O
sufficient O O
effectiveness O O
was O O
not O O
obtained O O
. O O

only O O
_num2 O O
mutations O O
of O O
the O O
gene O O
have O O
been O O
reported O O
in O O
hcp B-Dis O
patients O O
. O O

attempts O O
to O O
mathematically O O
model O O
the O O
dynamics O O
have O O
proved O O
only O O
partially O O
successful O O
suggesting O O
that O O
individual O O
specific O O
genetic O O
and O O
/ O O
or O O
environmental O O
factors O O
also O O
play O O
a O O
role O O
in O O
somatic O O
mosaicism O O
. O O
. O O

comparisons O O
with O O
allele O O
frequencies O O
based O O
on O O
prevalence O O
estimates O O
of O O
hh B-Dis B-Dis
showed O O
some O O
disagreements O O
with O O
the O O
rflp O O
data O O
, O O
particularly O O
in O O
finns O O
. O O

quantitative O O
analysis O O
showed O O
that O O
the O O
expression O O
of O O
cyp27 O O
gene O O
mrna O O
in O O
the O O
patient O O
represented O O
_num2 O O
. O O

we O O
found O O
two O O
common O O
mutations O O
that O O
together O O
accounted O O
for O O
_num2 O O
% O O
of O O
the O O
_num2 O O
unrelated O O
alleles O O
in O O
these O O
patients O O
. O O

recent O O
studies O O
demonstrated O O
the O O
existence O O
of O O
a O O
genetically O O
distinct O O
, O O
usually O O
lethal O O
form O O
of O O
the O O
schwartz-jampel B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
sjs B-Dis B-Dis
-rrb- O O
of O O
myotonia B-Dis B-Dis
and O I-Dis
skeletal B-Dis I-Dis
dysplasia I-Dis I-Dis
, O O
which O O
we O O
called O O
sjs B-Dis O
type I-Dis O
_num1 I-Dis O
. O O

the O O
encoded O O
protein O O
has O O
a O O
unique O O
organization O O
of O O
egf O O
and O O
ldlr O O
repeats O O
; O O
therefore O O
, O O
lrp5 O O
likely O O
represents O O
a O O
new O O
category O O
of O O
the O O
ldlr O O
family O O
. O O

the O O
mutant O O
mice O O
exhibited O O
defects O O
in O O
hemostasis O O
with O O
a O O
highly O O
prolonged O O
bleeding O O
time O O
and O O
spontaneous O O
bleeding O O
events O O
in O O
approximately O O
_num2 O O
% O O
of O O
neonates O O
. O O

these O O
observations O O
point O O
to O O
another O O
region O O
of O O
the O O
rb1 O O
gene O O
where O O
mutations O O
only O O
modify O O
the O O
function O O
of O O
the O O
gene O O
and O O
raise O O
important O O
questions O O
for O O
genetic O O
counseling O O
in O O
families O O
with O O
these O O
distinctive O O
phenotypes O O
. O O
. O O

these O O
results O O
would O O
not O O
be O O
expected O O
if O O
immunostaining O O
at O O
intercalated O O
discs O O
were O O
due O O
to O O
a O O
product O O
of O O
the O O
emerin O O
gene O O
and O O
, O O
therefore O O
, O O
cast O O
some O O
doubt O O
upon O O
the O O
hypothesis O O
that O O
cardiac B-Dis B-Dis
defects I-Dis I-Dis
in O O
edmd B-Dis B-Dis
are O O
caused O O
by O O
absence O O
of O O
emerin O O
from O O
intercalated O O
discs O O
. O O

however O O
, O O
direct O O
visualization O O
and O O
quantitation O O
of O O
hex O O
a O O
by O O
the O O
methods O O
described O O
may O O
prevent O O
false-positive O O
prenatal O O
diagnosis O O
of O O
tsd B-Dis B-Dis
in O O
fetuses O O
having O O
the O O
incomplete O O
hex B-Dis O
a I-Dis O
deficiency I-Dis B-Dis
of O I-Dis
the O I-Dis
type O O
described O O
in O O
the O O
four O O
healthy O O
individuals O O
a O O
mouse O O
model O O
for O O
prader-willi B-Dis B-Dis
syndrome I-Dis I-Dis
imprinting-centre O O
mutations O O
. O O

meningococcal B-Dis B-Dis
disease I-Dis I-Dis
is O O
endemic O O
in O O
the O O
cape O O
and O O
almost O O
all O O
pedigrees O B-Dis
of O I-Dis
total O I-Dis
c6 B-Dis I-Dis
deficiency I-Dis I-Dis
-lrb- O O
c6q0 O O
-rrb- O O
have O O
been O O
ascertained O O
because O O
of O O
recurrent O O
disease O O
. O O

i1307k O O
apc O O
and O O
hmlh1 O O
mutations O O
in O O
a O O
non-jewish O O
family O O
with O O
hereditary B-Dis B-Dis
non-polyposis I-Dis I-Dis
colorectal I-Dis I-Dis
cancer I-Dis I-Dis
. O O

in O O
sca1 B-Dis O
, O O
saccade O O
amplitude O O
was O O
significantly O O
increased O O
, O O
resulting O O
in O O
hypermetria B-Dis O
. O O

here O O
, O O
we O O
show O O
that O O
wt1 O O
- O O
kts O O
isoforms O O
associate O O
and O O
synergize O O
with O O
sf-1 O O
to O O
promote O O
mis O O
expression O O
. O O

hfe O O
binds O O
to O O
transferrin O O
receptor O O
-lrb- O O
tfr O O
-rrb- O O
and O O
reduces O O
its O O
affinity O O
for O O
iron-loaded O O
transferrin O O
, O O
implicating O O
hfe O O
in O O
iron O O
metabolism O O
. O O

all O O
exon O O
/ O O
intron O O
boundaries O O
conform O O
to O O
the O O
gt O O
/ O O
ag O O
rule O O
. O O

the O O
skewed O O
prevalence O O
of O O
g301c O O
in O O
only O O
colombian O O
patients O O
and O O
haplotype O O
analysis O O
by O O
restriction O O
fragment O O
length O O
polymorphisms O O
in O O
the O O
galns O O
gene O O
suggest O O
that O O
g301c O O
originated O O
from O O
a O O
common O O
ancestor O O
. O O

this O O
acceptor O O
splice-site O O
mutation O O
led O O
to O O
the O O
formation O O
of O O
aberrant O O
transcripts O O
present O O
at O O
extremely O O
low O O
levels O O
. O O

schwartz-jampel B-Dis B-Dis
syndrome I-Dis I-Dis
type I-Dis O
_num1 I-Dis O
and O O
stuve-wiedemann B-Dis B-Dis
syndrome I-Dis I-Dis
: O O
a O O
case O O
for O O
`` O O
lumping O O
'' O O
. O O

ataxia-telangiectasia B-Dis B-Dis
: O O
identification O O
and O O
detection O O
of O O
founder-effect O O
mutations O O
in O O
the O O
atm O O
gene O O
in O O
ethnic O O
populations O O
. O O

the O O
pathological O O
significance O O
of O O
the O O
point O O
mutations O O
g197w O O
, O O
w427r O O
, O O
and O O
the O O
in-frame O O
deletion O O
390delgly O O
were O O
assessed O O
by O O
their O O
respective O O
expression O O
in O O
a O O
prokaryotic O O
system O O
using O O
site-directed O O
mutagenesis O O
. O O

previous O O
findings O O
in O O
caucasian O O
populations O O
of O O
a O O
dm B-Dis B-Dis
founder O O
chromosome O O
raise O O
a O O
question O O
about O O
the O O
molecular O O
events O O
involved O O
in O O
the O O
expansion O O
mutation O O
. O O

pulse-chase O O
analysis O O
using O O
proband O O
fibroblasts O O
revealed O O
that O O
the O O
w474c-containing O O
alpha-subunit O O
precursor O O
was O O
normally O O
synthesized O O
, O O
but O O
not O O
phosphorylated O O
or O O
secreted O O
, O O
and O O
the O O
mature O O
lysosomal O O
alpha-subunit O O
was O O
not O O
detected O O
. O O

the O O
findings O O
in O O
this O O
family O O
suggest O O
that O O
delgag291 O O
is O O
part O O
of O O
the O O
cause O O
of O O
japanese O O
ald B-Dis B-Dis
with O O
phenotypic O O
variations O O
. O O

these O O
results O O
establish O O
a O O
molecular O O
link O O
between O O
hfe O O
and O O
a O O
key O O
protein O O
involved O O
in O O
iron O O
transport O O
, O O
the O O
tfr O O
, O O
and O O
raise O O
the O O
possibility O O
that O O
alterations O O
in O O
this O O
regulatory O O
mechanism O O
may O O
play O O
a O O
role O O
in O O
the O O
pathogenesis O O
of O O
hereditary B-Dis B-Dis
hemochromatosis I-Dis I-Dis
. O O
. O O

we O O
speculate O O
that O O
this O O
insertion O O
of O O
an O O
l1 O O
sequence O O
in O O
dmd O B-Dis
is O O
responsible O O
for O O
some O O
of O O
the O O
population O O
of O O
japanese O O
patients O O
with O O
xldcm B-Dis O
. O O
. O O

a O O
gene O O
encoding O O
a O O
transmembrane O O
protein O O
is O O
mutated O O
in O O
patients O O
with O O
diabetes B-Dis B-Dis
mellitus I-Dis I-Dis
and O O
optic B-Dis B-Dis
atrophy I-Dis I-Dis
-lrb- O O
wolfram B-Dis B-Dis
syndrome I-Dis I-Dis
-rrb- O O
. O O

germline O O
pten O O
mutations O O
were O O
identified O O
in O O
four O O
of O O
seven O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
bzs B-Dis O
families O O
studied O O
. O O

the O O
i1307k O O
polymorphism O O
has O O
previously O O
only O O
been O O
identified O O
in O O
individuals O O
of O O
self-reported O O
ashkenazi O O
jewish O O
origins O O
. O O

although O O
the O O
link O O
between O O
the O O
brca1 O O
tumour B-Dis B-Dis
suppressor O O
gene O O
and O O
hereditary B-Dis B-Dis
breast I-Dis I-Dis
and I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
is O O
established O O
, O O
the O O
role O O
, O O
if O O
any O O
, O O
of O O
brca1 O O
in O O
non-familial B-Dis O
cancers I-Dis B-Dis
is O O
unclear O O
. O O

_num2 O O
x O O
_num2 O O
-lrb- O O
-3 O O
-rrb- O O
; O O
sibpal O O
pempirical O O
value O O
< O O
_num1 O O
x O O
_num2 O O
-lrb- O O
-3 O O
-rrb- O O
-rrb- O O
that O O
are O O
linked O O
to O O
mental O O
health O O
wellness O O
. O O

four O O
of O O
moroccan O O
origin O O
-lrb- O O
_num1 O O
. O O

secondly O O
, O O
there O O
appeared O O
to O O
be O O
an O O
interdependent O O
association O O
between O O
mutations O O
upstream O O
and O O
within O O
the O O
ptpase O O
core O O
motif O O
, O O
the O O
core O O
motif O O
containing O O
the O O
majority O O
of O O
missense O O
mutations O O
, O O
and O O
the O O
involvement O O
of O O
all O O
major O O
organ O O
systems O O
-lrb- O O
central O O
nervous O O
system O O
, O O
thyroid O O
, O O
breast O O
, O O
skin O O
and O O
gastrointestinal O O
tract O O
-rrb- O O
. O O

_num1 O O
kb O O
and O O
a O O
3-untranslated O O
region O O
-lrb- O O
utr O O
-rrb- O O
of O O
< O O
_num2 O O
bp O O
, O O
whereas O O
northern O O
analysis O O
has O O
indicated O O
mrna O O
sizes O O
of O O
5-8 O O
kb O O
. O O

we O O
report O O
here O O
the O O
complete O O
genomic O O
organization O O
of O O
the O O
human O O
cld B-Dis O
gene O O
which O O
spans O O
approximately O O
39kb O O
, O O
and O O
comprises O O
_num2 O O
exons O O
. O O

the O O
cyclin-dependent O O
kinase O O
inhibitor O O
, O O
_an O O
, O O
accumulates O O
upon O O
serum O O
withdrawal O O
, O O
only O O
in O O
the O O
presence O O
of O O
vhl B-Dis B-Dis
, O O
as O O
a O O
result O O
of O O
the O O
stabilization O O
of O O
the O O
protein O O
. O O

autosomal B-Dis B-Dis
recessive I-Dis I-Dis
alport I-Dis I-Dis
syndrome I-Dis I-Dis
is O O
a O O
progressive O O
hematuric B-Dis B-Dis
glomerulonephritis I-Dis I-Dis
characterized O O
by O O
glomerular B-Dis O
basement I-Dis B-Dis
membrane I-Dis I-Dis
abnormalities I-Dis I-Dis
and O O
associated O O
with O O
mutations O O
in O O
either O O
the O O
col4a3 O O
or O O
the O O
col4a4 O O
gene O O
, O O
which O O
encode O O
the O O
alpha3 O O
and O O
alpha4 O O
type O O
iv O O
collagen O O
chains O O
, O O
respectively O O
. O O

two O O
of O O
the O O
children O O
exhibited O O
a O O
homozygous O O
deficiency O O
characterized O O
by O O
the O O
absence O O
of O O
the O O
150-kd O O
form O O
of O O
factor O O
h O O
and O O
the O O
presence O O
, O O
upon O O
immunoblotting O O
, O O
of O O
the O O
42-kd O O
factor O O
h-like O O
protein O O
_num1 O O
-lrb- O O
fhl-1 O O
-rrb- O O
and O O
other O O
fh-related O O
protein O O
-lrb- O O
fhr O O
-rrb- O O
bands O O
. O O

a O O
transcribed O O
sequence O O
identified O O
from O O
the O O
c04107-containing O O
bac O O
was O O
found O O
to O O
be O O
homologous O O
to O O
a O O
gene O O
expressed O O
from O O
human O O
chromosome O O
2p13-p16 O O
, O O
a O O
region O O
devoid O O
of O O
any O O
positional O O
candidate O O
genes O O
. O O

a O O
second O O
mutation O O
that O O
has O O
no O O
effect O O
on O O
beta2m O O
association O O
, O O
h63d O O
, O O
was O O
found O O
in O O
eight O O
out O O
of O O
nine O O
patients O O
heterozygous O O
for O O
the O O
c282y O O
mutant O O
. O O

_num1 O O
% O O
-6 O O
. O O

diagnosis O O
of O O
hemochromatosis B-Dis B-Dis
. O O

another O O
nephew O O
-lrb- O O
patient O O
_num1 O O
-rrb- O O
of O O
patient O O
_num1 O O
was O O
classified O O
as O O
having O O
an O O
adolescent O O
form O O
. O O

abnormal O O
hepatic B-Dis B-Dis
copper I-Dis I-Dis
accumulation I-Dis I-Dis
is O O
recognized O O
as O O
an O O
inherited B-Dis B-Dis
disorder I-Dis I-Dis
in O O
man O O
, O O
mouse O O
, O O
rat O O
and O O
dog O O
. O O

mice O O
harbouring O O
an O O
intragenic O O
deletion O O
in O O
snrpn O O
are O O
phenotypically O O
normal O O
, O O
suggesting O O
that O O
mutations O O
of O O
snrpn O O
are O O
not O O
sufficient O O
to O O
induce O O
pws B-Dis B-Dis
. O O

hereditary B-Dis B-Dis
coproporphyria I-Dis I-Dis
-lrb- O O
hc B-Dis B-Dis
-rrb- O O
is O O
an O O
acute O B-Dis
hepatic B-Dis I-Dis
porphyria I-Dis I-Dis
with O O
autosomal O O
dominant O O
inheritance O O
caused O O
by O O
deficient B-Dis O
activity I-Dis O
of I-Dis O
coproporphyrinogen I-Dis O
iii I-Dis O
oxidase I-Dis O
-lrb- O O
cpo O O
-rrb- O O
. O O

conclusion O O
susceptibility O O
to O O
as B-Dis B-Dis
is O O
largely O O
genetically O O
determined O O
, O O
and O O
the O O
environmental O O
trigger O O
for O O
the O O
disease O O
is O O
probably O O
ubiquitous O O
. O O

results O O
in O O
persons O O
at O O
average O O
risk O O
for O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
, O O
i1307k O O
was O O
found O O
in O O
_num1 O O
. O O

severe O O
early-onset O O
obesity B-Dis B-Dis
, O O
adrenal B-Dis B-Dis
insufficiency I-Dis I-Dis
and O O
red O O
hair O O
pigmentation O O
caused O O
by O O
pomc O O
mutations O O
in O O
humans O O
. O O

clinical O O
recognition O O
of O O
vlcad B-Dis B-Dis
deficiency I-Dis I-Dis
is O O
important O O
because O O
it O O
is O O
one O O
of O O
the O O
few O O
directly O O
treatable O O
causes O O
of O O
cardiomyopathy B-Dis B-Dis
in O O
children O O
. O O
. O O

the O O
4612del165 O O
mutations O O
in O O
three O O
different O O
families O O
were O O
all O O
ascribed O O
to O O
the O O
same O O
t O O
-- O O
> O O
a O O
substitution O O
at O O
the O O
splice O O
donor O O
site O O
in O O
intron O O
_num2 O O
. O O

previous O O
studies O O
have O O
suggested O O
that O O
the O O
highly O O
variable O O
metabolic O O
phenotypes O O
of O O
pah B-Dis B-Dis
deficiency I-Dis I-Dis
correlate O O
with O O
pah O O
genotypes O O
. O O

we O O
propose O O
that O O
wt1 O O
and O O
dax-1 O O
functionally O O
oppose O O
each O O
other O O
in O O
testis O O
development O O
by O O
modulating O O
sf-1-mediated O O
transactivation O O
. O O
. O O

the O O
relatively O O
high O O
residual O O
galns O O
activity O O
seen O O
when O O
the O O
t312s O O
mutant O O
cdna O O
is O O
overexpressed O O
in O O
mutant O O
cells O O
provides O O
an O O
explanation O O
for O O
the O O
mild O O
phenotype O O
in O O
patients O O
with O O
this O O
mutation O O
. O O

an O O
affected O O
girl O O
who O O
presented O O
at O O
_num1 O O
months O O
of O O
age O O
and O O
her O O
similarly O O
affected O O
younger O O
brother O O
and O O
father O O
were O O
all O O
found O O
to O O
have O O
a O O
novel O O
missense O O
mutation O O
-lrb- O O
_an O O
-- O O
> O O
t O O
-rrb- O O
encoding O O
the O O
amino O O
acid O O
substitution O O
gly23 O O
-- O O
> O O
val O O
within O O
npii O O
. O O

results O O
showed O O
that O O
the O O
_num3 O O
g O O
-- O O
> O O
a O O
mutation O O
was O O
present O O
in O O
these O O
populations O O
-lrb- O O
allele O O
frequency O O
_num1 O O
. O O

mutation O O
spectrum O O
and O O
genotype-phenotype O O
analyses O O
in O O
cowden B-Dis B-Dis
disease I-Dis I-Dis
and O O
bannayan-zonana B-Dis B-Dis
syndrome I-Dis I-Dis
, O O
two O O
hamartoma B-Dis O
syndromes I-Dis O
with O O
germline O O
pten O O
mutation O O
. O O

_num2 O O
. O O

neither O O
vwf O O
nor O O
vwf O O
propolypeptide O O
-lrb- O O
von B-Dis B-Dis
willebrand I-Dis I-Dis
antigen O O
ii O O
-rrb- O O
were O O
detectable O O
in O O
plasma O O
, O O
platelets O O
, O O
or O O
endothelial O O
cells O O
of O O
the O O
homozygous O O
mutant O O
mice O O
. O O

the O O
arsa O O
enzyme O O
activity O O
in O O
subjects O O
with O O
and O O
without O O
the O O
r496h O O
mutation O O
was O O
determined O O
and O O
found O O
to O O
be O O
normal O O
. O O

_num3 O O
c O O
-- O O
> O O
g O O
was O O
present O O
at O O
an O O
allele O O
frequency O O
of O O
_num1 O O
. O O

the O O
presence O O
of O O
a O O
founder O O
mutation O O
among O O
relatively O O
small O O
ethnic O O
population O O
groups O O
in O O
western O O
europe O O
could O O
indicate O O
a O O
high O O
carrier O O
frequency O O
in O O
such O O
communities O O
. O O

the O O
c-t O O
mutation O O
is O O
located O O
within O O
a O O
recently O O
proposed O O
putative O O
alternative O O
translation O O
initiation O O
codon O O
-lrb- O O
tic-1 O O
-rrb- O O
, O O
supporting O O
that O O
tic-1 O O
is O O
the O O
real O O
tic O O
rather O O
than O O
tic-2 O O
. O O
. O O

the O O
other O O
four O O
children O O
presented O O
with O O
heterozygous O O
deficiency O B-Dis
and O O
exhibited O O
a O O
normal O O
immunoblotting O O
pattern O O
of O O
proteins O O
of O O
the O O
fh O O
family O O
. O O

the O O
first O O
, O O
1195delc O O
located O O
in O O
exon O O
_num1 O O
, O O
is O O
a O O
novel O O
mutation O O
, O O
while O O
the O O
second O O
, O O
1936delg O O
in O O
exon O O
_num2 O O
, O O
has O O
been O O
described O O
before O O
to O O
cause O O
c6d B-Dis O
in O O
an O O
unrelated O O
african-american O O
individual O O
. O O

the O O
highest O O
allele O O
frequency O O
-lrb- O O
_num1 O O
. O O

on O O
the O O
basis O O
of O O
the O O
phenotypic O O
characteristics O O
of O O
_num3 O O
functionally O O
hemizygous O O
patients O O
, O O
_num3 O O
of O O
the O O
mutations O O
were O O
assigned O O
to O O
one O O
of O O
four O O
arbitrary O O
phenotype O O
categories O O
. O O

congenital B-Dis B-Dis
chloride I-Dis I-Dis
diarrhea I-Dis I-Dis
-lrb- O O
cld B-Dis B-Dis
-rrb- O O
is O O
caused O O
by O O
mutations O O
in O O
a O O
gene O O
which O O
encodes O O
an O O
intestinal O O
anion O O
transporter O O
. O O

like O O
brca1 O O
and O O
rad51 O O
, O O
brca2 O O
relocates O O
to O O
pcna O O
+ O O
replication O O
sites O O
following O O
exposure O O
of O O
s O O
phase O O
cells O O
to O O
hydroxyurea O O
or O O
uv O O
irradiation O O
. O O

_num1 O O
-rrb- O O
. O O

to O O
evaluate O O
the O O
role O O
of O O
i1307k O O
in O O
cancer B-Dis O
, O O
we O O
genotyped O O
_num1 O O
, O O
_num3 O O
ashkenazi O O
volunteers O O
in O O
a O O
community O O
survey O O
. O O

the O O
apc O B-Dis
i1307k O O
allele O O
was O O
identified O O
in O O
_num2 O O
-lrb- O O
_num2 O O
. O O

the O O
distribution O O
and O O
relative O O
frequencies O O
of O O
the O O
i113f O O
and O O
t312s O O
mutations O O
in O O
australia O O
corresponded O O
to O O
those O O
observed O O
in O O
northern O O
ireland O O
and O O
are O O
unique O O
to O O
these O O
two O O
populations O O
, O O
suggesting O O
that O O
both O O
mutations O O
were O O
probably O O
introduced O O
to O O
australia O O
by O O
irish O O
migrants O O
during O O
the O O
19th O O
century O O
. O O

mutations O O
were O O
found O O
in O O
_num2 O O
of O O
_num2 O O
families O O
. O O

_num1 O O
% O O
of O O
_num3 O O
non-european O O
jews O O
-lrb- O O
p O O
= O O
_num1 O O
. O O

a O O
japanese O O
family O O
with O O
adrenoleukodystrophy B-Dis B-Dis
with O O
a O O
codon O O
_num3 O O
deletion O O
: O O
a O O
clinical O O
, O O
biochemical O O
, O O
pathological O O
, O O
and O O
genetic O O
report O O
. O O

patients O O
with O O
generalized O O
atrophic B-Dis B-Dis
benign I-Dis I-Dis
epidermolysis I-Dis I-Dis
bullosa I-Dis I-Dis
, O O
a O O
usually O O
nonlethal O O
form O O
of O O
junctional B-Dis O
epidermolysis I-Dis O
bullosa I-Dis O
, O O
have O O
generalized O O
blistering B-Dis O
, O O
nail B-Dis B-Dis
dystrophy I-Dis I-Dis
, O O
patchy B-Dis O
alopecia I-Dis O
, O O
and O O
dental B-Dis B-Dis
abnormalities I-Dis I-Dis
. O O

this O O
disorder O O
is O O
reminiscent O O
of O O
another O O
rare O O
condition O O
, O O
the O O
stuve-wiedemann B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
sws B-Dis O
-rrb- O O
, O O
which O O
comprises O O
campomelia B-Dis O
at O O
birth O O
with O O
skeletal B-Dis B-Dis
dysplasia I-Dis I-Dis
, O O
contractures B-Dis B-Dis
, O O
and O O
early B-Dis O
death I-Dis O
. O O

the O O
mutation O O
changed O O
the O O
adrenodoxin O O
cofactor O O
binding O O
residue O O
362arg O O
to O O
362ser O O
-lrb- O O
_ds O O
362arg O O
to O O
_ds O O
362ser O O
-rrb- O O
, O O
and O O
was O O
responsible O O
for O O
deficiency B-Dis B-Dis
in I-Dis O
the I-Dis O
sterol I-Dis O
27-hydroxylase I-Dis O
activity I-Dis O
, O O
as O O
confirmed O O
by O O
expression O O
of O O
mutant O O
cdna O O
into O O
cos-1 O O
cells O O
. O O

the O O
other O O
allele O O
-lrb- O O
hp2 O O
-rrb- O O
of O O
individuals O O
with O O
hp2 O O
/ O O
hpdel O O
was O O
found O O
to O O
have O O
, O O
in O O
all O O
exons O O
, O O
no O O
mutation O O
, O O
by O O
dna O O
sequencing O O
. O O

thirty-nine O O
of O O
the O O
mutations-including O O
_num2 O O
small O O
mutations O O
, O O
_num1 O O
large O O
structural O O
alterations O O
, O O
and O O
hypermethylation O O
in O O
_num1 O O
tumors-were O O
not O O
detected O O
in O O
the O O
corresponding O O
peripheral O O
blood O O
dna O O
. O O

among O O
those O O
families O O
with O O
disease O O
due O O
to O O
brca1 O O
that O O
were O O
tested O O
by O O
one O O
of O O
the O O
standard O O
screening O O
methods O O
, O O
mutations O O
were O O
detected O O
in O O
the O O
coding O O
sequence O O
or O O
splice O O
sites O O
in O O
an O O
estimated O O
_num2 O O
% O O
-lrb- O O
_num2 O O
% O O
ci O O
_num2 O O
% O O
-77 O O
% O O
-rrb- O O
. O O

three O O
patients O O
with O O
the O O
i1307k O O
allele O O
were O O
detected O O
, O O
each O O
of O O
ashkenazi O O
descent O O
. O O

a O O
mouse O O
model O O
of O O
severe O O
von B-Dis B-Dis
willebrand I-Dis I-Dis
disease I-Dis I-Dis
: O O
defects O O
in O O
hemostasis O B-Dis
and O I-Dis
thrombosis B-Dis I-Dis
. O O

we O O
conclude O O
that O O
these O O
mice O O
very O O
closely O O
mimic O O
severe O O
human O O
von B-Dis B-Dis
willebrand I-Dis I-Dis
disease I-Dis I-Dis
and O O
will O O
be O O
very O O
useful O O
for O O
investigating O O
the O O
role O O
of O O
vwf O O
in O O
normal O O
physiology O O
and O O
in O O
disease O O
models O O
. O O
. O O

significant O O
intra O O
- O O
and O O
interfamilial O O
phenotypic O O
variability O O
is O O
present O O
for O O
either O O
twist O O
mutations O O
or O O
fgfr O O
mutations O O
. O O

molecular O O
study O O
and O O
neuropsychological O O
analysis O O
were O O
performed O O
concurrently O O
on O O
_num2 O O
patients O O
with O O
duchenne B-Dis B-Dis
muscular I-Dis I-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dmd B-Dis B-Dis
-rrb- O O
in O O
order O O
to O O
find O O
a O O
molecular O O
explanation O O
for O O
the O O
cognitive B-Dis O
impairment I-Dis O
observed O O
in O O
most O O
dmd B-Dis B-Dis
patients O O
. O O

three O O
major O O
criteria O O
, O O
saccade O O
amplitude O O
, O O
saccade O O
velocity O O
, O O
and O O
presence O O
of O O
gaze-evoked B-Dis O
nystagmus I-Dis O
, O O
permitted O O
the O O
correct O O
assignment O O
of O O
_num2 O O
% O O
of O O
the O O
sca1 B-Dis O
, O O
_num2 O O
% O O
of O O
the O O
sca2 B-Dis O
, O O
and O O
_num2 O O
% O O
of O O
the O O
patients O O
with O O
sca3 B-Dis O
to O O
their O O
genetically O O
confirmed O O
patient O O
group O O
and O O
, O O
therefore O O
, O O
may O O
help O O
orient O O
diagnoses O O
of O O
sca1 B-Dis O
, O O
sca2 B-Dis O
, O O
and O O
sca3 B-Dis O
at O O
early O O
clinical O O
stages O O
of O O
the O O
diseases O O
. O O
. O O

the O O
rb1 O O
gene O O
mutation O O
in O O
a O O
child O O
with O O
ectopic B-Dis O
intracranial I-Dis O
retinoblastoma I-Dis B-Dis
. O O

one O O
male O O
and O O
two O O
female O O
idms B-Dis O
patients O O
with O O
wt1 O O
mutations O O
underwent O O
normal O O
puberty O O
. O O

our O O
data O O
indicate O O
that O O
the O O
pah-mutation O O
genotype O O
is O O
the O O
main O O
determinant O O
of O O
metabolic O O
phenotype O O
in O O
most O O
patients O O
with O O
pah B-Dis B-Dis
deficiency I-Dis I-Dis
. O O

we O O
have O O
sequenced O O
the O O
expressed O O
exons O O
of O O
the O O
c6 O O
gene O O
from O O
selected O O
cases O O
and O O
have O O
found O O
three O O
molecular O B-Dis
defects O I-Dis
leading O O
to O O
total O B-Dis
deficiency O I-Dis
879delg O O
, O O
which O O
is O O
the O O
common O O
defect O O
in O O
the O O
cape O O
and O O
hitherto O O
unreported O O
, O O
and O O
1195delc O O
and O O
1936delg O O
, O O
which O O
have O O
been O O
previously O O
reported O O
in O O
african-americans O O
. O O

in O O
sca2 B-Dis O
, O O
saccade O O
velocity O O
was O O
markedly O O
decreased O O
. O O

a O O
wide O O
variety O O
of O O
atm O O
mutation O O
types O O
, O O
including O O
missense O O
mutations O O
and O O
in-frame O O
deletions O O
, O O
were O O
seen O O
in O O
these O O
patients O O
. O O

however O O
, O O
some O O
of O O
these O O
patients O O
can O O
transmit O O
retinoblastoma B-Dis B-Dis
predisposition O O
to O O
their O O
offspring O O
. O O

_num1 O O
-rrb- O O
. O O

the O O
von B-Dis B-Dis
hippel-lindau I-Dis I-Dis
tumor I-Dis I-Dis
suppressor O O
gene O O
is O O
required O O
for O O
cell O O
cycle O O
exit O O
upon O O
serum O O
withdrawal O O
. O O

three O O
other O O
splice O O
variants O O
, O O
including O O
one O O
derived O O
from O O
the O O
skipping O O
of O O
exon O O
_num2 O O
, O O
were O O
also O O
identified O O
. O O

exon-specific O O
primers O O
developed O O
in O O
this O O
study O O
will O O
facilitate O O
mutation O O
screening O O
studies O O
of O O
patients O O
with O O
the O O
disease O O
. O O

conclusions O O
oral-contraceptive O O
use O O
may O O
reduce O O
the O O
risk O O
of O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
in O O
women O O
with O O
pathogenic O O
mutations O O
in O O
the O O
brca1 O O
or O O
brca2 O O
gene O O
founder O O
brca1 O O
and O O
brca2 O O
mutations O O
in O O
french O O
canadian O B-Dis
breast B-Dis I-Dis
and I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
families O O
. O O

a O O
number O O
of O O
arsa O O
gene O O
mutations O O
responsible O O
for O O
mld B-Dis B-Dis
have O O
been O O
identified O O
. O O

in O O
this O O
study O O
, O O
we O O
analyzed O O
two O O
families O O
with O O
fndi B-Dis B-Dis
using O O
direct O O
automated O O
fluorescent O O
, O O
solid O O
phase O O
, O O
single-stranded O O
dna O O
sequencing O O
of O O
pcr-amplified O O
avp-npii O O
dna O O
. O O

these O O
results O O
indicate O O
that O O
smad4 O O
is O O
initially O O
required O O
for O O
the O O
differentiation O O
of O O
the O O
visceral O O
endoderm O O
and O O
that O O
the O O
gastrulation B-Dis O
defect I-Dis O
in O O
the O O
epiblast O O
is O O
secondary O O
and O O
non-cell O O
autonomous O O
. O O

the O O
trinucleotide O O
repeat O O
instability O O
mechanisms O O
involved O O
in O O
dm B-Dis B-Dis
and O O
other O O
human O O
genetic B-Dis B-Dis
diseases I-Dis I-Dis
are O O
unknown O O
. O O

three O O
families O O
shared O O
microsatellite O O
polymorphisms O O
covering O O
at O O
most O O
_num2 O O
cm O O
, O O
whereas O O
the O O
others O O
shared O O
smaller O O
regions O O
consistent O O
with O O
cross-over O O
events O O
during O O
passage O O
of O O
this O O
mutation O O
through O O
several O O
generations O O
. O O

_num2 O O
% O O
-rrb- O O
, O O
and O O
, O O
furthermore O O
, O O
it O O
was O O
always O O
seen O O
in O O
conjunction O O
with O O
hla O O
haplotypes O O
common O O
in O O
caucasians O O
, O O
suggesting O O
that O O
_num3 O O
g O O
-- O O
> O O
a O O
may O O
have O O
been O O
introduced O O
into O O
these O O
populations O O
by O O
caucasian O O
admixture O O
. O O

hemochromatosis B-Dis B-Dis
, O O
the O O
inherited B-Dis B-Dis
disorder I-Dis I-Dis
of I-Dis O
iron I-Dis O
metabolism I-Dis O
, O O
leads O O
, O O
if O O
untreated O O
, O O
to O O
progressive O O
iron B-Dis O
overload I-Dis O
and O O
premature B-Dis O
death I-Dis O
. O O

in O O
addition O O
, O O
we O O
have O O
studied O O
_num2 O O
a-t B-Dis B-Dis
patients O O
, O O
in O O
_num2 O O
families O O
, O O
who O O
developed O O
leukemia B-Dis B-Dis
, O O
lymphoma B-Dis B-Dis
, O O
preleukemic O O
t-cell O O
proliferation O O
, O O
or O O
hodgkin B-Dis B-Dis
lymphoma I-Dis I-Dis
, O O
mostly O O
in O O
childhood O O
. O O

_num2 O O
mg O O
/ O O
ml O O
; O O
n O O
= O O
_num1 O O
-rrb- O O
, O O
showing O O
a O O
gene-dosage O O
effect O O
. O O

mutations O O
in O O
the O O
atp7b O O
genes O O
have O O
also O O
been O O
demonstrated O O
in O O
mouse O O
and O O
rat O O
. O O

mutation O O
analysis O O
of O O
ube3a O O
in O O
angelman B-Dis B-Dis
syndrome I-Dis I-Dis
patients O O
. O O

oral-contraceptive O O
use O O
protected O O
against O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
both O O
for O O
carriers O O
of O O
the O O
brca1 O O
mutation O O
-lrb- O O
odds O O
ratio O O
, O O
_num1 O O
. O O

somatic O O
pten O O
deletions O O
and O O
mutations O O
were O O
observed O O
in O O
sporadic B-Dis O
breast I-Dis B-Dis
, I-Dis I-Dis
brain I-Dis I-Dis
, I-Dis I-Dis
prostate I-Dis I-Dis
and I-Dis I-Dis
kidney I-Dis I-Dis
cancer I-Dis I-Dis
cell O O
lines O O
and O O
in O O
several O O
primary O B-Dis
tumours B-Dis I-Dis
such O O
as O O
endometrial B-Dis B-Dis
carcinomas I-Dis I-Dis
, O O
malignant B-Dis B-Dis
melanoma I-Dis I-Dis
and O O
thyroid B-Dis B-Dis
tumours I-Dis I-Dis
. O O

a O O
polyclonal O O
rabbit O O
antiserum O O
against O O
emerin O O
did O O
recognize O O
both O O
nuclear O O
membrane O O
and O O
intercalated O O
discs O O
but O O
, O O
after O O
affinity O O
purification O O
against O O
a O O
pure-emerin O O
band O O
on O O
a O O
western O O
blot O O
, O O
it O O
stained O O
only O O
the O O
nuclear O O
membrane O O
. O O

rescued O O
embryos O O
show O O
severe O O
anterior O B-Dis
truncations O I-Dis
, O O
indicating O O
a O O
second O O
important O O
role O O
for O O
smad4 O O
in O O
anterior O O
patterning O O
during O O
embryogenesis O O
. O O

specifically O O
and O O
more O O
directly O O
, O O
an O O
association O O
was O O
also O O
observed O O
between O O
the O O
presence O O
of O O
a O O
pten O O
mutation O O
and O O
malignant B-Dis B-Dis
breast I-Dis I-Dis
disease I-Dis I-Dis
. O O

_num1 O O
years O O
. O O

cloning O O
of O O
a O O
novel O O
member O O
of O O
the O O
low-density O O
lipoprotein O O
receptor O O
family O O
. O O

the O O
present O O
study O O
used O O
pcr O O
and O O
restriction-enzyme O O
digestion O O
to O O
analyze O O
the O O
frequency O O
of O O
the O O
_num3 O O
g O O
-- O O
> O O
a O O
and O O
_num3 O O
c O O
-- O O
> O O
g O O
mutations O O
in O O
hla-typed O O
samples O O
from O O
non-caucasian O O
populations O O
, O O
comprising O O
australian O O
aboriginal O O
, O O
chinese O O
, O O
and O O
pacific O O
islanders O O
. O O

these O O
observations O O
suggest O O
a O O
role O O
for O O
fh O O
and O O
/ O O
or O O
fh O O
receptors O O
in O O
the O O
pathogenesis O O
of O O
idiopathic O O
hus B-Dis O
. O O
. O O

thirty-two O O
unrelated O O
patients O O
with O O
features O O
of O O
saethre-chotzen B-Dis B-Dis
syndrome I-Dis I-Dis
, O O
a O O
common O O
autosomal B-Dis O
dominant I-Dis O
condition I-Dis O
of O O
craniosynostosis B-Dis B-Dis
and O I-Dis
limb B-Dis I-Dis
anomalies I-Dis I-Dis
, O O
were O O
screened O O
for O O
mutations O O
in O O
twist O O
, O O
fgfr2 O O
, O O
and O O
fgfr3 O O
. O O

in O O
one O O
of O O
the O O
families O O
, O O
affected O O
individuals O O
presented O O
a O O
novel O O
nonsense O O
mutation O O
in O O
exon O O
_num1 O O
of O O
the O O
gene O O
, O O
consisting O O
in O O
a O O
g O O
to O O
t O O
transition O O
at O O
nucleotide O O
_num4 O O
, O O
which O O
produces O O
a O O
stop O O
signal O O
in O O
codon O O
_num2 O O
-lrb- O O
glu O O
-rrb- O O
of O O
npii O O
. O O

deletion O O
of O O
this O O
ic O O
abolishes O O
local O O
paternally O O
derived O O
gene O O
expression O O
and O O
results O O
in O O
prader-willi B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
pws B-Dis B-Dis
-rrb- O O
. O O

more O O
than O O
_num2 O O
different O O
twist O O
mutations O O
are O O
now O O
known O O
in O O
the O O
literature O O
. O O

in O O
summary O O
, O O
our O O
results O O
show O O
frequent O O
involvement O O
of O O
the O O
_an O O
gene O O
in O O
familial B-Dis B-Dis
melanoma I-Dis I-Dis
and O O
confirm O O
the O O
role O O
of O O
the O O
cdk4 O O
gene O O
as O O
a O O
melanoma B-Dis B-Dis
predisposing O O
gene O O
. O O
. O O

the O O
major O O
cause O O
of O O
hepatic B-Dis B-Dis
copper I-Dis I-Dis
accumulation I-Dis I-Dis
in O O
man O O
is O O
a O O
dysfunctional O O
atp7b O O
gene O O
, O O
causing O O
wilson B-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
wd B-Dis B-Dis
-rrb- O O
. O O

no O O
locus O O
other O O
than O O
chromosome O O
11p13 O O
has O O
been O O
implicated O O
in O O
aniridia B-Dis B-Dis
, O O
and O O
pax6 O O
is O O
clearly O O
the O O
major O O
, O O
if O O
not O O
only O O
, O O
gene O O
responsible O O
. O O

in O O
order O O
to O O
further O O
characterize O O
the O O
dynamics O O
of O O
dm B-Dis B-Dis
_ds O O
repeat O O
somatic O O
instability O O
, O O
we O O
have O O
studied O O
repeat O O
length O O
changes O O
over O O
time O O
in O O
_num3 O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
patients O O
with O O
varying O O
clinical O O
severity O O
and O O
_ds O O
repeat O O
size O O
over O O
time O O
intervals O O
of O O
1-7 O O
years O O
. O O

this O O
mutation O O
changes O O
the O O
codon O O
for O O
glutamine O O
to O O
a O O
termination O O
codon O O
at O O
amino O O
acid O O
position O O
_num2 O O
. O O

as O O
the O O
mutation O O
occurred O O
at O O
the O O
penultimate O O
nucleotide O O
of O O
exon O O
_num1 O O
-lrb- O O
-2 O O
position O O
of O O
exon O O
6-intron O O
_num1 O O
splice O O
site O O
-rrb- O O
of O O
the O O
gene O O
, O O
we O O
hypothesized O O
that O O
the O O
mutation O O
may O O
partially O O
affect O O
the O O
normal O O
splicing O O
efficiency O O
in O O
exon O O
_num1 O O
and O O
cause O O
alternative O O
splicing O O
elsewhere O O
, O O
which O O
resulted O O
in O O
decreased O O
transcript O O
in O O
the O O
patient O O
. O O

the O O
penetrance O O
of O O
brca2 O O
was O O
estimated O O
by O O
maximizing O O
the O O
lod O O
score O O
in O O
brca2-mutation O O
families O O
, O O
over O O
all O O
possible O O
penetrance O O
functions O O
. O O

the O O
odds O O
of O O
detection O O
of O O
any O O
of O O
the O O
four O O
brca2 O O
mutations O O
was O O
_num1 O O
. O O

furthermore O O
, O O
we O O
observed O O
no O O
correlation O O
between O O
the O O
somatic O O
mutation O O
rate O O
and O O
tissue O O
proliferation O O
capacity O O
. O O

direct O O
sequencing O O
of O O
amplified O O
c9 O O
cdna O O
and O O
dna O O
revealed O O
a O O
nonsense O O
substitution O O
-lrb- O O
_ds O O
-- O O
> O O
_ds O O
-rrb- O O
at O O
codon O O
_num2 O O
in O O
exon O O
_num1 O O
in O O
the O O
four O O
c9-deficient B-Dis O
individuals O O
. O O

to O O
test O O
for O O
possible O O
nosologic O O
identity O O
between O O
these O O
disorders O O
, O O
we O O
reviewed O O
the O O
literature O O
and O O
obtained O O
a O O
follow-up O O
of O O
the O O
only O O
two O O
surviving O O
patients O O
, O O
one O O
with O O
sjs B-Dis O
type I-Dis O
_num1 I-Dis O
at O O
age O O
_num2 O O
years O O
and O O
another O O
with O O
sws B-Dis O
at O O
age O O
_num1 O O
years O O
. O O

in O O
addition O O
, O O
we O O
found O O
seven O O
individuals O O
with O O
hypohaptoglobinemia B-Dis O
in O O
three O O
families O O
, O O
and O O
the O O
genotypes O O
of O O
six O O
of O O
the O O
seven O O
individuals O O
were O O
found O O
to O O
be O O
hp2 O O
/ O O
hpdel O O
. O O

this O O
instability O O
appears O O
to O O
be O O
biased O O
towards O O
further O O
expansion O O
and O O
continuous O O
throughout O O
the O O
life O O
of O O
an O O
individual O O
, O O
features O O
that O O
could O O
be O O
associated O O
with O O
the O O
progressive O O
nature O O
of O O
the O O
disease O O
. O O

altered O O
expression O O
of O O
genes O O
regulated O O
posttranscriptionally O O
by O O
cug-bp O O
therefore O O
may O O
contribute O O
to O O
dm B-Dis O
pathogenesis O O
. O O
. O O

constitutional O O
rb1-gene O O
mutations O O
in O O
patients O O
with O O
isolated O O
unilateral B-Dis B-Dis
retinoblastoma I-Dis I-Dis
. O O

six O O
different O O
mutations O O
were O O
identified O O
on O O
_num2 O O
of O O
the O O
_num2 O O
alleles O O
examined O O
. O O

the O O
majority O O
of O O
jewish O O
185delag O O
mutation O O
carriers O O
have O O
a O O
common O O
allelic O O
pattern O O
, O O
supporting O O
the O O
founder O O
effect O O
notion O O
, O O
but O O
dating O O
the O O
mutations O O
origin O O
to O O
an O O
earlier O O
date O O
than O O
currently O O
estimated O O
. O O

the O O
extraordinary O O
conservation O O
of O O
the O O
pax6 O O
protein O O
at O O
the O O
amino O O
acid O O
level O O
amongst O O
vertebrates O O
predicts O O
that O O
pathological O O
missense O O
mutations O O
should O O
in O O
fact O O
be O O
common O O
even O O
though O O
they O O
are O O
hardly O O
ever O O
seen O O
in O O
aniridia B-Dis B-Dis
patients O O
. O O

prevalence O O
of O O
_an O O
and O O
cdk4 O O
germline O O
mutations O O
in O O
_num2 O O
melanoma B-Dis B-Dis
prone O O
families O O
in O O
france O O
. O O

scatchard O O
plots O O
of O O
these O O
data O O
indicate O O
that O O
the O O
added O O
heterodimer O O
substantially O O
reduced O O
the O O
affinity O O
of O O
tfr O O
for O O
transferrin O O
. O O

to O O
characterize O O
the O O
mutational O O
spectrum O O
in O O
various O O
ethnic O O
groups O O
, O O
mutations O O
in O O
the O O
galns O O
gene O O
in O O
colombian O O
mps B-Dis B-Dis
iva I-Dis I-Dis
patients O O
were O O
investigated O O
, O O
and O O
genetic O O
backgrounds O O
were O O
extensively O O
analyzed O O
to O O
identify O O
racial O O
origin O O
, O O
based O O
on O O
mitochondrial O O
dna O O
-lrb- O O
mtdna O O
-rrb- O O
lineages O O
. O O

we O O
compared O O
horizontal O O
eye O O
movements O O
-lrb- O O
visually O O
guided O O
saccades O O
, O O
antisaccades O O
, O O
and O O
smooth O O
pursuit O O
-rrb- O O
in O O
control O O
subjects O O
-lrb- O O
n O O
= O O
_num2 O O
-rrb- O O
and O O
patients O O
with O O
three O O
forms O O
of O O
autosomal O B-Dis
dominant O I-Dis
cerebellar B-Dis I-Dis
ataxias I-Dis I-Dis
type I-Dis I-Dis
i I-Dis I-Dis
spinocerebellar I-Dis I-Dis
ataxias I-Dis I-Dis
_num1 I-Dis O
and I-Dis O
_num1 I-Dis O
-lrb- O O
sca1 B-Dis O
, O O
n O O
= O O
_num2 O O
; O O
sca2 B-Dis O
, O O
n O O
= O O
_num2 O O
-rrb- O O
and O O
sca3 B-Dis O
/ O O
machado-joseph B-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
mjd B-Dis B-Dis
-rrb- O O
-lrb- O O
n O O
= O O
_num2 O O
-rrb- O O
. O O

the O O
mutant O O
myotubes O O
exhibit O O
smaller O O
and O O
slower O O
ca2 O O
+ O O
responses O O
upon O O
triggering O O
by O O
acetylcholine O O
or O O
high O O
external O O
k O O
+ O O
. O O

the O O
most O O
common O O
phenotypic O O
features O O
, O O
present O O
in O O
more O O
than O O
a O O
third O O
of O O
our O O
patients O O
with O O
twist O O
mutations O O
, O O
are O O
coronal B-Dis O
synostosis I-Dis O
, O O
brachycephaly B-Dis O
, O O
low B-Dis O
frontal I-Dis O
hairline I-Dis O
, O O
facial B-Dis O
asymmetry I-Dis O
, O O
ptosis B-Dis O
, O O
hypertelorism B-Dis B-Dis
, O O
broad B-Dis O
great I-Dis O
toes I-Dis O
, O O
and O O
clinodactyly B-Dis O
. O O

these O O
clustered O O
in O O
the O O
region O O
corresponding O O
to O O
the O O
kinase O O
domain O O
, O O
which O O
is O O
highly O O
conserved O O
in O O
atm-related O O
proteins O O
in O O
mouse O O
, O O
yeast O O
and O O
drosophila O O
. O O

the O O
concept O O
of O O
segregation O O
distortion O O
, O O
where O O
there O O
is O O
preferential O O
transmission O O
of O O
the O O
larger O O
allele O O
at O O
the O O
dm B-Dis B-Dis
locus O O
, O O
has O O
been O O
put O O
forward O O
to O O
explain O O
partially O O
the O O
maintenance O O
of O O
dm B-Dis B-Dis
in O O
the O O
population O O
. O O

these O O
reagents O O
detect O O
a O O
220-kd O O
protein O O
localized O O
in O O
discrete O O
nuclear O O
foci O O
in O O
all O O
epithelial O O
cell O O
lines O O
, O O
including O O
those O O
derived O O
from O O
breast B-Dis B-Dis
malignancies I-Dis I-Dis
. O O

ube3a O O
encodes O O
a O O
ubiquitin-protein O O
ligase O O
and O O
shows O O
brain-specific O O
imprinting O O
. O O

we O O
have O O
used O O
single O O
strand O O
conformation O O
polymorphism O O
analysis O O
to O O
study O O
the O O
_num2 O O
exons O O
of O O
the O O
rb1 O O
gene O O
in O O
individuals O O
from O O
a O O
family O O
showing O O
mild O O
expression O O
of O O
the O O
retinoblastoma B-Dis B-Dis
phenotype O O
. O O

five O O
novel O O
germ-line O O
apc B-Dis B-Dis
mutations O O
were O O
identified O O
in O O
seven O O
kindreds O O
. O O

mice O O
with O O
a O O
larger O O
deletion O O
involving O O
both O O
snrpn O O
and O O
the O O
putative O O
pws-ic O O
lack O O
expression O O
of O O
the O O
imprinted O O
genes O O
zfp127 O O
-lrb- O O
mouse O O
homologue O O
of O O
znf127 O O
-rrb- O O
, O O
ndn O O
and O O
ipw O O
, O O
and O O
manifest O O
several O O
phenotypes O O
common O O
to O O
pws B-Dis B-Dis
infants O O
. O O

in O O
conclusion O O
, O O
our O O
results O O
emphasize O O
that O O
the O O
manifestation O O
and O O
transmissibility O O
of O O
retinoblastoma B-Dis B-Dis
depend O O
on O O
the O O
nature O O
of O O
the O O
first O O
mutation O O
, O O
its O O
time O O
in O O
development O O
, O O
and O O
the O O
number O O
and O O
types O O
of O O
cells O O
that O O
are O O
affected O O
. O O
. O O

_num1 O O
respectively O O
, O O
regions O O
prone O O
to O O
amplification O O
in O O
some O O
human O O
cancers B-Dis B-Dis
. O O

the O O
seven O O
exons O O
, O O
the O O
exon O O
/ O O
intron O O
boundaries O O
and O O
part O O
of O O
_num1 O O
noncoding O O
sequence O O
of O O
the O O
cpo O O
gene O O
were O O
systematically O O
analyzed O O
by O O
an O O
exon-by-exon O O
denaturing O O
gradient O O
gel O O
electrophoresis O O
-lrb- O O
dgge O O
-rrb- O O
strategy O O
followed O O
by O O
direct O O
sequencing O O
in O O
seven O O
unrelated O O
heterozygous O O
hc B-Dis B-Dis
patients O O
from O O
france O O
, O O
holland O O
, O O
and O O
czech O O
republic O O
. O O

in O O
all O O
aapc B-Dis B-Dis
kindreds O O
, O O
a O O
predominance O O
of O O
right-sided O O
colorectal B-Dis B-Dis
adenomas I-Dis I-Dis
and O O
rectal B-Dis B-Dis
polyp I-Dis I-Dis
sparing O I-Dis
was O O
observed O O
. O O

a O O
younger O O
half-sister O O
, O O
who O O
had O O
no O O
underlying O O
disease O O
, O O
was O O
also O O
found O O
to O O
lack O O
immunochemically O O
detectable O O
c5 O O
. O O

germ-line O O
mutations O O
of O O
the O O
tumor B-Dis B-Dis
suppressor O O
apc O O
are O O
implicated O O
in O O
attenuated B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
coli I-Dis I-Dis
-lrb- O O
aapc B-Dis B-Dis
-rrb- O O
, O O
a O O
variant O O
of O O
familial B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
-lrb- O O
fap B-Dis B-Dis
-rrb- O O
. O O

a O O
novel O O
arg362ser O O
mutation O O
in O O
the O O
sterol O O
27-hydroxylase O O
gene O O
-lrb- O O
cyp27 O O
-rrb- O O
: O O
its O O
effects O O
on O O
pre-mrna O O
splicing O O
and O O
enzyme O O
activity O O
. O O

we O O
conclude O O
that O O
the O O
apc O B-Dis
i1307k O O
variant O O
leads O O
to O O
increased O O
adenoma B-Dis O
formation O O
and O O
directly O O
contributes O O
to O O
_num1 O O
% O O
-4 O O
% O O
of O O
all O O
ashkenazi O O
jewish O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
. O O

the O O
copper O O
transport O O
genes O O
ctr1 O O
and O O
ctr2 O O
were O O
also O O
excluded O O
as O O
candidate O O
genes O O
for O O
_ds B-Dis O
since O O
they O O
both O O
mapped O O
to O O
canine O O
chromosome O O
region O O
cfa11q22 O O
. O O

clinical O O
and O O
radiographic O O
examinations O O
were O O
performed O O
to O O
establish O O
diagnoses O O
, O O
and O O
disease O O
severity O O
was O O
assessed O O
using O O
a O O
combination O O
of O O
validated O O
scoring O O
systems O O
. O O

we O O
have O O
studied O O
the O O
codon O O
_num3 O O
-lrb- O O
cys O O
/ O O
tyr O O
-rrb- O O
polymorphism O O
in O O
different O O
ethnic O O
groups O O
. O O

furthermore O O
, O O
we O O
identified O O
a O O
glycine O O
to O O
alanine O O
substitution O O
in O O
the O O
collagenous O O
domain O O
that O O
is O O
apparently O O
silent O O
in O O
the O O
heterozygous O O
carriers O O
, O O
in O O
_num2 O O
. O O

these O O
findings O O
represent O O
the O O
first O O
examples O O
of O O
a O O
genetic B-Dis O
defect I-Dis O
within O O
the O O
pomc O O
gene O O
and O O
define O O
a O O
new O O
monogenic B-Dis B-Dis
endocrine I-Dis I-Dis
disorder I-Dis I-Dis
resulting O O
in O O
early-onset O O
obesity B-Dis B-Dis
, O O
adrenal B-Dis B-Dis
insufficiency I-Dis I-Dis
and O O
red O O
hair O O
pigmentation O O
. O O
. O O

epigenetic O O
loss O O
, O O
however O O
, O O
has O O
not O O
received O O
general O O
acceptance O O
due O O
to O O
controversy O O
regarding O O
the O O
subcellular O O
localization O O
of O O
brca1 O O
proteins O O
, O O
reports O O
of O O
which O O
have O O
ranged O O
from O O
exclusively O O
nuclear O O
, O O
to O O
conditionally O O
nuclear O O
, O O
to O O
the O O
er O O
/ O O
golgi O O
, O O
to O O
cytoplasmic O O
invaginations O O
into O O
the O O
nucleus O O
. O O

we O O
analyzed O O
a O O
series O O
of O O
_num2 O O
patients O O
, O O
_num2 O O
with O O
isolated B-Dis O
dms I-Dis O
-lrb- O O
idms B-Dis O
-rrb- O O
, O O
_num2 O O
with O O
dds B-Dis B-Dis
, O O
and O O
_num1 O O
with O O
urogenital B-Dis B-Dis
abnormalities I-Dis I-Dis
and O I-Dis
/ O I-Dis
or O I-Dis
wt B-Dis I-Dis
. O O

the O O
phenotypes O O
and O O
genotypes O O
in O O
one O O
of O O
these O O
three O O
families O O
showed O O
the O O
father O O
to O O
be O O
hypohaptoglobinemic B-Dis O
-lrb- O O
hp2 O O
-rrb- O O
and O O
hp2 O O
/ O O
hpdel O O
, O O
the O O
mother O O
to O O
be O O
hp2-1 O O
and O O
hp1 O O
/ O O
hp2 O O
, O O
one O O
of O O
the O O
two O O
children O O
to O O
be O O
hypohaptoglobinemic B-Dis O
-lrb- O O
hp2 O O
-rrb- O O
and O O
hp2 O O
/ O O
hpdel O O
, O O
and O O
the O O
other O O
child O O
to O O
be O O
hp1 O O
and O O
hp1 O O
/ O O
hpdel O O
, O O
showing O O
an O O
anomalous O O
inheritance O O
of O O
hp O O
phenotypes O O
in O O
the O O
child O O
with O O
hp1 O O
. O O

the O O
estimated O O
cumulative O O
risk O O
of O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
reached O O
_num2 O O
% O O
-lrb- O O
_num2 O O
% O O
ci O O
_num1 O O
% O O
-44 O O
% O O
-rrb- O O
by O O
age O O
_num2 O O
years O O
and O O
_num2 O O
% O O
-lrb- O O
_num2 O O
% O O
ci O O
_num2 O O
% O O
-95 O O
% O O
-rrb- O O
by O O
age O O
_num2 O O
years O O
. O O

haplotype O O
analysis O O
using O O
_num1 O O
rflps O O
provides O O
additional O O
data O O
that O O
the O O
i113f O O
mutation O O
originated O O
from O O
a O O
common O O
ancestor O O
. O O

four O O
were O O
deletions O O
involving O O
a O O
loss O O
of O O
a O O
single O O
exon O O
exon O O
_num1 O O
, O O
exon O O
_num2 O O
, O O
exon O O
_num2 O O
or O O
exon O O
_num2 O O
. O O

truncation O O
mutations O O
in O O
the O O
transactivation O O
region O O
of O O
pax6 O O
result O O
in O O
dominant-negative O O
mutants O O
. O O

they O O
are O O
distributed O O
along O O
the O O
c7 O O
gene O O
, O O
but O O
predominantly O O
towards O O
the O O
_num1 O O
end O O
. O O

3x O O
greater O O
if O O
there O O
were O O
at O O
least O O
five O O
cases O O
of O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
in O O
the O O
family O O
. O O

in O O
the O O
chinese O O
samples O O
analyzed O O
, O O
_num3 O O
c O O
-- O O
> O O
g O O
was O O
present O O
in O O
association O O
with O O
a O O
wide O O
variety O O
of O O
hla O O
haplotypes O O
, O O
showing O O
this O O
mutation O O
to O O
be O O
widespread O O
and O O
likely O O
to O O
predate O O
the O O
more O O
genetically O O
restricted O O
_num3 O O
g O O
-- O O
> O O
a O O
mutation O O
. O O

insertional O O
mutation O O
by O O
transposable O O
element O O
, O O
l1 O O
, O O
in O O
the O O
dmd B-Dis B-Dis
gene O O
results O O
in O O
x-linked B-Dis B-Dis
dilated I-Dis I-Dis
cardiomyopathy I-Dis I-Dis
. O O

genomic O O
sequencing O O
of O O
a O O
bac O O
clone O O
h_rg364p16 O O
revealed O O
the O O
presence O O
of O O
another O O
, O O
highly O O
homologous O O
gene O O
_num1 O O
of O O
the O O
cld B-Dis O
gene O O
, O O
with O O
a O O
similar O O
genomic O O
structure O O
, O O
recently O O
identified O O
as O O
the O O
pendred B-Dis B-Dis
syndrome I-Dis I-Dis
gene O O
-lrb- O O
pds B-Dis B-Dis
-rrb- O O
. O O
. O O

in O O
contrast O O
, O O
wt1 O O
missense O O
mutations O O
, O O
associated O O
with O O
male B-Dis O
pseudohermaphroditism I-Dis B-Dis
in O O
denys-drash B-Dis B-Dis
syndrome I-Dis I-Dis
, O O
fail O O
to O O
synergize O O
with O O
sf-1 O O
. O O

prevalence O O
of O O
the O O
i1307k O O
apc B-Dis B-Dis
gene O O
variant O O
in O O
israeli O O
jews O O
of O O
differing O O
ethnic O O
origin O O
and O O
risk O O
for O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
. O O

moreover O O
, O O
a O O
_num2 O O
. O O

we O O
describe O O
a O O
french O O
canadian O O
hereditary B-Dis B-Dis
non-polyposis I-Dis I-Dis
colorectal I-Dis I-Dis
cancer I-Dis I-Dis
-lrb- O O
hnpcc B-Dis B-Dis
-rrb- O O
kindred O O
which O O
carries O O
a O O
novel O O
truncating O O
mutation O O
in O O
hmlh1 O O
. O O

the O O
odds O O
of O O
detection O O
of O O
any O O
of O O
the O O
four O O
brca1 O O
mutations O O
was O O
_num2 O O
. O O

we O O
have O O
established O O
the O O
genomic O O
organization O O
of O O
ube3a O O
and O O
the O O
sequence O O
of O O
intron-exon O O
borders O O
. O O

comparison O O
of O O
molecular O O
and O O
psychometric O O
findings O O
demonstrated O O
that O O
deletions O O
and O O
duplications O O
that O O
were O O
localized O O
in O O
the O O
distal O O
part O O
of O O
the O O
gene O O
seemed O O
to O O
be O O
preferentially O O
associated O O
with O O
cognitive B-Dis O
impairment I-Dis O
. O O

we O O
have O O
also O O
mapped O O
two O O
highly O O
homologous O O
processed O O
pseudogenes O O
, O O
ube3ap1 O O
and O O
ube3ap2 O O
, O O
to O O
chromosomes O O
_num1 O O
and O O
_num2 O O
, O O
respectively O O
, O O
and O O
determined O O
their O O
genomic O O
organization O O
. O O

_num2 O O
, O O
p O O
= O O
_num1 O O
. O O

_num1 O O
to O O
_num1 O O
. O O

to O O
obtain O O
clues O O
to O O
the O O
normal O O
biological O O
role O O
of O O
dmpk O O
in O O
cellular O O
ion O O
homeostasis O O
, O O
we O O
have O O
compared O O
the O O
resting O O
-lsb- O O
ca2 O O
+ O O
-rsb- O O
i O O
, O O
the O O
amplitude O O
and O O
shape O O
of O O
depolarization-induced O O
ca2 O O
+ O O
transients O O
, O O
and O O
the O O
content O O
of O O
atp-driven O O
ion O O
pumps O O
in O O
cultured O O
skeletal O O
muscle O O
cells O O
of O O
wild-type O O
and O O
dmpk O O
-lsb- O O
- O O
/ O O
- O O
-rsb- O O
knockout O O
mice O O
. O O

methods O O
the O O
apc B-Dis B-Dis
gene O O
was O O
analysed O O
in O O
_num3 O O
unrelated O O
fap B-Dis B-Dis
and O O
_num2 O O
non-fap O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
patients O O
using O O
denaturing O O
gradient O O
gel O O
electrophoresis O O
, O O
the O O
protein O O
truncation O O
test O O
, O O
and O O
direct O O
sequencing O O
. O O

determination O O
of O O
the O O
genomic O O
structure O O
of O O
the O O
col4a4 O O
gene O O
and O O
of O O
novel O O
mutations O O
causing O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
alport I-Dis I-Dis
syndrome I-Dis I-Dis
. O O

as O O
has O O
been O O
reported O O
by O O
others O O
, O O
mutations O O
that O O
lead O O
to O O
exon O O
skipping O O
or O O
premature O O
protein O O
truncation O O
were O O
also O O
predominant O O
in O O
our O O
mutants O O
. O O

the O O
genetic O O
locus O O
of O O
the O O
disease O O
is O O
the O O
avp-neurophysin O O
ii O O
-lrb- O O
npii O O
-rrb- O O
gene O O
, O O
and O O
mutations O O
that O O
cause O O
adndi B-Dis O
have O O
been O O
found O O
in O O
both O O
the O O
signal O O
peptide O O
of O O
the O O
prepro-avp-npii O O
precursor O O
and O O
within O O
npii O O
itself O O
. O O

by O O
analysing O O
tumour B-Dis B-Dis
dna O O
from O O
patients O O
with O O
sporadic B-Dis B-Dis
t-cell I-Dis I-Dis
prolymphocytic I-Dis I-Dis
leukaemia I-Dis I-Dis
-lrb- O O
t-pll B-Dis B-Dis
-rrb- O O
, O O
a O O
rare O O
clonal B-Dis O
malignancy I-Dis O
with O O
similarities O O
to O O
a O O
mature B-Dis O
t-cell I-Dis O
leukaemia I-Dis O
seen O O
in O O
a-t B-Dis B-Dis
, O O
we O O
demonstrate O O
a O O
high O O
frequency O O
of O O
atm O O
mutations O O
in O O
t-pll B-Dis O
. O O

the O O
late O O
infantile O O
patient O O
inherited O O
from O O
his O O
mother O O
the O O
frequent O O
0-type O O
mutation O O
_num3 O O
+ O O
1g O O
> O O
a O O
, O O
and O O
from O O
his O O
father O O
a O O
novel O O
, O O
single O O
basepair O O
microdeletion O O
of O O
guanine O O
at O O
nucleotide O O
_num1 O O
in O O
exon O O
_num1 O O
-lrb- O O
7delg O O
-rrb- O O
. O O

constitutive O O
dna O O
from O O
_num2 O O
cd B-Dis O
families O O
and O O
seven O O
bzs B-Dis O
families O O
was O O
screened O O
for O O
germline O O
pten O O
mutations O O
. O O

mutation O O
a464v O O
was O O
not O O
found O O
in O O
_num2 O O
unrelated O O
mld B-Dis B-Dis
patients O O
and O O
_num2 O O
controls O O
. O O

the O O
smooth O O
pursuit O O
gain O O
was O O
decreased O O
. O O

c5 O O
was O O
undetectable O O
in O O
her O O
serum O O
by O O
both O O
immunodiffusion O O
and O O
hemolytic O O
assays O O
. O O

genetic O O
heterogeneity O O
of O O
saethre-chotzen B-Dis B-Dis
syndrome I-Dis I-Dis
, O O
due O O
to O O
twist O O
and O O
fgfr O O
mutations O O
. O O

results O O
presented O O
here O O
show O O
that O O
brca1 O O
and O O
brca2 O O
coexist O O
in O O
a O O
biochemical O O
complex O O
and O O
colocalize O O
in O O
subnuclear O O
foci O O
in O O
somatic O O
cells O O
and O O
on O O
the O O
axial O O
elements O O
of O O
developing O O
synaptonemal O O
complexes O O
. O O

the O O
1936delg O O
defect O O
was O O
observed O O
only O O
once O O
in O O
the O O
cape O O
, O O
but O O
its O O
associated O O
haplotype O O
could O O
be O O
deduced O O
. O O

this O O
suggests O O
that O O
these O O
two O O
founder O O
mutations O O
may O O
be O O
predominant O O
among O O
japanese O O
atm O O
mutant O O
alleles O O
. O O

southern O O
blot O O
and O O
pcr O O
analyses O O
have O O
indicated O O
that O O
the O O
individual O O
with O O
anhaptoglobinemia B-Dis O
was O O
homozygous O O
for O O
the O O
gene O O
deletion O O
and O O
that O O
the O O
gene O O
deletion O O
was O O
included O O
at O O
least O O
from O O
the O O
promoter O O
region O O
of O O
hp O O
to O O
hpr O O
alpha O O
but O O
not O O
to O O
hpr O O
beta O O
-lrb- O O
hpdel O O
-rrb- O O
. O O

therefore O O
, O O
progression O O
to O O
s O O
phase O O
is O O
accompanied O O
by O O
the O O
aggregation O O
of O O
nuclear O O
bard1 O O
polypeptides O O
into O O
brca1 O O
nuclear O O
dots O O
. O O

coincidence O O
of O O
two O O
novel O O
arylsulfatase O O
a O O
alleles O O
and O O
mutation O O
_num3 O O
+1 O O
g O O
> O O
a O O
within O O
a O O
family O O
with O O
metachromatic B-Dis B-Dis
leukodystrophy I-Dis I-Dis
: O O
molecular O O
basis O O
of O O
phenotypic O O
heterogeneity O O
. O O

the O O
follow-up O O
observation O O
of O O
an O O
identical O O
and O O
unique O O
pattern O O
of O O
progressive O B-Dis
bone B-Dis I-Dis
dysplasia I-Dis I-Dis
in O O
the O O
two O O
patients O O
-lrb- O O
one O O
with O O
sjs B-Dis O
type I-Dis O
_num1 I-Dis O
, O O
one O O
with O O
sws B-Dis O
-rrb- O O
surviving O O
beyond O O
infancy O O
adds O O
to O O
the O O
evidence O O
in O O
favor O O
of O O
identity O O
. O O

7x O O
greater O O
if O O
one O O
or O O
more O O
cases O O
of O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
were O O
also O O
present O O
in O O
the O O
family O O
. O O

two O O
frequent O O
missense O O
mutations O O
in O O
pendred B-Dis B-Dis
syndrome I-Dis I-Dis
. O O

pax6 O O
mutations O O
reviewed O O
. O O

mutations O O
in O O
the O O
hexa O O
gene O O
, O O
encoding O O
the O O
alpha-subunit O O
of O O
beta-hexosaminidase O O
a O O
-lrb- O O
hex O O
a O O
-rrb- O O
, O O
that O O
abolish O O
hex O O
a O O
enzyme O O
activity O O
cause O O
tay-sachs B-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
tsd B-Dis B-Dis
-rrb- O O
, O O
the O O
fatal O O
infantile B-Dis O
form I-Dis O
of I-Dis O
g I-Dis O
-lrb- I-Dis O
m2 I-Dis O
-rrb- I-Dis O
gangliosidosis I-Dis O
, I-Dis O
type I-Dis O
_num1 I-Dis O
. O O

the O O
mutations O O
4612del165 O O
and O O
7883del5 O O
were O O
found O O
in O O
more O O
than O O
two O O
unrelated O O
families O O
; O O
_num2 O O
% O O
-lrb- O O
_num1 O O
of O O
_num2 O O
-rrb- O O
of O O
the O O
mutant O O
alleles O O
had O O
one O O
of O O
the O O
two O O
mutations O O
. O O

eight O O
of O O
the O O
cases O O
were O O
familial O O
, O O
and O O
five O O
were O O
sporadic O O
. O O

this O O
missense O O
mutation O O
, O O
which O O
replaces O O
ala O O
with O O
thr O O
, O O
is O O
frequent O O
among O O
fndi B-Dis O
patients O O
and O O
is O O
thought O O
to O O
reduce O O
the O O
efficiency O O
of O O
cleavage O O
by O O
signal O O
peptidases O O
. O O
. O O

deficiency B-Dis B-Dis
of I-Dis I-Dis
the I-Dis I-Dis
sixth I-Dis I-Dis
component I-Dis I-Dis
of I-Dis I-Dis
human I-Dis I-Dis
complement I-Dis I-Dis
-lrb- O O
c6 O O
-rrb- O O
has O O
been O O
reported O O
in O O
a O O
number O O
of O O
families O O
from O O
the O O
western O O
cape O O
, O O
south O O
africa O O
. O O

the O O
i1307k O O
allele O O
was O O
found O O
in O O
_num1 O O
. O O

we O O
report O O
another O O
mutation O O
in O O
a O O
japanese O O
family O O
. O O

the O O
identification O O
of O O
common O O
brca1 O O
and O O
brca2 O O
mutations O O
will O O
facilitate O O
carrier O O
detection O O
in O O
french O O
canadian O B-Dis
breast B-Dis I-Dis
cancer I-Dis I-Dis
and O O
breast B-Dis B-Dis
/ I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
families O O
. O O

furthermore O O
, O O
our O O
findings O O
are O O
best O O
interpreted O O
as O O
true O O
gamete O O
complementation O O
resulting O O
in O O
maternal B-Dis O
upd I-Dis B-Dis
_num2 I-Dis O
and O O
pws B-Dis B-Dis
segregation O O
distortion O O
in O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
. O O

hla O O
typing O O
for O O
hla-b27 O O
, O O
hla-b60 O O
, O O
and O O
hla-dr1 O O
was O O
performed O O
by O O
polymerase O O
chain O O
reaction O O
with O O
sequence-specific O O
primers O O
, O O
and O O
zygosity O O
was O O
assessed O O
using O O
microsatellite O O
markers O O
. O O

assays O O
requiring O O
minimal O O
amounts O O
of O O
genomic O O
dna O O
were O O
designed O O
to O O
allow O O
rapid O O
screening O O
for O O
common O O
ethnic O O
mutations O O
. O O

germline O O
mutations O O
in O O
the O O
_an O O
and O O
cdk4 O O
genes O O
have O O
been O O
reported O O
in O O
a O O
subset O O
of O O
melanoma B-Dis B-Dis
pedigrees O O
, O O
but O O
their O O
prevalence O O
is O O
not O O
well O O
known O O
. O O

brca1 O O
allelic O O
patterns O O
were O O
determined O O
for O O
four O O
of O O
these O O
individuals O O
and O O
for O O
_num2 O O
additional O O
non-ashkenazi O O
185delag O O
mutation O O
carriers O O
who O O
had O O
breast B-Dis B-Dis
/ I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
. O O

one O O
of O O
these O O
, O O
not O O
previously O O
reported O O
, O O
was O O
_num4 O O
a O O
or O O
c O O
that O O
introduces O O
a O O
new O O
restriction O O
site O O
for O O
eco0109 O O
i. O O
all O O
the O O
4003deltc O O
alleles O O
showed O O
the O O
same O O
haplotype O O
for O O
these O O
five O O
polymorphic O O
markers O O
. O O

it O O
occurred O O
in O O
_num2 O O
. O O

germline O O
mutations O O
in O O
the O O
atm O O
gene O O
are O O
responsible O O
for O O
the O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
disorder I-Dis I-Dis
ataxia-telangiectasia I-Dis I-Dis
-lrb- O O
a-t B-Dis B-Dis
-rrb- O O
. O O

detection O O
of O O
heterozygous O O
carriers O O
of O O
the O O
ataxia-telangiectasia B-Dis B-Dis
-lrb- O O
atm O O
-rrb- O O
gene O O
by O O
g2 O O
phase O O
chromosomal O O
radiosensitivity O O
of O O
peripheral O O
blood O O
lymphocytes O O
. O O

we O O
also O O
show O O
that O O
the O O
879delg O O
and O O
1195delc O B-Dis
defects O I-Dis
are O O
associated O O
with O O
characteristic O O
c6 O O
/ O O
c7 O O
region O O
dna O O
marker O O
haplotypes O O
, O O
although O O
small O O
variations O O
were O O
observed O O
. O O

_num1 O O
h O B-Dis
in O O
the O O
presence O O
or O O
absence O O
of O O
_num2 O O
microg O O
cycloheximide O O
per O O
ml O O
. O O

skin O O
photosensitivity O O
may O O
also O O
be O O
present O O
. O O

heterozygous O O
mutations O O
in O O
the O O
human O O
pax6 O O
gene O O
result O O
in O O
various O O
phenotypes O O
, O O
including O O
aniridia B-Dis B-Dis
, O O
peters B-Dis B-Dis
anomaly I-Dis I-Dis
, O O
autosomal B-Dis B-Dis
dominant I-Dis I-Dis
keratitis I-Dis I-Dis
, O O
and O O
familial B-Dis B-Dis
foveal I-Dis I-Dis
dysplasia I-Dis I-Dis
. O O

the O O
resulting O O
w474c O O
substitution O O
clearly O O
interferes O O
with O O
alpha-subunit O O
processing O O
, O O
but O O
because O O
the O O
base O O
substitution O O
falls O O
at O O
the O O
first O O
position O O
of O O
exon O O
_num2 O O
, O O
aberrant O O
splicing O O
may O O
also O O
contribute O O
to O O
hex B-Dis O
a I-Dis O
deficiency I-Dis O
in O O
this O O
proband O O
. O O
. O O

additional O O
mutations O O
were O O
observed O O
in O O
japanese O O
, O O
utah O O
mormon O O
, O O
and O O
african O O
american O O
patients O O
. O O

the O O
estimated O O
sensitivity O O
was O O
identical O O
for O O
direct O O
sequencing O O
and O O
other O O
techniques O O
. O O

a O O
century O O
after O O
its O O
recognition O O
as O O
a O O
syndrome O O
by O O
vaughan O O
pendred O O
, O O
the O O
disease O O
gene O O
-lrb- O O
pds B-Dis B-Dis
-rrb- O O
was O O
mapped O O
to O O
chromosome O O
7q22-q31 O O
. O O

this O O
report O O
documents O O
a O O
novel O O
splice-site O O
mutation O O
in O O
col17a1 O O
in O O
a O O
patient O O
with O O
generalized O O
atrophic B-Dis B-Dis
benign I-Dis I-Dis
epidermolysis I-Dis I-Dis
bullosa I-Dis I-Dis
, O O
and O O
applies O O
a O O
new O O
methodology O O
to O O
define O O
and O O
characterize O O
the O O
resulting O O
mrna O O
splice O O
variants O O
. O O

_num2 O O
% O O
in O O
the O O
two O O
populations O O
analyzed O O
-lrb- O O
australian O O
aboriginal O O
and O O
chinese O O
-rrb- O O
. O O

the O O
other O O
_num1 O O
novel O O
mutations O O
identified O O
in O O
these O O
_num2 O O
patients O O
were O O
each O O
limited O O
to O O
a O O
single O O
family O O
. O O

the O O
premature O O
termination O O
eliminates O O
part O O
of O O
the O O
c-terminal O O
domain O O
of O O
npii O O
, O O
including O O
a O O
cysteine O O
residue O O
in O O
position O O
_num2 O O
, O O
which O O
could O O
be O O
involved O O
in O O
the O O
correct O O
folding O O
of O O
the O O
prohormone O O
. O O

furthermore O O
, O O
at O O
_num1 O O
degrees O O
c O O
, O O
the O O
added O O
soluble O O
complex O O
of O O
hfe O O
/ O O
beta2m O O
inhibited O O
binding O O
of O O
transferrin O O
to O O
hela O O
cell O O
tfr O O
in O O
a O O
concentration-dependent O O
manner O O
. O O

genetic O O
basis O O
and O O
molecular O O
mechanism O O
for O O
idiopathic B-Dis B-Dis
ventricular I-Dis I-Dis
fibrillation I-Dis I-Dis
. O O

the O O
same O O
mutation O O
was O O
present O O
heterozygously O O
in O O
the O O
dna O O
from O O
the O O
constitutional O O
cells O O
of O O
the O O
patient O O
, O O
proving O O
it O O
to O O
be O O
of O O
germline O O
origin O O
. O O

a O O
single O O
band O O
shift O O
using O O
sscp O O
was O O
identified O O
in O O
exon O O
_num2 O O
which O O
resulted O O
in O O
a O O
missense O O
mutation O O
converting O O
a O O
cys O O
-- O O
> O O
arg O O
at O O
nucleotide O O
position O O
_num2 O O
in O O
the O O
exon O O
. O O

kinetic O O
studies O O
of O O
binding O O
and O O
dissociation O O
revealed O O
that O O
various O O
truncation O O
mutants O O
have O O
3-5-fold O O
higher O O
affinity O O
to O O
various O O
dna-binding O O
sites O O
when O O
compared O O
with O O
the O O
wild-type O O
pax6 O O
. O O

familial B-Dis B-Dis
neurohypophyseal I-Dis I-Dis
diabetes I-Dis I-Dis
insipidus I-Dis I-Dis
-lrb- O O
fndi B-Dis B-Dis
-rrb- O O
is O O
an O O
autosomal B-Dis B-Dis
dominant I-Dis I-Dis
disease I-Dis I-Dis
caused O O
by O O
deficiency O B-Dis
in O I-Dis
the O I-Dis
antidiuretic O O
hormone O O
arginine O O
vasopressin O O
-lrb- O O
avp O O
-rrb- O O
encoded O O
by O O
the O O
avp-neurophysin O O
ii O O
-lrb- O O
avp-npii O O
-rrb- O O
gene O O
on O O
chromosome O O
20p13 O O
. O O

allele-specific O O
pcr O O
indicated O O
that O O
the O O
probands O O
two O O
brothers O O
also O O
inherited O O
the O O
1195delc O O
mutation O O
from O O
their O O
heterozygous O O
mother O O
and O O
the O O
1936delg O O
mutation O O
from O O
their O O
homozygous O O
father O O
. O O
. O O

four O O
patients O O
had O O
a O O
germ-line O O
e1317q O O
missense O O
variant O O
of O O
apc O O
that O O
was O O
not O O
present O O
in O O
controls O O
; O O
one O O
of O O
these O O
individuals O O
had O O
an O O
unusually O O
large O O
number O O
of O O
metaplastic B-Dis O
polyps I-Dis B-Dis
of I-Dis O
the I-Dis O
colorectum I-Dis O
. O O

the O O
identification O O
of O O
the O O
second O O
mutational O O
event O O
in O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
tumors B-Dis B-Dis
establishes O O
pten O O
/ O O
mmac1 O O
as O O
a O O
main O O
inactivation O O
target O O
of O O
10q O B-Dis
loss O I-Dis
in O O
sporadic B-Dis B-Dis
prostate I-Dis I-Dis
cancer I-Dis I-Dis
. O O
. O O

neither O O
the O O
content O O
nor O O
the O O
activity O O
of O O
na O O
+ O O
/ O O
k O O
+ O O
atpase O O
and O O
sarcoplasmic O O
reticulum O O
ca2 O O
+ O O
- O O
atpase O O
are O O
affected O O
by O O
dmpk O O
absence O O
. O O

qualitative O O
analysis O O
of O O
the O O
dp71 O O
transcript O O
and O O
testing O O
for O O
the O O
specific O O
first O O
exon O O
of O O
dp140 O O
were O O
also O O
carried O O
out O O
. O O

the O O
somatic O O
mutation O O
rates O O
in O O
different O O
tissues O O
were O O
also O O
not O O
correlated O O
to O O
the O O
relative O O
inter-tissue O O
difference O O
in O O
transcriptional O O
levels O O
of O O
the O O
three O O
genes O O
-lrb- O O
dmahp O O
, O O
dmpk O O
and O O
_num2 O O
-rrb- O O
surrounding O O
the O O
repeat O O
. O O
. O O

this O O
is O O
corrected O O
by O O
the O O
reintroduction O O
of O O
wild-type O O
vhl B-Dis B-Dis
, O O
implicating O O
vhl B-Dis B-Dis
as O I-Dis
the O O
first O O
tumor B-Dis B-Dis
suppressor O O
involved O O
in O O
the O O
regulation O O
of O O
cell O O
cycle O O
exit O O
, O O
which O O
is O O
consistent O O
with O O
its O O
gatekeeper O O
function O O
in O O
the O O
kidney O O
. O O
. O O

in O O
two O O
familial O O
cases O O
and O O
one O O
sporadic O O
case O O
, O O
mosaicism O O
for O O
ube3a O O
mutations O O
was O O
detected O O
in O O
the O O
mother O O
of O O
three O O
as B-Dis O
sons O O
, O O
in O O
the O O
maternal O O
grandfather O O
of O O
two O O
as B-Dis O
first O O
cousins O O
, O O
and O O
in O O
the O O
mother O O
of O O
an O O
as B-Dis O
daughter O O
. O O

human O O
mlh1 O B-Dis
deficiency O I-Dis
predisposes O O
to O O
hematological B-Dis B-Dis
malignancy I-Dis I-Dis
and O O
neurofibromatosis B-Dis B-Dis
type I-Dis I-Dis
_num1 I-Dis I-Dis
. O O

since O O
a O O
mutation O O
at O O
cdna O O
nucleotide O O
_num4 O O
-lrb- O O
2302insc O O
-rrb- O O
had O O
been O O
previously O O
described O O
, O O
this O O
region O O
of O O
the O O
atp7b O O
gene O O
may O O
be O O
susceptible O O
to O O
gene O O
rearrangements O O
causing O O
wilson B-Dis B-Dis
disease I-Dis I-Dis
. O O

our O O
data O O
suggest O O
that O O
the O O
c O O
to O O
a O O
mutation O O
at O O
the O O
penultimate O O
nucleotide O O
of O O
exon O O
_num1 O O
of O O
the O O
cyp27 O O
gene O O
not O O
only O O
causes O O
the O O
deficiency O O
in O O
the O O
sterol O O
27-hydroxylase O O
activity O O
, O O
but O O
also O O
partially O O
leads O O
to O O
alternative O O
pre-mrna O O
splicing O O
of O O
the O O
gene O O
. O O

all O O
the O O
patients O O
carried O O
a O O
pathogenic O O
mutation O O
in O O
either O O
brca1 O O
-lrb- O O
_num3 O O
women O O
-rrb- O O
or O O
brca2 O O
-lrb- O O
_num2 O O
women O O
-rrb- O O
. O O

_num2 O O
-rrb- O O
. O O

a O O
niece O O
-lrb- O O
b. O O
b. O O
-rrb- O O
with O O
_num2 O O
chromosomes O O
and O O
the O O
derivative O O
_num1 O O
but O O
without O O
the O O
der O O
-lrb- O O
_num2 O O
-rrb- O O
demonstrated O O
a O O
phenotype O O
consistent O O
with O O
that O O
reported O O
for O O
haploinsufficiency O O
of O O
distal O O
_num1 O O
p. O O
uniparental B-Dis B-Dis
disomy I-Dis I-Dis
associated O O
with O O
unbalanced O O
segregation O O
of O O
non-robertsonian O O
translocations O O
has O O
been O O
reported O O
previously O O
but O O
has O O
not O O
, O O
to O O
our O O
knowledge O O
, O O
been O O
observed O O
in O O
a O O
case O O
of O O
pws B-Dis B-Dis
. O O

these O O
mutations O O
resulted O O
in O O
the O O
absence O O
or O O
a O O
dramatic O O
decrease O O
of O O
cpo O O
activity O O
. O O

we O O
proposed O O
and O O
tested O O
a O O
simple O O
model O O
for O O
correlation O O
between O O
genotype O O
and O O
phenotypic O O
outcome O O
. O O

genomic O O
organization O O
of O O
the O O
ube3a O O
/ O O
e6-ap O O
gene O O
and O O
related O O
pseudogenes O O
. O O

one O O
is O O
the O O
t312s O O
mutation O O
, O O
a O O
novel O O
mutation O O
found O O
exclusively O O
in O O
milder O O
patients O O
. O O

agu B-Dis O
is O O
inherited O O
as O B-Dis
an O O
autosomal O O
recessive O O
trait O O
and O O
occurs O O
with O O
a O O
high O O
frequency O O
in O O
finland O O
because O O
of O O
a O O
founder O O
effect O O
. O O

risk O O
of O O
developing O O
colorectal B-Dis O
, I-Dis O
breast I-Dis B-Dis
and I-Dis I-Dis
other I-Dis I-Dis
cancers I-Dis I-Dis
were O O
compared O O
between O O
genotyped O O
i1307k O O
carriers O O
and O O
non-carriers O O
and O O
their O O
first-degree O O
relatives O O
. O O

clinical O O
manifestations O O
of O O
the O O
disease O O
are O O
characterized O O
by O O
acute O O
attacks O O
of O O
neurological B-Dis B-Dis
dysfunction I-Dis I-Dis
often O O
precipitated O O
by O O
drugs O O
, O O
fasting O O
, O O
cyclical O O
hormonal O O
changes O O
, O O
or O O
infectious B-Dis O
diseases I-Dis O
. O O

_num1 O O
% O O
-rrb- O O
of O O
_num3 O O
patients O O
. O O

the O O
mutation O O
is O O
in O O
an O O
area O O
of O O
the O O
gene O O
that O O
encodes O O
the O O
protein-binding O O
region O O
known O O
as O O
the O O
pocket O O
region O O
and O O
has O O
been O O
detected O O
in O O
other O O
cases O O
of O O
retinoblastoma B-Dis B-Dis
. O O
. O O

recent O O
studies O O
in O O
animal O O
models O O
elucidated O O
a O O
central O O
role O O
of O O
alpha-msh O O
in O O
the O O
regulation O O
of O O
food O O
intake O O
by O O
activation O O
of O O
the O O
brain O O
melanocortin-4-receptor O O
-lrb- O O
mc4-r O O
; O O
refs O O
3-5 O O
-rrb- O O
and O O
the O O
linkage O O
of O O
human O O
obesity B-Dis O
to O O
chromosome O O
_num1 O O
in O O
close O O
proximity O O
to O O
the O O
pomc O O
locus O O
, O O
led O O
to O O
the O O
proposal O O
of O O
an O O
association O O
of O O
pomc O O
with O O
human O O
obesity B-Dis B-Dis
. O O

conversely O O
, O O
brca1 O O
expression O O
was O O
reduced O O
or O O
undetectable O O
in O O
the O O
majority O O
of O O
high-grade O B-Dis
, O O
ductal B-Dis O
carcinomas I-Dis B-Dis
, O O
suggesting O O
that O O
absence O O
of O O
brca1 O O
may O O
contribute O O
to O O
the O O
pathogenesis O O
of O O
a O O
significant O O
percentage O O
of O O
sporadic B-Dis B-Dis
breast I-Dis I-Dis
cancers I-Dis I-Dis
. O O
. O O

furthermore O O
, O O
compared O O
with O O
noncarriers O O
, O O
apc O B-Dis
i1307k O O
carriers O O
had O O
increased O O
numbers O O
of O O
adenomas B-Dis B-Dis
and O O
colorectal B-Dis B-Dis
cancers I-Dis I-Dis
per O O
patient O O
-lrb- O O
p O O
= O O
. O O

the O O
data O O
from O O
the O O
haplotypes O O
indicate O O
that O O
these O O
three O O
molecular O O
defects O O
account O O
for O O
the O O
defects O O
in O O
all O O
the O O
_num2 O O
unrelated O O
c6q0 O O
individuals O O
we O O
have O O
studied O O
from O O
the O O
cape O O
. O O

the O O
relationship O O
of O O
the O O
genes O O
coding O O
for O O
hla O O
to O O
those O O
coding O O
for O O
properdin O O
factor O O
b O O
allotypes O O
and O O
for O O
deficiency B-Dis B-Dis
of I-Dis I-Dis
the I-Dis I-Dis
second I-Dis I-Dis
component I-Dis I-Dis
of I-Dis I-Dis
complement I-Dis I-Dis
-lrb- O O
c2 O O
-rrb- O O
was O O
studied O O
in O O
families O O
of O O
patients O O
with O O
connective O O
tissue O O
disorders O O
. O O

dna O O
sequence O O
analysis O O
and O O
allele-specific O O
amplification O O
in O O
two O O
siblings O O
revealed O O
a O O
homozygous O O
mlh1 O O
mutation O O
-lrb- O O
c676t O O
-- O O
> O O
arg226stop O O
-rrb- O O
. O O

here O O
we O O
show O O
that O O
the O O
steady-state O O
levels O O
of O O
bard1 O O
, O O
unlike O O
those O O
of O O
brca1 O O
, O O
remain O O
relatively O O
constant O O
during O O
cell O O
cycle O O
progression O O
. O O

an O O
analysis O O
of O O
the O O
putative O O
promoter O O
region O O
sequence O O
shows O O
a O O
putative O O
_ds O O
box O O
and O O
predicts O O
multiple O O
transcription O O
factor O O
binding O O
sites O O
. O O

we O O
report O O
here O O
the O O
identification O O
of O O
a O O
unique O O
de O O
novo O O
l1 O O
insertion O O
in O O
the O O
muscle O O
exon O O
_num1 O O
in O O
dmd O B-Dis
in O O
three O O
xldcm B-Dis B-Dis
patients O O
from O O
two O O
unrelated O O
japanese O O
families O O
. O O

large-scale O O
rna O O
differential O O
display O O
technology O O
applied O O
to O O
these O O
cell O O
lines O O
identified O O
several O O
differentially O O
expressed O O
genes O O
, O O
including O O
an O O
alpha O O
carbonic O O
anhydrase O O
gene O O
, O O
termed O O
ca12 O O
. O O

the O O
lifetime O O
risk O O
of O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
appears O O
similar O O
to O O
the O O
risk O O
in O O
brca1 O O
carriers O O
, O O
but O O
there O O
was O O
some O O
suggestion O O
of O O
a O O
lower O O
risk O O
in O O
brca2 O O
carriers O O
< O O
_num2 O O
years O O
of O O
age O O
. O O

the O O
t O O
-lrb- O O
_num1 O O
; O O
_num2 O O
-rrb- O O
was O O
present O O
in O O
the O O
balanced O O
state O O
in O O
the O O
patients O O
father O O
and O O
a O O
sister O O
. O O

after O O
initial O O
treatment O O
with O O
intravenous O O
glucose O O
and O O
carnitine O O
, O O
the O O
patient O O
has O O
thrived O O
on O O
a O O
low-fat O O
diet O O
supplemented O O
with O O
medium-chain O O
triglyceride O O
oil O O
and O O
carnitine O O
and O O
avoidance O O
of O O
fasting O O
. O O

in O O
this O O
model O O
, O O
the O O
exteriorized O O
mesentery O O
was O O
superfused O O
with O O
ferric O O
chloride O O
and O O
the O O
accumulation O O
of O O
fluorescently O O
labeled O O
platelets O O
was O O
observed O O
by O O
intravital O O
microscopy O O
. O O

or O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
, I-Dis O
for O O
the O O
apc O O
i1307k O O
polymorphism O O
. O O

_num1 O O
% O O
of O O
the O O
general O O
population O O
, O O
suggesting O O
that O O
it O O
is O O
not O O
disease O O
associated O O
. O O

we O O
have O O
found O O
a O O
direct O O
progression O O
of O O
the O O
size O O
heterogeneity O O
over O O
time O O
related O O
to O O
initial O O
_ds O O
repeat O O
size O O
and O O
the O O
time O O
interval O O
and O O
always O O
biased O O
towards O O
further O O
expansion O O
. O O

additionally O O
, O O
the O O
x-linked O O
, O O
candidate O O
dosage-sensitive O O
sex-reversal O O
gene O O
, O O
dax-1 O O
, O O
antagonizes O O
synergy O O
between O O
sf-1 O O
and O O
wt1 O O
, O O
most O O
likely O O
through O O
a O O
direct O O
interaction O O
with O O
sf-1 O O
. O O

to O O
facilitate O O
the O O
evaluation O O
of O O
atm O O
heterozygotes O O
for O O
susceptibility O O
to O O
other O O
diseases O O
, O O
such O O
as O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
, O O
we O O
have O O
attempted O O
to O O
define O O
the O O
most O O
common O O
mutations O O
and O O
their O O
frequencies O O
in O O
ataxia-telangiectasia B-Dis B-Dis
-lrb- O O
a-t B-Dis B-Dis
-rrb- O O
homozygotes O O
from O O
_num2 O O
ethnic O O
populations O O
. O O

background O O
women O O
with O O
mutations O O
in O O
either O O
the O O
brca1 O O
or O O
the O O
brca2 O O
gene O O
have O O
a O O
high O O
lifetime O O
risk O O
of O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
. O O

the O O
observed O O
phenotype O O
matched O O
the O O
predicted O O
phenotype O O
in O O
_num2 O O
% O O
of O O
the O O
cases O O
, O O
and O O
in O O
only O O
_num1 O O
of O O
_num3 O O
patients O O
was O O
the O O
observed O O
phenotype O O
more O O
than O O
one O O
category O O
away O O
from O O
that O O
expected O O
. O O

aspartylglucosaminuria B-Dis B-Dis
among O O
palestinian O O
arabs O O
. O O

the O O
hemochromatosis B-Dis B-Dis
gene O O
, O O
hfe O O
, O O
recently O O
has O O
been O O
identified O O
, O O
and O O
characterization O O
of O O
this O O
gene O O
has O O
shown O O
that O O
it O O
contains O O
two O O
mutations O O
that O O
result O O
in O O
amino O O
acid O O
substitutions-cdna O O
nucleotides O O
_num3 O O
g O O
-- O O
> O O
a O O
-lrb- O O
c282y O O
-rrb- O O
and O O
_num3 O O
c O O
-- O O
> O O
g O O
-lrb- O O
h63d O O
-rrb- O O
. O O

we O O
report O O
a O O
japanese O O
family O O
with O O
adrenoleukodystrophy B-Dis B-Dis
-lrb- O O
ald B-Dis B-Dis
-rrb- O O
with O O
a O O
three O O
base O O
pair O O
deletion O O
-lrb- O O
delgag O O
_num3 O O
-rrb- O O
in O O
the O O
ald B-Dis B-Dis
gene O O
. O O

we O O
propose O O
that O O
the O O
loss O O
of O O
wild-type O O
vhl B-Dis B-Dis
gene O O
results O O
in O O
a O O
specific O O
cellular O O
defect O O
in O O
serum-dependent O O
growth O O
control O O
, O O
which O O
may O O
initiate O O
tumor B-Dis B-Dis
formation O O
. O O

all O O
these O O
new O O
molecular O B-Dis
defects O I-Dis
involve O O
single-nucleotide O O
events O O
, O O
deletions O O
and O O
substitutions O O
, O O
some O O
of O O
which O O
alter O O
splice O O
sites O O
, O O
and O O
others O O
codons O O
. O O

sibships O O
where O O
the O O
status O O
of O O
all O O
the O O
members O O
had O O
been O O
identified O O
were O O
examined O O
to O O
determine O O
the O O
transmission O O
of O O
the O O
dm B-Dis O
expansion O O
from O O
affected O O
parents O O
to O O
their O O
offspring O O
. O O

a O O
crossover O O
was O O
shown O O
to O O
have O O
occurred O O
between O O
genes O O
for O O
factor O O
b O O
and O O
hla-d O O
, O O
in O O
which O O
hla-d O O
segregared O O
with O O
hla-a O O
and O O
b O O
. O O

the O O
frequencies O O
with O O
which O O
we O O
detected O O
mutations O O
were O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
_num2 O O
in O O
sporadic O O
cases O O
and O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
_num2 O O
in O O
familial O O
cases O O
. O O
. O O

_num1 O O
to O O
_num1 O O
. O O

mucopolysaccharidosis B-Dis B-Dis
iva I-Dis I-Dis
-lrb- O O
mps B-Dis B-Dis
iva I-Dis I-Dis
-rrb- O O
is O O
an O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
lysosomal I-Dis I-Dis
storage I-Dis I-Dis
disorder I-Dis I-Dis
caused O O
by O O
a O O
genetic B-Dis B-Dis
defect I-Dis I-Dis
in O O
n-acetylgalactosamine-6-sulfate O O
sulfatase O O
-lrb- O O
galns O O
-rrb- O O
. O O

the O O
observation O O
of O O
these O O
symptoms O O
in O O
two O O
probands O O
prompted O O
us O O
to O O
search O O
for O O
mutations O O
within O O
their O O
pomc O O
genes O O
. O O

their O O
late O O
father O O
had O O
the O O
adult O O
type O O
of O O
dm B-Dis B-Dis
, O O
with O O
onset O O
around O O
_num2 O O
years O O
. O O

the O O
atp7b O O
gene O O
has O O
been O O
excluded O O
in O O
the O O
much O O
rarer O O
human O O
copper B-Dis B-Dis
overload I-Dis I-Dis
disease O I-Dis
non-indian B-Dis O
childhood I-Dis O
cirrhosis I-Dis B-Dis
, O O
indicating O O
genetic O O
heterogeneity O O
. O O

myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
, O O
the O O
most O O
prevalent O O
muscular B-Dis B-Dis
disorder I-Dis I-Dis
in O O
adults O O
, O O
is O O
caused O O
by O O
-lrb- O O
_ds O O
-rrb- O O
n-repeat O O
expansion O O
in O O
a O O
gene O O
encoding O O
a O O
protein O O
kinase O O
-lrb- O O
dm B-Dis B-Dis
protein O O
kinase O O
; O O
dmpk O O
-rrb- O O
and O O
involves O O
changes O O
in O O
cytoarchitecture O O
and O O
ion O O
homeostasis O O
. O O

identification O O
of O O
three O O
novel O O
mutations O O
and O O
a O O
high O O
frequency O O
of O O
the O O
arg778leu O O
mutation O O
in O O
korean O O
patients O O
with O O
wilson B-Dis B-Dis
disease I-Dis I-Dis
. O O

further O O
evidence O O
for O O
a O O
major O O
ancient O O
mutation O O
underlying O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
from O O
linkage O O
disequilibrium O O
studies O O
in O O
the O O
japanese O O
population O O
. O O

_num1 O O
% O O
of O O
unselected O O
ashkenazi O O
jews O O
and O O
higher O O
proportions O O
of O O
ashkenazim O O
with O O
family O O
or O O
personal O O
histories O O
of O O
crc B-Dis O
-lrb- O O
ref O O
. O O

these O O
findings O O
are O O
consistent O O
with O O
the O O
hypothesis O O
that O O
certain O O
alleles O O
could O O
prevent O O
or O O
modify O O
the O O
clinical O O
manifestations O O
of O O
bpad B-Dis B-Dis
and O O
perhaps O O
other O O
related O O
affective B-Dis O
disorders I-Dis O
. O O

low O O
frequency O O
of O O
brca1 O O
germline O O
mutations O O
in O O
_num2 O O
german O B-Dis
breast B-Dis I-Dis
/ I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
families O O
. O O

we O O
have O O
also O O
observed O O
the O O
879delg O O
defect O O
in O O
two O O
dutch O O
c6-deficient B-Dis B-Dis
kindreds O O
, O O
but O O
the O O
879delg O O
defect O O
in O O
the O O
cape O O
probably O O
did O O
not O O
come O O
from O O
the O O
netherlands O O
. O O
. O O

mutations O O
are O O
small O O
deletions O O
or O O
point O O
mutations O O
frequently O O
affecting O O
splice O O
sites O O
. O O

genotype-phenotype O O
studies O O
were O O
not O O
performed O O
on O O
this O O
small O O
group O O
of O O
bzs B-Dis O
families O O
. O O

objective O O
to O O
determine O O
the O O
relative O O
effects O O
of O O
genetic O O
and O O
environmental O O
factors O O
in O O
susceptibility O O
to O O
ankylosing B-Dis B-Dis
spondylitis I-Dis I-Dis
-lrb- O O
as B-Dis B-Dis
-rrb- O O
. O O

the O O
largest O O
proportion O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
families O O
due O O
to O O
other O O
genes O O
was O O
found O O
in O O
families O O
with O O
four O O
or O O
five O O
cases O O
of O O
female O B-Dis
breast B-Dis I-Dis
cancer I-Dis I-Dis
only O O
. O O

methods O O
twins O O
with O O
as B-Dis O
were O O
identified O O
from O O
the O O
royal O O
national O O
hospital O O
for O O
rheumatic B-Dis B-Dis
diseases I-Dis I-Dis
database O O
. O O

these O O
results O O
will O O
form O O
the O O
basis O O
for O O
studies O O
of O O
mutation O O
and O O
imprinting O O
of O O
ube3a O O
. O O

one O O
missense O O
mutation O O
-lrb- O O
l236p O O
-rrb- O O
was O O
found O O
in O O
a O O
homozygous O O
state O O
in O O
two O O
consanguineous O O
families O O
and O O
in O O
a O O
heterozygous O O
state O O
in O O
five O O
additional O O
non-consanguineous O O
families O O
. O O

in O O
individuals O O
with O O
mutations O O
in O O
either O O
region O O
_num1 O O
or O O
region O O
_num1 O O
, O O
the O O
average O O
number O O
of O O
adenomas B-Dis B-Dis
tended O O
to O O
be O O
lower O O
than O O
those O O
in O O
individuals O O
with O O
mutations O O
in O O
region O O
_num1 O O
, O O
although O O
age O O
at O O
diagnosis O O
was O O
similar O O
. O O

among O O
these O O
mutations O O
two O O
are O O
missense O O
-lrb- O O
g197w O O
, O O
w427r O O
-rrb- O O
, O O
two O O
are O O
nonsense O O
-lrb- O O
q306x O O
, O O
q385x O O
-rrb- O O
, O O
two O O
are O O
small O O
deletions O O
-lrb- O O
662de14bp O O
; O O
1168del3bp O O
removing O O
a O O
glycine O O
at O O
position O O
_num3 O O
-rrb- O O
, O O
and O O
one O O
is O O
a O O
splicing O O
mutation O O
-lrb- O O
ivs1-15c O O
-- O O
> O O
g O O
-rrb- O O
which O O
creates O O
a O O
new O O
acceptor O O
splice O O
site O O
. O O

in O O
marked O O
contrast O O
to O O
the O O
atm O O
mutation O O
pattern O O
in O O
a-t B-Dis B-Dis
, O O
the O O
most O O
frequent O O
nucleotide O O
changes O O
in O O
this O O
leukaemia B-Dis O
were O O
missense O O
mutations O O
. O O

in O O
patients O O
of O O
dutch O O
ethnic O O
origin O O
, O O
however O O
, O O
no O O
significant O O
founder O O
effect O O
could O O
be O O
identified O O
. O O

systematic O O
analysis O O
of O O
coproporphyrinogen O O
oxidase O O
gene O O
defects O O
in O O
hereditary B-Dis B-Dis
coproporphyria I-Dis I-Dis
and O O
mutation O O
update O O
. O O

however O O
, O O
the O O
mechanism O O
of O O
hypohaptoglobinemia B-Dis O
remains O O
unknown O O
genotype-phenotype O O
correlations O O
in O O
attenuated B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
coli I-Dis I-Dis
. O O

_num4 O O
-rrb- O O
, O O
although O O
there O O
is O O
a O O
less O O
severe O O
a-t B-Dis B-Dis
phenotype O O
in O O
terms O O
of O O
the O O
degree O O
of O O
cerebellar B-Dis B-Dis
degeneration I-Dis I-Dis
. O O

appreciable O O
beta O O
hexosaminidase O O
a O O
-lrb- O O
hex O O
a O O
-rrb- O O
activity O O
has O O
been O O
detected O O
in O O
cultured O O
skin O O
fibroblasts O O
and O O
melanoma B-Dis B-Dis
tissue O O
from O O
healthy O O
individuals O O
previously O O
reported O O
as O O
having O O
deficiency B-Dis B-Dis
of I-Dis I-Dis
hex I-Dis I-Dis
a I-Dis I-Dis
activity O O
indistinguishable O O
from O O
that O O
of O O
patients O O
with O O
tay-sachs B-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
tsd B-Dis B-Dis
-rrb- O O
. O O

in O O
this O O
study O O
we O O
investigated O O
_num2 O O
german O B-Dis
breast B-Dis I-Dis
/ I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
families O O
for O O
germline O O
mutations O O
in O O
the O O
brca1 O O
gene O O
. O O

the O O
genetic O O
basis O O
of O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
is O O
the O O
expansion O O
of O O
an O O
unstable O O
_ds O O
repeat O O
in O O
the O O
_num2 O O
utr O O
of O O
the O O
dm B-Dis O
protein O O
kinase O O
gene O O
on O O
chromosome O O
_num2 O O
. O O

the O O
mutation O O
destroyed O O
an O O
ndei O O
restriction O O
enzyme O O
site O O
. O O

a O O
lod O O
score O O
of O O
_num2 O O
was O O
calculated O O
for O O
linkage O O
between O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
and O O
hla-b O O
at O O
a O O
maximum O O
likelihood O O
value O O
of O O
the O O
recombinant O O
fraction O O
of O O
_num1 O O
. O O

mutations O O
of O O
the O O
human O O
pax6 O O
gene O O
underlie O O
aniridia B-Dis B-Dis
-lrb- O O
congenital B-Dis B-Dis
absence I-Dis I-Dis
of I-Dis I-Dis
the I-Dis I-Dis
iris I-Dis I-Dis
-rrb- O O
, O O
a O O
rare O O
dominant O O
malformation B-Dis O
of I-Dis O
the I-Dis O
eye I-Dis O
. O O

affected O O
individuals O O
in O O
three O O
families O O
are O O
homozygous O O
for O O
4003deltc O O
, O O
whereas O O
those O O
in O O
two O O
others O O
are O O
compound O O
heterozygotes O O
. O O

attenuated B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
coli I-Dis I-Dis
patients O O
have O O
'' O O
multiple O O
'' O O
colorectal B-Dis B-Dis
adenomas I-Dis I-Dis
-lrb- O O
typically O O
fewer O O
than O O
_num3 O O
-rrb- O O
without O O
the O O
florid O O
phenotype O O
of O O
classical O O
fap B-Dis B-Dis
. O O

defective O O
thrombosis B-Dis O
in O O
mutant O O
mice O O
was O O
also O O
evident O O
in O O
an O O
in O O
vivo O O
model O O
of O O
vascular B-Dis B-Dis
injury I-Dis I-Dis
. O O

pendred B-Dis B-Dis
syndrome I-Dis I-Dis
is O O
an O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
disorder I-Dis I-Dis
characterized O O
by O O
early O O
childhood O O
deafness B-Dis B-Dis
and O O
goiter B-Dis B-Dis
. O O

_num1 O O
kb O O
of O O
5-utr O O
and O O
> O O
_num1 O O
kb O O
of O O
3-utr O O
. O O

knowledge O O
of O O
the O O
potential O O
reasons O O
for O O
these O O
changes O O
in O O
results O O
and O O
impact O O
of O O
these O O
risk O O
reversals O O
on O O
both O O
patients O O
and O O
the O O
counseling O O
team O O
can O O
assist O O
in O O
the O O
development O O
of O O
strategies O O
for O O
the O O
prevention O O
and O O
, O O
where O O
necessary O O
, O O
management O O
of O O
a O O
risk O O
reversal O O
in O O
any O O
predictive O O
testing O O
program O O
. O O
. O O

background O O
/ O O
aims O O
the O O
development O O
of O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
and O O
a O O
variable O O
range O O
of O O
extracolonic O O
manifestations O O
in O O
familial B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
-lrb- O O
fap B-Dis B-Dis
-rrb- O O
is O O
the O O
result O O
of O O
the O O
dominant O O
inheritance O O
of O O
adenomatous B-Dis B-Dis
polyposis I-Dis I-Dis
coli I-Dis I-Dis
-lrb- O O
apc B-Dis B-Dis
-rrb- O O
gene O O
mutations O O
. O O

conclusions O O
extended O O
genotype-phenotype O O
correlations O O
made O O
in O O
this O O
study O O
may O O
have O O
the O O
potential O O
to O O
determine O O
the O O
most O O
appropriate O O
surveillance O O
and O O
prophylactic O O
treatment O O
regimens O O
for O O
those O O
patients O O
with O O
mutations O O
associated O O
with O O
life O O
threatening O O
conditions O O
. O O

the O O
mutations O O
include O O
three O O
single O O
base O O
deletions O O
, O O
one O O
splice O O
site O O
mutation O O
and O O
_num2 O O
missense O O
mutations O O
. O O

as O O
constitutional O O
dna O O
was O O
not O O
available O O
, O O
a O O
putative O O
hereditary O O
predisposition O O
to O O
t-pll B-Dis O
will O O
require O O
further O O
investigation O O
. O O
. O O

tfr O O
hfe O O
stoichiometry O O
-lrb- O O
_num1 O O
_num1 O O
-rrb- O O
differs O O
from O O
tfr O O
transferrin O O
stoichiometry O O
-lrb- O O
_num1 O O
_num1 O O
-rrb- O O
, O O
implying O O
a O O
different O O
mode O O
of O O
binding O O
for O O
hfe O O
and O O
transferrin O O
to O O
tfr O O
, O O
consistent O O
with O O
our O O
demonstration O O
that O O
hfe O O
, O O
transferrin O O
, O O
and O O
tfr O O
form O O
a O O
ternary O O
complex O O
. O O

reversal O O
of O O
severe O O
hypertrophic B-Dis B-Dis
cardiomyopathy I-Dis I-Dis
and O O
excellent O O
neuropsychologic O O
outcome O O
in O O
very-long-chain B-Dis B-Dis
acyl-coenzyme I-Dis I-Dis
a I-Dis I-Dis
dehydrogenase I-Dis I-Dis
deficiency I-Dis I-Dis
. O O

the O O
chromosomal O O
order O O
of O O
genes O O
controlling O O
the O O
major O O
histocompatibility O O
complex O O
, O O
properdin O O
factor O O
b O O
, O O
and O O
deficiency B-Dis B-Dis
of I-Dis I-Dis
the I-Dis I-Dis
second I-Dis I-Dis
component I-Dis I-Dis
of I-Dis I-Dis
complement I-Dis I-Dis
. O O

the O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
linkage O O
consortium O O
. O O

the O O
hypothesis O O
that O O
sws B-Dis O
and O O
sjs B-Dis O
type I-Dis O
_num1 I-Dis O
are O O
the O O
same O O
disorder O O
should O O
be O O
testable O O
by O O
molecular O O
methods O O
. O O
. O O

additional O O
experiments O O
are O O
needed O O
to O O
define O O
the O O
role O O
of O O
_ds O O
ix O O
and O O
_ds O O
xii O O
enzymes O O
in O O
the O O
regulation O O
of O O
ph O O
in O O
the O O
extracellular O O
microenvironment O O
and O O
its O O
potential O O
impact O O
on O O
cancer B-Dis B-Dis
cell O O
growth O O
. O O

five O O
of O O
the O O
cases O O
were O O
observed O O
in O O
children O O
presenting O O
with O O
idiopathic O B-Dis
hemolytic B-Dis I-Dis
uremic I-Dis I-Dis
syndrome I-Dis I-Dis
-lrb- O O
hus B-Dis O
-rrb- O O
. O O

the O O
gene O O
, O O
termed O O
low-density O O
lipoprotein O O
receptor O O
related O O
protein O O
_num1 O O
-lrb- O O
lrp5 O O
-rrb- O O
, O O
encodes O O
a O O
protein O O
of O O
_num4 O O
amino O O
acids O O
that O O
contains O O
conserved O O
modules O O
which O O
are O O
characteristic O O
of O O
the O O
low-density O O
lipoprotein O O
-lrb- O O
ldl O O
-rrb- O O
receptor O O
family O O
. O O

we O O
then O O
proceeded O O
with O O
sequence O O
analysis O O
of O O
the O O
entire O O
pten O O
/ O O
mmac1 O O
coding O O
region O O
and O O
tested O O
for O O
homozygous O O
deletion O O
with O O
new O O
intragenic O O
markers O O
in O O
these O O
_num2 O O
cases O O
with O O
10q23 O O
loss O O
of O O
heterozygosity O O
. O O

missense O O
mutations O O
in O O
the O O
most O O
ancient O O
residues O O
of O O
the O O
pax6 O O
paired O O
domain O O
underlie O O
a O O
spectrum O O
of O O
human O O
congenital B-Dis B-Dis
eye I-Dis I-Dis
malformations I-Dis I-Dis
. O O

these O O
studies O O
suggest O O
that O O
the O O
genes O O
for O O
factor O B-Dis
b O I-Dis
and O I-Dis
c2 B-Dis I-Dis
deficiency I-Dis I-Dis
are O O
located O O
outside O O
those O O
for O O
hla O O
, O O
that O O
the O O
order O O
of O O
genese O O
is O O
hla-a O O
, O O
- O O
b O O
, O O
- O O
d O O
, O O
factor O O
b O O
allotype O O
, O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
, O O
that O O
the O O
genes O O
coding O O
for O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
and O O
factor O O
b O O
allotypes O O
are O O
approximately O O
_num1 O O
-- O O
_num1 O O
centimorgans O O
from O O
the O O
hla-a O O
and O O
hla-b O O
loci O O
, O O
and O O
that O O
the O O
apparent O O
lack O O
of O O
recombinants O O
between O O
the O O
factor O O
b O O
gene O O
and O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
gene O O
suggests O O
that O O
these O O
two O O
genes O O
lie O O
in O O
close O O
proximity O O
to O O
one O O
another O O
. O O

in O O
specific O O
c5 O O
titrations O O
, O O
however O O
, O O
it O O
was O O
noted O O
that O O
when O O
limited O O
amounts O O
of O O
c5 O O
were O O
assayed O O
in O O
the O O
presence O O
of O O
low O O
dilutions O O
of O O
either O O
c5d B-Dis B-Dis
serum O O
, O O
curving O O
rather O O
than O O
linear O O
dose-response O O
plots O O
were O O
consistently O O
obtained O O
, O O
suggesting O O
some O O
inhibitory O O
effect O O
. O O

two O O
altered O O
dp71 O O
transcripts O O
and O O
two O O
deleted O O
dp140 O O
dna O O
sequences O O
were O O
found O O
in O O
four O O
patients O O
with O O
severe O O
cerebral B-Dis B-Dis
dysfunction I-Dis I-Dis
. O O

in O O
order O O
to O O
define O O
the O O
types O O
of O O
disease-causing O O
atm O O
mutations O O
in O O
japanese O O
a-t B-Dis B-Dis
patients O O
as O O
well O O
as O O
to O O
look O O
for O O
possible O O
mutational O O
hotspots O O
, O O
reverse-transcribed O O
rna O O
derived O O
from O O
ten O O
patients O O
belonging O O
to O O
eight O O
unrelated O O
japanese O O
a-t B-Dis B-Dis
families O O
was O O
analyzed O O
for O O
mutations O O
by O O
the O O
restriction O O
endonuclease O O
fingerprinting O O
method O O
. O O

_num2 O O
, O O
n O O
= O O
_num2 O O
subjects O O
-rrb- O O
. O O

most O O
patients O O
were O O
found O O
to O O
be O O
compound O O
heterozygote O O
. O O

these O O
findings O O
suggest O O
that O O
some O O
sequences O O
located O O
in O O
the O O
distal O O
part O O
of O O
the O O
gene O O
and O O
, O O
in O O
particular O O
, O O
some O O
dmd B-Dis B-Dis
isoforms O O
expressed O O
in O O
the O O
brain O O
may O O
be O O
related O O
to O O
the O O
cognitive B-Dis O
impairment I-Dis O
associated O O
with O O
dmd B-Dis B-Dis
. O O
. O O

_num1 O O
and O O
_num2 O O
. O O

as O O
in O O
the O O
human O O
disease O O
, O O
the O O
factor O O
viii O O
level O O
in O O
these O O
mice O O
was O O
reduced O O
strongly O O
as O O
a O O
result O O
of O O
the O O
lack O O
of O O
protection O O
provided O O
by O O
vwf O O
. O O

the O O
rb1 O O
gene O O
mutation O O
was O O
investigated O O
in O O
a O O
child O O
with O O
ectopic B-Dis O
intracranial I-Dis O
retinoblastoma I-Dis B-Dis
using O O
dna O O
obtained O O
from O O
both O O
the O O
pineal B-Dis B-Dis
and I-Dis I-Dis
retinal I-Dis I-Dis
tumours I-Dis I-Dis
of O O
the O O
patient O O
. O O

somatic O O
instability O O
of O O
the O O
_ds O O
repeat O O
in O O
mice O O
transgenic O O
for O O
the O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
region O O
is O O
age O O
dependent O O
but O O
not O O
correlated O O
to O O
the O O
relative O O
intertissue O O
transcription O O
levels O O
and O O
proliferative O O
capacities O O
. O O

while O O
the O O
proband O O
-lrb- O O
patient O O
_num1 O O
-rrb- O O
was O O
classified O O
as O O
having O O
a O O
rare O O
intermediate O O
type O O
of O O
adult O O
cerebral O O
and O O
cerebello-brain O O
stem O O
forms O O
, O O
his O O
younger O O
brother O O
-lrb- O O
patient O O
_num1 O O
-rrb- O O
and O O
nephew O O
-lrb- O O
patient O O
_num1 O O
-rrb- O O
had O O
a O O
childhood O O
ald B-Dis B-Dis
type O O
. O O

_num1 O O
% O O
of O O
_num3 O O
european O O
and O O
_num1 O O
. O O

compelling O O
evidence O O
supports O O
a O O
significant O O
genetic O O
component O O
in O O
the O O
susceptibility O O
to O O
develop O O
bpad B-Dis B-Dis
. O O

we O O
studied O O
the O O
molecular O O
basis O O
of O O
c9 B-Dis B-Dis
deficiency I-Dis I-Dis
in O O
four O O
japanese O O
c9-deficient B-Dis O
patients O O
who O O
had O O
suffered O O
from O O
meningococcal B-Dis B-Dis
meningitis I-Dis I-Dis
. O O

conversely O O
, O O
the O O
majority O O
of O O
families O O
with O O
male B-Dis B-Dis
and I-Dis I-Dis
female I-Dis I-Dis
breast I-Dis I-Dis
cancer I-Dis I-Dis
were O O
due O O
to O O
brca2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
. O O

the O O
i113f O O
and O O
t312s O O
mutations O O
accounted O O
for O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
and O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
_num2 O O
unrelated O O
alleles O O
, O O
respectively O O
. O O

these O O
mutations O O
were O O
scattered O O
over O O
the O O
entire O O
length O O
of O O
pten O O
, O O
with O O
the O O
exception O O
of O O
the O O
first O O
, O O
fourth O O
and O O
last O O
exons O O
. O O

the O O
patients O O
father O O
and O O
two O O
brothers O O
also O O
had O O
c6d B-Dis O
, O O
but O O
gave O O
no O O
history O O
of O O
meningitis B-Dis B-Dis
or O O
other O O
neisserial B-Dis B-Dis
infection I-Dis I-Dis
. O O

the O O
frequency O O
of O O
_an O O
gene O O
mutation O O
in O O
our O O
sample O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
is O O
among O O
the O O
highest O O
rates O O
yet O O
reported O O
and O O
the O O
cdk4 O O
mutation O O
is O O
the O O
second O O
mutation O O
detected O O
in O O
this O O
gene O O
worldwide O O
. O O

a O O
t1-weighted O O
magnetic O O
resonance O O
imaging O O
of O O
the O O
fathers O O
pituitary O O
gland O O
demonstrates O O
an O O
attenuated O O
posterior O O
pituitary O O
bright O O
spot O O
. O O

in O O
vitro-differentiated O O
dmpk O O
-lsb- O O
- O O
/ O O
- O O
-rsb- O O
myotubes O O
exhibit O O
a O O
higher O O
resting O O
-lsb- O O
ca2 O O
+ O O
-rsb- O O
i O O
than O O
do O O
wild-type O O
myotubes O O
because O O
of O O
an O O
altered O O
open O O
probability O O
of O O
voltage-dependent O O
l-type O O
ca2 O O
+ O O
and O O
na O O
+ O O
channels O O
. O O

the O O
corresponding O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
risks O O
were O O
_num1 O O
. O O

recent O O
studies O O
have O O
shown O O
that O O
hereditary B-Dis B-Dis
hemochromatosis I-Dis I-Dis
-lrb- O O
hh B-Dis B-Dis
-rrb- O O
is O O
likely O O
to O O
be O O
caused O O
by O O
homozygosity O O
for O O
a O O
cys282tyr O O
mutation O O
in O O
the O O
hfe O O
gene O O
located O O
_num1 O O
. O O

thus O O
, O O
the O O
postulated O O
rate O O
mutant O O
gene O O
appears O O
to O O
code O O
for O O
the O O
expression O O
of O O
low O O
amounts O O
of O O
hex O O
a. O O
heterozygotes O O
for O O
the O O
rare O O
mutant O O
may O O
be O O
indistinguishable O O
from O O
heterozygotes O O
for O O
the O O
common O O
tsd B-Dis B-Dis
mutant O O
. O O

the O O
deduced O O
protein O O
sequence O O
was O O
classified O O
as O O
a O O
one-pass O O
transmembrane O O
_ds O O
possessing O O
an O O
apparently O O
intact O O
catalytic O O
domain O O
in O O
the O O
extracellular O O
_ds O O
module O O
. O O

the O O
percentage O O
of O O
errors O O
in O O
antisaccades O O
was O O
greatly O O
increased O O
and O O
was O O
significantly O O
correlated O O
with O O
age O O
at O O
disease O O
onset O O
. O O

the O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
mutation O O
is O O
an O O
unstable O O
-lrb- O O
_ds O O
-rrb- O O
n O O
repeat O O
, O O
present O O
at O O
a O O
copy O O
number O O
of O O
5-37 O O
repeats O O
on O O
normal O O
chromosomes O O
but O O
amplified O O
to O O
50-3000 O O
copies O O
on O O
dm B-Dis B-Dis
chromosomes O O
. O O

although O O
emerin O O
was O O
abundant O O
in O O
the O O
membranes O O
of O O
cardiomyocyte O O
nuclei O O
, O O
it O O
was O O
absent O O
from O O
many O O
non-myocyte O O
cells O O
in O O
the O O
heart O O
. O O

although O O
both O O
domains O O
of O O
the O O
vhl B-Dis B-Dis
protein O O
contribute O O
to O O
regulation O O
of O O
ca12 O O
expression O O
, O O
the O O
elongin O O
binding O O
domain O O
alone O O
could O O
effectively O O
regulate O O
ca9 O O
expression O O
. O O

_num4 O O
-rrb- O O
, O O
suggesting O O
that O O
differences O O
in O O
methods O O
used O O
for O O
mutation O O
detection O O
or O O
phenotype O O
classification O O
may O O
account O O
for O O
a O O
considerable O O
proportion O O
of O O
genotype-phenotype O O
inconsistencies O O
. O O

recently O O
, O O
however O O
, O O
a O O
missense O O
variant O O
of O O
apc B-Dis O
-lrb- O O
i1307k O O
-rrb- O O
was O O
described O O
that O O
confers O O
an O O
increased O O
risk O O
of O O
colorectal B-Dis B-Dis
tumors I-Dis I-Dis
, O O
including O O
multiple O B-Dis
adenomas B-Dis I-Dis
, O O
in O O
ashkenazim O O
. O O

among O O
the O O
seven O O
contributing O O
centers O O
, O O
the O O
proportion O O
of O O
patients O O
for O O
whom O O
the O O
observed O O
phenotype O O
did O O
not O O
match O O
the O O
predicted O O
phenotype O O
was O O
_num1 O O
% O O
-23 O O
% O O
-lrb- O O
p O O
< O O
. O O

in O O
most O O
patients O O
with O O
isolated O O
unilateral B-Dis B-Dis
retinoblastoma I-Dis I-Dis
, O O
tumor B-Dis B-Dis
development O O
is O O
initiated O O
by O O
somatic O O
inactivation O O
of O O
both O O
alleles O O
of O O
the O O
rb1 O O
gene O O
. O O

the O O
proband O O
, O O
a O O
20-year-old O O
black O O
female O O
with O O
systemic B-Dis B-Dis
lupus I-Dis I-Dis
erythematosus I-Dis I-Dis
since O O
age O O
_num2 O O
, O O
lacked O O
serum O O
hemolytic O O
complement O O
activity O O
, O O
even O O
during O O
remission O O
. O O

heterozygous O O
germ-line O O
mutations O O
in O O
the O O
dna O O
mismatch O O
repair O O
genes O O
lead O O
to O O
hereditary B-Dis B-Dis
nonpolyposis I-Dis I-Dis
colorectal I-Dis I-Dis
cancer I-Dis I-Dis
. O O

only O O
six O O
other O O
cases O O
of O O
paternal O O
transmission O O
of O O
congenital B-Dis O
dm I-Dis B-Dis
have O O
been O O
reported O O
recently O O
. O O

in O O
combination O O
with O O
molecular O O
genetic O O
analyses O O
, O O
this O O
test O O
may O O
be O O
of O O
value O O
in O O
studies O O
of O O
familial B-Dis B-Dis
and I-Dis I-Dis
sporadic I-Dis I-Dis
cancers I-Dis I-Dis
aimed O O
at O O
determination O O
of O O
the O O
potential O O
involvement O O
of O O
atm O O
mutations O O
in O O
tumor B-Dis B-Dis
risk O O
or O O
development O O
. O O
. O O

in O O
_num1 O O
patients O O
without O O
a O O
detectable O O
mutation O O
in O O
peripheral O O
blood O O
, O O
mosaicism O O
was O O
suggested O O
because O O
_num1 O O
of O O
the O O
patients O O
showed O O
multifocal O B-Dis
tumors B-Dis I-Dis
and O O
the O O
other O O
later O O
developed O O
bilateral B-Dis O
retinoblastoma I-Dis B-Dis
. O O

a O O
hot O O
spot O O
for O O
pten O O
mutation O O
in O O
cd B-Dis O
was O O
identified O O
in O O
exon O O
_num1 O O
that O O
contains O O
the O O
ptpase O O
core O O
motif O O
, O O
with O O
_num2 O O
of O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
cd B-Dis O
mutations O O
identified O O
in O O
this O O
exon O O
. O O

results O O
six O O
of O O
_num1 O O
monozygotic O O
-lrb- O O
mz O O
-rrb- O O
twin O O
pairs O O
were O O
disease O O
concordant O O
, O O
compared O O
with O O
_num1 O O
of O O
_num2 O O
b27-positive O O
dizygotic O O
-lrb- O O
dz O O
-rrb- O O
twin O O
pairs O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
and O O
_num1 O O
of O O
_num2 O O
dz O O
twin O O
pairs O O
overall O O
-lrb- O O
_num2 O O
. O O

by O O
hemolytic O O
assay O O
, O O
she O O
exhibited O O
1-2 O O
% O O
of O O
the O O
normal O O
serum O O
c5 O O
level O O
and O O
normal O O
concentrations O O
of O O
other O O
complement O O
components O O
. O O

affected O O
individuals O O
are O O
not O O
symptomatic O O
at O O
birth O O
, O O
but O O
usually O O
develop O O
diabetes B-Dis B-Dis
insipidus I-Dis I-Dis
at O O
1-6 O O
yr O O
of O O
age O O
. O O

_num1 O O
-lrb- O O
_num2 O O
percent O O
confidence O O
interval O O
, O O
_num1 O O
. O O

strikingly O O
, O O
all O O
four O O
mutations O O
are O O
located O O
within O O
the O O
pax6 O O
paired O O
domain O O
and O O
affect O O
amino O O
acids O O
which O O
are O O
highly O O
conserved O O
in O O
all O O
known O O
paired O O
domain O O
proteins O O
. O O

in O O
this O O
family O O
affected O O
individuals O O
developed O O
unilateral B-Dis B-Dis
tumors I-Dis I-Dis
and O O
, O O
as O O
a O O
result O O
of O O
linkage O O
analysis O O
, O O
unaffected O O
mutation O O
carriers O O
were O O
also O O
identified O O
within O O
the O O
pedigree O O
. O O

we O O
report O O
on O O
an O O
unusual O O
case O O
of O O
maternal B-Dis B-Dis
disomy I-Dis I-Dis
_num2 I-Dis I-Dis
in O O
pws B-Dis B-Dis
that O O
is O O
most O O
consistent O O
with O O
adjacent-1 O O
segregation O O
of O O
a O O
paternal O O
t O O
-lrb- O O
_num1 O O
; O O
_num2 O O
-rrb- O O
-lrb- O O
_an O O
; O O
_an O O
. O O

a O O
new O O
tumor B-Dis B-Dis
suppressor O O
gene O O
, O O
pten O O
/ O O
mmac1 O O
, O O
was O O
isolated O O
recently O O
at O O
this O O
region O O
of O O
chromosome O O
10q23 O O
and O O
found O O
to O O
be O O
inactivated O O
by O O
mutation O O
in O O
three O O
prostate B-Dis B-Dis
cancer I-Dis I-Dis
cell O O
lines O O
. O O

homozygous O O
smad4 O O
mutant O O
mice O O
die O O
before O O
day O O
_num1 O O
. O O

the O O
two O O
other O O
siblings O O
, O O
apparently O O
healthy O O
at O O
_num2 O O
-lrb- O O
1 O O
/ O O
2 O O
-rrb- O O
and O O
_num2 O O
years O O
, O O
respectively O O
, O O
and O O
their O O
father O O
, O O
apparently O O
healthy O O
as O O
well O O
, O O
presented O O
arsa O O
and O O
gs O B-Dis
values O O
within O O
the O O
range O O
of O O
mld B-Dis B-Dis
patients O O
. O O

two O O
of O O
seventeen O O
mutated O O
t-pll B-Dis O
samples O O
had O O
a O O
previously O O
reported O O
a-t B-Dis B-Dis
allele O O
. O O

to O O
date O O
, O O
mutation O O
screening O O
in O O
the O O
two O O
genes O O
has O O
been O O
hampered O O
by O O
the O O
lack O O
of O O
genomic O O
structure O O
information O O
. O O

the O O
contribution O O
of O O
brca1 O O
and O O
brca2 O O
to O O
inherited B-Dis B-Dis
breast I-Dis I-Dis
cancer I-Dis I-Dis
was O O
assessed O O
by O O
linkage O O
and O O
mutation O O
analysis O O
in O O
_num3 O O
families O O
, O O
each O O
with O O
at O O
least O O
four O O
cases O O
of O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
, O O
collected O O
by O O
the O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
linkage O O
consortium O O
. O O

mutations O O
were O O
located O O
in O O
three O O
different O O
regions O O
of O O
the O O
apc B-Dis O
gene O O
-lrb- O O
_num1 O O
-rrb- O O
at O O
the O O
_num1 O O
end O O
spanning O O
exons O O
_num1 O O
and O O
_num1 O O
, O O
-lrb- O O
_num1 O O
-rrb- O O
within O O
exon O O
_num1 O O
, O O
and O O
-lrb- O O
_num1 O O
-rrb- O O
at O O
the O O
_num1 O O
distal O O
end O O
of O O
the O O
gene O O
. O O

by O O
protein-truncation O O
test O O
-lrb- O O
ptt O O
-rrb- O O
assay O O
, O O
the O O
entire O O
coding O O
region O O
of O O
the O O
apc B-Dis B-Dis
gene O O
was O O
screened O O
in O O
affected O O
individuals O O
from O O
_num2 O O
aapc B-Dis B-Dis
kindreds O O
, O O
and O O
their O O
phenotypic O O
differences O O
were O O
examined O O
. O O

we O O
report O O
, O O
in O O
two O O
a-t B-Dis B-Dis
families O O
, O O
an O O
atm O O
mutation O O
-lrb- O O
7271t O O
-- O O
> O O
g O O
-rrb- O O
that O O
may O O
be O O
associated O O
with O O
an O O
increased O O
risk O O
of O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
in O O
both O O
homozygotes O O
and O O
heterozygotes O O
-lrb- O O
relative O O
risk O O
_num2 O O
. O O

the O O
c282y O O
mutation O O
nearly O O
completely O O
prevents O O
the O O
association O O
of O O
the O O
mutant O O
hfe O O
protein O O
with O O
the O O
tfr O O
. O O

von B-Dis B-Dis
willebrand I-Dis I-Dis
factor I-Dis I-Dis
-lrb- I-Dis I-Dis
vwf I-Dis I-Dis
-rrb- I-Dis I-Dis
deficiency I-Dis I-Dis
causes O O
severe O B-Dis
von B-Dis I-Dis
willebrand I-Dis I-Dis
disease I-Dis I-Dis
in O O
humans O O
. O O

the O O
first O O
recognized O O
human O O
kindred O O
with O O
hereditary B-Dis B-Dis
deficiency I-Dis I-Dis
of I-Dis I-Dis
the I-Dis I-Dis
fifth I-Dis I-Dis
component I-Dis I-Dis
of I-Dis I-Dis
complement I-Dis I-Dis
-lrb- O O
c5 O O
-rrb- O O
is O O
described O O
. O O

a O O
dna-based O O
test O O
for O O
the O O
hfe O O
gene O O
is O O
commercially O O
available O O
, O O
but O O
its O O
place O O
in O O
the O O
diagnosis O O
of O O
hemochromatosis B-Dis B-Dis
is O O
still O O
being O O
evaluated O O
. O O

molecular O O
analysis O O
of O O
the O O
apc B-Dis B-Dis
gene O O
in O O
_num3 O O
families O O
: O O
extended O O
genotype-phenotype O O
correlations O O
in O O
fap B-Dis B-Dis
and O O
evidence O O
for O O
the O O
role O O
of O O
apc B-Dis O
amino O O
acid O O
changes O O
in O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
predisposition O O
. O O

addition O O
of O O
soluble O O
wild-type O O
hfe O O
/ O O
beta2m O O
heterodimers O O
to O O
cultured O O
cells O O
also O O
decreased O O
the O O
apparent O O
affinity O O
of O O
the O O
tfr O O
for O O
its O O
ligand O O
under O O
steady-state O O
conditions O O
, O O
both O O
in O O
_num3 O O
cells O O
and O O
in O O
hela O O
cells O O
. O O

factor B-Dis O
h I-Dis B-Dis
deficiency I-Dis I-Dis
is O I-Dis
the O I-Dis
only O I-Dis
complement B-Dis I-Dis
deficiency I-Dis I-Dis
associated O O
with O O
hus B-Dis B-Dis
. O O

brca1 O O
and O O
brca2 O O
account O O
for O O
most O O
cases O O
of O O
familial O O
, O O
early O O
onset O O
breast B-Dis B-Dis
and I-Dis I-Dis
/ I-Dis I-Dis
or I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
and O O
encode O O
products O O
that O O
each O O
interact O O
with O O
hrad51 O O
. O O

to O O
investigate O O
whether O O
a O O
founder O O
chromosome O O
for O O
the O O
dm B-Dis B-Dis
mutation O O
exists O O
in O O
the O O
japanese O O
population O O
, O O
we O O
genotyped O O
families O O
using O O
polymorphic O O
markers O O
near O O
the O O
-lrb- O O
_ds O O
-rrb- O O
n O O
repeat O O
region O O
and O O
constructed O O
haplotypes O O
. O O

the O O
185delag O O
brca1 O O
mutation O O
originated O O
before O O
the O O
dispersion O O
of O O
jews O O
in O O
the O O
diaspora O O
and O O
is O O
not O O
limited O O
to O O
ashkenazim O O
. O O

mutations O O
in O O
apc O B-Dis
are O O
classically O O
associated O O
with O O
familial B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
-lrb- O O
fap B-Dis B-Dis
-rrb- O O
, O O
a O O
highly O O
penetrant O O
autosomal B-Dis B-Dis
dominant I-Dis I-Dis
disorder I-Dis I-Dis
characterized O O
by O O
multiple O O
intestinal O O
polyps B-Dis B-Dis
and O O
, O O
without O O
surgical O O
intervention O O
, O O
the O O
development O O
of O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
-lrb- O O
crc B-Dis O
-rrb- O O
. O O

the O O
missense O O
mutation O O
was O O
also O O
found O O
in O O
_num1 O O
. O O

several O O
mabs O O
against O O
different O O
emerin O O
epitopes O O
did O O
not O O
recognize O O
intercalated O O
discs O O
in O O
the O O
heart O O
, O O
though O O
they O O
recognized O O
cardiomyocyte O O
nuclei O O
strongly O O
, O O
both O O
at O O
the O O
rim O O
and O O
in O O
intranuclear O O
spots O O
or O O
channels O O
. O O

the O O
hp O O
gene O O
cluster O O
consists O O
of O O
coding O O
regions O O
of O O
the O O
alpha O O
chain O O
and O O
beta O O
chain O O
of O O
the O O
haptoglobin O O
gene O O
-lrb- O O
hp O O
-rrb- O O
and O O
of O O
the O O
alpha O O
chain O O
and O O
beta O O
chain O O
of O O
the O O
haptoglobin-related O O
gene O O
-lrb- O O
hpr O O
-rrb- O O
, O O
in O O
tandem O O
from O O
the O O
_num1 O O
side O O
. O O

_num1 O O
% O O
of O O
total O O
beta O O
hexosaminidase O O
activity O O
, O O
has O O
been O O
obtained O O
by O O
cellulose O O
acetate O O
gel O O
electrophoresis O O
, O O
deae-cellulose O O
ion-exchange O O
chromatography O O
, O O
radial O O
immunodiffusion O O
, O O
and O O
radioimmunoassay O O
. O O

we O O
have O O
studied O O
a O O
set O O
of O O
_num3 O O
patients O O
with O O
multiple O O
colorectal B-Dis B-Dis
adenomas I-Dis I-Dis
and I-Dis I-Dis
/ I-Dis I-Dis
or I-Dis I-Dis
carcinoma I-Dis I-Dis
and O O
analyzed O O
codons O O
1263-1377 O O
-lrb- O O
exon O O
15g O O
-rrb- O O
of O O
the O O
apc B-Dis B-Dis
gene O O
for O O
germ-line O O
variants O O
. O O

two O O
identical O O
de O O
novo O O
5-bp O O
duplications O O
in O O
exon O O
_num2 O O
were O O
found O O
. O O

no O O
desmoid B-Dis B-Dis
tumors I-Dis I-Dis
were O O
found O O
in O O
these O O
kindreds O O
. O O

a O O
genome-wide O O
search O O
for O O
chromosomal O O
loci O O
linked O O
to O O
mental O B-Dis
health O O
wellness O O
in O O
relatives O O
at O O
high O O
risk O O
for O O
bipolar B-Dis B-Dis
affective I-Dis I-Dis
disorder I-Dis I-Dis
among O O
the O O
old O O
order O O
amish O O
. O O

however O O
, O O
immunostaining O O
revealed O O
that O O
bard1 O O
resides O O
within O O
brca1 O O
nuclear O O
dots O O
during O O
s O O
phase O O
of O O
the O O
cell O O
cycle O O
, O O
but O O
not O O
during O O
the O O
g1 O O
phase O O
. O O

in O O
agreement O O
with O O
previous O O
observations O O
the O O
tyr O O
allele O O
appeared O O
to O O
be O O
rare O O
or O O
absent O O
in O O
asiatic O O
-lrb- O O
indian O O
, O O
chinese O O
-rrb- O O
populations O O
. O O

_num1 O O
% O O
of O O
american O O
jews O O
, O O
_num2 O O
% O O
of O O
their O O
familial O B-Dis
colorectal B-Dis I-Dis
cancer I-Dis I-Dis
cases O O
, O O
but O O
not O O
in O O
non-jews O O
. O O

thus O O
, O O
the O O
occurrence O O
of O O
sensorineural B-Dis B-Dis
deafness I-Dis I-Dis
in O O
this O O
patient O O
extends O O
considerably O O
the O O
phenotypic O O
range O O
of O O
piebaldism B-Dis B-Dis
due O O
to O O
kit O O
gene O O
mutation O O
in O O
humans O O
and O O
tightens O O
the O O
clinical O O
similarity O O
between O O
piebaldism B-Dis B-Dis
and O O
the O O
various O O
forms O O
of O O
waardenburg B-Dis B-Dis
syndrome I-Dis I-Dis
. O O
. O O

seven O O
families O O
were O O
found O O
to O O
have O O
the O O
fgfr3 O O
p250r O O
mutation O O
, O O
and O O
one O O
individual O O
was O O
found O O
to O O
have O O
an O O
fgfr2 O O
vv269-270 O O
deletion O O
. O O

however O O
, O O
bac O O
clones O O
containing O O
atp7b O O
and O O
_an O O
mapped O O
to O O
the O O
canine O O
chromosome O O
regions O O
cfa22q11 O O
and O O
cfa10q26 O O
, O O
respectively O O
, O O
demonstrating O O
that O O
wd B-Dis B-Dis
can O O
not O O
be O O
homologous O O
to O O
_ds B-Dis O
. O O
. O O

his O O
two O O
sibs O O
suffer O O
from O O
childhood O O
onset O O
dm B-Dis B-Dis
. O O

_num2 O O
-rrb- O O
and O O
was O O
not O O
detected O O
in O O
_num2 O O
non-european O O
jews O O
at O O
increased O O
cancer B-Dis O
risk O O
. O O

ethnic O O
differences O O
in O O
the O O
hfe O O
codon O O
_num3 O O
-lrb- O O
cys O O
/ O O
tyr O O
-rrb- O O
polymorphism O O
. O O

for O O
_num2 O O
randomly O O
selected O O
tumors B-Dis B-Dis
, O O
sscp O O
, O O
hetero-duplex O O
analysis O O
, O O
sequencing O O
, O O
and O O
southern O O
blot O O
analysis O O
were O O
used O O
to O O
identify O O
mutations O O
. O O

germ-line O O
and O O
somatic O O
truncating O O
mutations O O
of O O
the O O
apc O B-Dis
gene O O
are O O
thought O O
to O O
initiate O O
colorectal B-Dis B-Dis
tumor I-Dis I-Dis
formation O O
in O O
familial B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
syndrome I-Dis I-Dis
and O I-Dis
sporadic O I-Dis
colorectal O I-Dis
carcinogenesis O I-Dis
, O O
respectively O O
. O O

to O O
identify O O
founder O O
effects O O
, O O
we O O
examined O O
independently O O
ascertained O O
french O O
canadian O O
cancer B-Dis B-Dis
families O O
for O O
the O O
distribution O O
of O O
these O O
eight O O
mutations O O
. O O

a464v O O
, O O
although O O
clearly O O
modifying O O
arsa O O
and O O
gs O B-Dis
levels O O
, O O
apparently O O
bears O O
little O O
significance O O
for O O
clinical O O
manifestation O O
of O O
mld B-Dis B-Dis
, O O
mimicking O O
the O O
frequent O O
arsa O O
pseudodeficiency O O
allele O O
. O O

using O O
this O O
approach O O
, O O
an O O
abnormally O O
spliced O O
transcript O O
was O O
identified O O
that O O
contains O O
an O O
extra O O
_num3 O O
bases O O
upstream O O
from O O
exon O O
_num2 O O
, O O
resulting O O
in O O
a O O
premature O O
termination O O
codon O O
_num2 O O
bp O O
downstream O O
from O O
the O O
cryptic O O
splice O O
site O O
. O O

studies O O
on O O
cell-associated O O
transferrin O O
at O O
_num2 O O
degrees O O
c O O
suggest O O
that O O
the O O
overexpressed O O
wild-type O O
hfe O O
protein O O
decreases O O
the O O
affinity O O
of O O
the O O
tfr O O
for O O
transferrin O O
. O O

the O O
spectrum O O
of O O
pax6 O O
mutations O O
in O O
aniridia B-Dis B-Dis
patients O O
is O O
highly O O
biased O O
, O O
with O O
_num2 O O
% O O
of O O
all O O
reported O O
mutations O O
leading O O
to O O
premature O O
truncation O O
of O O
the O O
protein O O
-lrb- O O
nonsense O O
, O O
splicing O O
, O O
insertions O O
and O O
deletions O O
-rrb- O O
and O O
just O O
_num1 O O
% O O
leading O O
to O O
substitution O O
of O O
one O O
amino O O
acid O O
by O O
another O O
-lrb- O O
missense O O
-rrb- O O
. O O

seventeen O O
mutations O O
were O O
distinct O O
, O O
of O O
which O O
_num2 O O
were O O
not O O
reported O O
previously O O
. O O

the O O
fathers O O
genotype O O
thus O O
was O O
7delg O O
/ O O
a464v O O
. O O

the O O
i1307k O O
apc B-Dis O
gene O O
variant O O
was O O
found O O
in O O
_num1 O O
. O O

aggregation O O
of O O
mutant O O
smad4 O O
es O O
cells O O
with O O
wild-type O O
tetraploid O O
morulae O O
rescues O O
the O O
gastrulation B-Dis O
defect I-Dis O
. O O

the O O
first O O
predictive O O
testing O O
for O O
huntington B-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
hd B-Dis B-Dis
-rrb- O O
was O O
based O O
on O O
analysis O O
of O O
linked O O
polymorphic O O
dna O O
markers O O
to O O
estimate O O
the O O
likelihood O O
of O O
inheriting O O
the O O
mutation O O
for O O
hd B-Dis B-Dis
. O O

_num1 O O
% O O
, O O
which O O
is O O
considerably O O
higher O O
than O O
those O O
in O O
other O O
asian O O
populations O O
. O O

to O O
assess O O
the O O
risk O O
of O O
this O O
common O O
apc B-Dis O
allelic O O
variant O O
in O O
colorectal O O
carcinogenesis O O
, O O
we O O
have O O
analyzed O O
a O O
large O O
cohort O O
of O O
unselected O O
ashkenazi O O
jewish O O
subjects O O
with O O
adenomatous B-Dis B-Dis
polyps I-Dis I-Dis
and O O
. O O

preliminary O O
in O O
vivo O O
footprinting O O
data O O
gave O O
evidence O O
for O O
protein-dna O O
contact O O
in O O
normal O O
genes O O
at O O
an O O
sp1 O O
consensus O O
binding O O
site O O
upstream O O
of O O
the O O
_ds O O
repeat O O
and O O
for O O
a O O
significant O O
reduction O O
of O O
this O O
interaction O O
in O O
cells O O
with O O
a O O
hypermethylated O O
dmpk O O
gene O O
. O O
. O O

_num1 O O
% O O
-lrb- O O
_num2 O O
% O O
ci O O
_num1 O O
% O O
-1 O O
% O O
-rrb- O O
by O O
age O O
_num2 O O
years O O
and O O
_num2 O O
% O O
-lrb- O O
_num2 O O
% O O
ci O O
_num1 O O
% O O
-47 O O
% O O
-rrb- O O
by O O
age O O
_num2 O O
years O O
. O O

inherited B-Dis O
colorectal I-Dis B-Dis
polyposis I-Dis I-Dis
and O I-Dis
cancer B-Dis I-Dis
risk O O
of O O
the O O
apc B-Dis B-Dis
i1307k O O
polymorphism O O
. O O

these O O
findings O O
show O O
that O O
brca1 O O
is O O
implicated O O
in O O
a O O
small O O
fraction O O
of O O
breast B-Dis B-Dis
/ I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
families O O
suggesting O O
the O O
involvement O O
of O O
another O O
susceptibility O O
gene O O
-lrb- O O
s O O
-rrb- O O
oral O O
contraceptives O O
and O O
the O O
risk O O
of O O
hereditary B-Dis B-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
. O O

occasional O O
missense O O
mutations O O
in O O
atm O O
were O O
also O O
found O O
in O O
tumour B-Dis B-Dis
dna O O
from O O
patients O O
with O O
b-cell B-Dis O
non-hodgkins I-Dis B-Dis
lymphomas I-Dis I-Dis
-lrb- O O
b-nhl B-Dis B-Dis
-rrb- O O
and O O
a O O
b-nhl B-Dis O
cell O O
line O O
. O O

progression O O
of O O
somatic O O
_ds O O
repeat O O
length O O
heterogeneity O O
in O O
the O O
blood O O
cells O O
of O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
patients O O
. O O

in O O
previous O O
studies O O
, O O
we O O
have O O
found O O
two O O
common O O
mutations O O
in O O
caucasians O O
and O O
japanese O O
, O O
respectively O O
. O O

_num3 O O
. O O

the O O
gene O O
segment O O
analyzed O O
corresponds O O
to O O
the O O
genomic O O
saci-hindiii O O
fragment O O
carrying O O
exons O O
11-15 O O
. O O

_num1 O O
% O O
of O O
_num2 O O
ashkenazi O O
israelis O O
with O O
familial O B-Dis
cancer B-Dis I-Dis
-lrb- O O
p O O
= O O
_num1 O O
. O O

heterozygotes O O
for O O
the O O
atm O O
gene O O
have O O
no O O
clinical O O
expression O O
of O O
a-t B-Dis B-Dis
but O O
may O O
be O O
cancer B-Dis B-Dis
prone O O
with O O
a O O
moderate O O
increase O O
in O O
in O O
vitro O O
radiosensitivity O O
. O O

all O O
tested O O
ashkenazi O O
mutation O O
carriers O O
share O O
the O O
same O O
allelic O O
pattern O O
at O O
the O O
brca1 O O
locus O O
. O O

the O O
r496h O O
mutation O O
of O O
arylsulfatase O O
a O O
does O O
not O O
cause O O
metachromatic B-Dis B-Dis
leukodystrophy I-Dis I-Dis
. O O

it O O
is O O
also O O
worthy O O
of O O
note O O
that O O
a O O
single O O
nonsense O O
point O O
mutation O O
, O O
r233x O O
, O O
was O O
observed O O
in O O
the O O
germline O O
dna O O
from O O
two O O
unrelated O O
cd B-Dis O
families O O
and O O
one O O
bzs B-Dis O
family O O
. O O

ataxia-telangiectasia B-Dis B-Dis
-lrb- O O
a-t B-Dis B-Dis
-rrb- O O
is O O
a O O
recessive B-Dis B-Dis
multi-system I-Dis I-Dis
disorder I-Dis I-Dis
caused O O
by O O
mutations O O
in O O
the O O
atm O O
gene O O
at O O
11q22-q23 O O
-lrb- O O
ref O O
. O O

this O O
distribution O O
of O O
emerin O O
was O O
similar O O
to O O
that O O
of O O
lamin O O
a O O
, O O
a O O
candidate O O
gene O O
for O O
an O O
autosomal O O
form O O
of O O
edmd B-Dis B-Dis
. O O

autosomal B-Dis B-Dis
dominant I-Dis I-Dis
neurohypophyseal I-Dis I-Dis
diabetes I-Dis I-Dis
insipidus I-Dis I-Dis
-lrb- O O
adndi B-Dis O
-rrb- O O
is O O
an O O
inherited B-Dis B-Dis
disease I-Dis I-Dis
caused O O
by O O
progressive O O
degeneration O B-Dis
of O I-Dis
the O I-Dis
magnocellular O O
neurons O O
of O O
the O O
hypothalamus O O
leading O O
to O O
decreased O O
ability O O
to O O
produce O O
the O O
hormone O O
arginine O O
vasopressin O O
-lrb- O O
avp O O
-rrb- O O
. O O

we O O
conclude O O
that O O
the O O
185delag O O
brca1 O O
mutation O O
occurs O O
in O O
some O O
non-ashkenazi O O
populations O O
at O O
rates O O
comparable O O
with O O
that O O
of O O
ashkenazim O O
. O O

conclusions O O
the O O
i1307k O O
apc O B-Dis
variant O O
may O O
represent O O
a O O
susceptibility O O
gene O O
for O O
colorectal B-Dis B-Dis
, I-Dis O
or I-Dis O
other I-Dis O
, I-Dis O
cancers I-Dis B-Dis
in O O
ashkenazi O O
jews O O
, O O
and O O
partially O O
explains O O
the O O
higher O O
incidence O O
of O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
in O O
european O O
israelis O O
. O O

both O O
genomic O O
mutations O O
and O O
their O O
effects O O
on O O
cdna O O
were O O
characterized O O
. O O

in O O
approximately O O
5-12 O O
% O O
of O O
these O O
cases O O
, O O
there O O
are O O
no O O
demonstrable O O
cardiac O O
or O O
non-cardiac O O
causes O O
to O O
account O O
for O O
the O O
episode O O
, O O
which O O
is O O
therefore O O
classified O O
as O O
idiopathic B-Dis B-Dis
ventricular I-Dis I-Dis
fibrillation I-Dis I-Dis
-lrb- O O
ivf B-Dis B-Dis
-rrb- O O
. O O

these O O
data O O
demonstrate O O
that O O
both O O
the O O
position O O
of O O
the O O
ic O O
and O O
its O O
role O O
in O O
the O O
coordinate O O
expression O O
of O O
genes O O
is O O
conserved O O
between O O
mouse O O
and O O
human O O
, O O
and O O
indicate O O
that O O
the O O
mouse O O
is O O
a O O
suitable O O
model O O
system O O
in O O
which O O
to O O
investigate O O
the O O
molecular O O
mechanisms O O
of O O
imprinting O O
in O O
this O O
region O O
of O O
the O O
genome O O
. O O
. O O

southern O O
blot O O
and O O
pcr O O
analysis O O
of O O
dna O O
of O O
one O O
patient O O
with O O
homozygous O B-Dis
deficiency O I-Dis
ruled O O
out O O
the O O
presence O O
of O O
a O O
large O O
deletion O O
of O O
the O O
fh O O
gene O O
as O O
the O O
underlying O O
defect O O
for O O
the O O
deficiency O O
. O O

_num1 O O
mb O O
telomeric O O
to O O
hla-a O O
. O O

of O O
_num2 O O
informative O O
meioses O O
, O O
three O O
recombinants O O
were O O
found O O
, O O
giving O O
a O O
recombinant O O
fraction O O
of O O
_num1 O O
. O O

_num3 O O
+ O O
/ O O
-0 O O
. O O

_num1 O O
for O O
colorectal B-Dis B-Dis
neoplasia I-Dis I-Dis
-lrb- O O
both O O
p O O
= O O
. O O

sequential O O
cleavage O O
of O O
the O O
precursor O O
protein O O
pre-pro-opiomelanocortin O O
-lrb- O O
pomc O O
-rrb- O O
generates O O
the O O
melanocortin O O
peptides O O
adrenocorticotrophin O O
-lrb- O O
acth O O
-rrb- O O
, O O
melanocyte-stimulating O O
hormones O O
-lrb- O O
msh O O
-rrb- O O
alpha O O
, O O
beta O O
and O O
gamma O O
as O O
well O O
as O O
the O O
opioid-receptor O O
ligand O O
beta-endorphin O O
. O O

the O O
presence O O
of O O
a O O
constitutional O O
mutation O O
was O O
not O O
associated O O
with O O
an O O
early O O
age O O
at O O
treatment O O
. O O

_an O O
is O O
an O O
anonymous O O
microsatellite O O
marker O O
closely O O
linked O O
to O O
_ds B-Dis O
. O O
. O O

in O O
an O O
attempt O O
to O O
resolve O O
this O O
issue O O
, O O
we O O
have O O
comprehensively O O
characterized O O
_num2 O O
anti-brca1 O O
antibodies O O
. O O

constitutional O O
mutations O O
of O O
the O O
wt1 O O
gene O O
, O O
encoding O O
a O O
zinc-finger O O
transcription O O
factor O O
involved O O
in O O
renal O O
and O O
gonadal O O
development O O
, O O
are O O
found O O
in O O
most O O
patients O O
with O O
denys-drash B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
dds B-Dis B-Dis
-rrb- O O
, O O
or O O
diffuse B-Dis B-Dis
mesangial I-Dis I-Dis
sclerosis I-Dis I-Dis
-lrb- O O
dms B-Dis O
-rrb- O O
associated O O
with O O
pseudohermaphroditism B-Dis B-Dis
and O O
/ O O
or O O
wilms B-Dis B-Dis
tumor I-Dis I-Dis
-lrb- O O
wt B-Dis B-Dis
-rrb- O O
. O O

methods O O
we O O
enrolled O O
_num3 O O
women O O
with O O
hereditary B-Dis B-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
and O O
_num3 O O
of O O
their O O
sisters O O
as O O
controls O O
in O O
a O O
case-control O O
study O O
. O O

emerin O O
is O O
a O O
nuclear O O
membrane O O
protein O O
which O O
is O O
missing O O
or O O
defective O O
in O O
emery-dreifuss B-Dis B-Dis
muscular I-Dis I-Dis
dystrophy I-Dis I-Dis
-lrb- O O
edmd B-Dis B-Dis
-rrb- O O
. O O

identification O O
of O O
a O O
novel O O
mutation O O
of O O
the O O
cpo O O
gene O O
in O O
a O O
japanese O O
hereditary B-Dis O
coproporphyria I-Dis O
family O O
. O O

when O O
resting O O
cells O O
are O O
induced O O
to O O
proliferate O O
, O O
the O O
steady-state O O
levels O O
of O O
brca1 O O
increase O O
in O O
late O O
g1 O O
and O O
reach O O
a O O
maximum O O
during O O
s O O
phase O O
. O O

these O O
data O O
provide O O
further O O
evidence O O
for O O
extensive O O
allelic O O
heterogeneity O O
in O O
mps B-Dis B-Dis
iva I-Dis I-Dis
in O O
british-irish O O
patients O O
and O O
provide O O
evidence O O
for O O
their O O
transmission O O
to O O
australia O O
by O O
british-irish O O
migrants O O
. O O
. O O

wolfram B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
wfs B-Dis B-Dis
; O O
omim O O
_num6 O O
-rrb- O O
is O O
an O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
neurodegenerative I-Dis I-Dis
disorder I-Dis I-Dis
defined O O
by O O
young-onset O B-Dis
non-immune O I-Dis
insulin-dependent B-Dis I-Dis
diabetes I-Dis I-Dis
mellitus I-Dis I-Dis
and O O
progressive O O
optic B-Dis B-Dis
atrophy I-Dis I-Dis
. O O

however O O
, O O
genotype-phenotype O O
analysis O O
inthe O O
group O O
of O O
cd B-Dis O
families O O
revealed O O
two O O
possible O O
associations O O
worthy O O
of O O
follow-up O O
in O O
independent O O
analyses O O
. O O

thus O O
, O O
a O O
total O O
of O O
_num2 O O
mutations O O
were O O
identified O O
in O O
tumors B-Dis B-Dis
of O O
_num2 O O
patients O O
. O O

by O O
investigating O O
the O O
common O O
autosomal O O
recessive O O
copper B-Dis O
toxicosis I-Dis O
-lrb- O O
_ds B-Dis O
-rrb- O O
in O O
bedlington O O
terriers O O
, O O
we O O
have O O
identified O O
a O O
new O O
locus O O
involved O O
in O O
progressive O O
liver B-Dis B-Dis
disease I-Dis I-Dis
. O O

both O O
a-t B-Dis B-Dis
homozygotes O O
and O O
heterozygotes O O
showed O O
significantly O O
increased O O
levels O O
of O O
radiation-induced O O
chromatid O O
damage O O
relative O O
to O O
that O O
of O O
normal O O
controls O O
. O O

maternal B-Dis B-Dis
uniparental I-Dis I-Dis
disomy I-Dis I-Dis
-lrb- I-Dis O
upd I-Dis B-Dis
-rrb- I-Dis O
for I-Dis O
chromosome I-Dis O
_num2 I-Dis O
is O O
responsible O O
for O O
an O O
estimated O O
_num2 O O
% O O
of O O
cases O O
of O O
prader-willi B-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
pws B-Dis B-Dis
-rrb- O O
. O O

the O O
atm O O
-lrb- O O
a-t O B-Dis
, O O
mutated O O
-rrb- O O
gene O O
on O O
human O O
chromosome O O
11q22 O O
. O O

in O O
a O O
gene O O
with O O
such O O
extraordinarily O O
high O O
sequence O O
conservation O O
throughout O O
evolution O O
, O O
there O O
are O O
presumed O O
undiscovered O O
missense O O
mutations O O
, O O
these O O
are O O
hypothesized O O
to O O
exist O O
in O O
as-yet O O
unidentified O O
phenotypes O O
. O O
. O O

genomic O O
structure O O
of O O
the O O
human O O
congenital B-Dis O
chloride I-Dis I-Dis
diarrhea I-Dis I-Dis
-lrb- O O
cld B-Dis B-Dis
-rrb- O O
gene O O
. O O

these O O
results O O
indicate O O
the O O
usefulness O O
of O O
cycloheximide O O
treatment O O
in O O
evaluating O O
the O O
abnormal O O
processing O O
of O O
mrna O O
due O O
to O O
splice-site O O
mutations O O
, O O
because O O
-lrb- O O
i O O
-rrb- O O
aberrant O O
splicing O O
often O O
generates O O
a O O
premature O O
termination O O
codon O O
, O O
-lrb- O O
ii O O
-rrb- O O
transcripts O O
with O O
premature O O
termination O O
codons O O
can O O
occur O O
at O O
low O O
or O O
undetectable O O
levels O O
due O O
to O O
nonsense-mediated O O
mrna O O
decay O O
, O O
and O O
-lrb- O O
iii O O
-rrb- O O
the O O
levels O O
of O O
these O O
transcripts O O
can O O
be O O
increased O O
by O O
cycloheximide O O
. O O

other O O
complement O O
components O O
were O O
normal O O
during O O
remission O O
of O O
lupus O O
, O O
but O O
c1 O O
, O O
c4 O O
, O O
c2 O O
, O O
and O O
c3 O O
levels O O
fell O O
during O O
exacerbations O O
. O O

aspartylglucosaminuria B-Dis B-Dis
-lrb- O O
agu B-Dis B-Dis
-rrb- O O
is O O
a O O
rare O B-Dis
disorder B-Dis I-Dis
of I-Dis O
glycoprotein I-Dis O
metabolism I-Dis O
caused O O
by O O
the O O
deficiency B-Dis B-Dis
of I-Dis I-Dis
the I-Dis I-Dis
lysosomal I-Dis I-Dis
enzyme I-Dis I-Dis
aspartylglucosaminidase I-Dis I-Dis
-lrb- O O
_ds O O
-rrb- O O
. O O

mutations O O
of O O
the O O
atm O O
gene O O
detected O O
in O O
japanese O O
ataxia-telangiectasia B-Dis B-Dis
patients O O
: O O
possible O O
preponderance O O
of O O
the O O
two O O
founder O O
mutations O O
4612del165 O O
and O O
7883del5 O O
. O O

a O O
-lrb- O O
_ds O O
-rrb- O O
nexpansion O O
in O O
the O O
3-untranslated O O
region O O
-lrb- O O
utr O O
-rrb- O O
of O O
the O O
dm O B-Dis
protein O O
kinase O O
gene O O
-lrb- O O
dmpk O O
-rrb- O O
is O O
responsible O O
for O O
causing O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
. O O

the O O
tumor B-Dis B-Dis
suppressor O O
gene O O
smad4 O O
/ O O
dpc4 O O
is O O
required O O
for O O
gastrulation O O
and O O
later O O
for O O
anterior O O
development O O
of O O
the O O
mouse O O
embryo O O
. O O

this O O
should O O
help O O
in O O
the O O
design O O
of O O
tailored O O
clinical-management O O
protocols O O
in O O
this O O
subset O O
of O O
fap B-Dis B-Dis
patients O O
. O O
. O O

molecular O O
heterogeneity O O
in O O
mucopolysaccharidosis B-Dis B-Dis
iva I-Dis I-Dis
in O O
australia O O
and O O
northern O O
ireland O O
: O O
nine O O
novel O O
mutations O O
including O O
t312s O O
, O O
a O O
common O O
allele O O
that O O
confers O O
a O O
mild O O
phenotype O O
. O O

numerous O O
cytogenetic O O
and O O
allelotype O O
studies O O
have O O
reported O O
frequent O O
loss O O
of O O
heterozygosity O O
on O O
chromosomal O O
arm O O
10q O O
in O O
sporadic B-Dis B-Dis
prostate I-Dis I-Dis
cancer I-Dis I-Dis
. O O

it O O
is O O
one O O
member O O
of O O
a O O
family O O
of O O
lamina-associated O O
proteins O O
which O O
includes O O
lap1 O O
, O O
lap2 O O
and O O
lamin O O
b O O
receptor O O
-lrb- O O
lbr O O
-rrb- O O
. O O

in O O
addition O O
, O O
in O O
this O O
family O O
, O O
there O O
appears O O
to O O
be O O
no O O
relationship O O
between O O
the O O
i1307k O O
polymorphism O O
and O O
the O O
presence O O
or O O
absence O B-Dis
of O I-Dis
cancer B-Dis I-Dis
. O O
. O O

six O O
different O O
haplotypes O O
were O O
found O O
and O O
dm B-Dis B-Dis
alleles O O
were O O
always O O
haplotype O O
a. O O
to O O
find O O
an O O
origin O O
of O O
the O O
-lrb- O O
_ds O O
-rrb- O O
n O O
repeat O O
mutation O O
and O O
to O O
investigate O O
the O O
mechanism O O
of O O
the O O
expansion O O
mutation O O
in O O
the O O
japanese O O
population O O
we O O
have O O
studied O O
_num2 O O
japanese O O
dm B-Dis B-Dis
families O O
comprising O O
_num3 O O
affected O O
and O O
_num3 O O
unaffected O O
members O O
. O O

germ-line O O
mutations O O
of O O
the O O
brca1 O O
gene O O
predispose O O
women O O
to O O
early-onset O O
breast B-Dis B-Dis
and I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
by O O
compromising O O
the O O
genes O O
presumptive O O
function O O
as O O
a O O
tumor B-Dis B-Dis
suppressor O O
. O O

in O O
the O O
australian O O
aboriginal O O
samples O O
, O O
_num3 O O
c O O
-- O O
> O O
g O O
was O O
found O O
to O O
be O O
associated O O
with O O
hla O O
haplotypes O O
common O O
in O O
caucasians O O
, O O
suggesting O O
that O O
it O O
was O O
introduced O O
by O O
recent O O
admixture O O
. O O

these O O
results O O
suggest O O
that O O
brca1 O O
participates O O
, O O
directly O O
or O O
indirectly O O
, O O
in O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
. O O
. O O

association O O
of O O
the O O
brca1 O O
protein O O
with O O
the O O
dna O O
repair O O
protein O O
rad51 O O
and O O
changes O O
in O O
the O O
phosphorylation O O
and O O
cellular O O
localization O O
of O O
the O O
protein O O
after O O
exposure O O
to O O
dna-damaging O O
agents O O
are O O
consistent O O
with O O
a O O
role O O
for O O
brca1 O O
in O O
dna O O
repair O O
. O O

using O O
methylation-sensitive O O
restriction O O
enzymes O O
, O O
we O O
characterized O O
the O O
methylation O O
pattern O O
on O O
the O O
_num1 O O
side O O
of O O
the O O
_ds O O
repeat O O
in O O
the O O
dmpk O O
gene O O
of O O
normal O O
individuals O O
and O O
of O O
patients O O
affected O O
with O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
, O O
showing O O
expansions O O
of O O
the O O
repetitive O O
sequence O O
. O O

ventricular B-Dis O
fibrillation I-Dis O
causes O O
more O O
than O O
_num3 O O
, O O
_num3 O O
sudden O B-Dis
deaths O I-Dis
each O O
year O O
in O O
the O O
usa O O
alone O O
. O O

_num1 O O
-rrb- O O
and O O
for O O
carriers O O
of O O
the O O
brca2 O O
mutation O O
-lrb- O O
odds O O
ratio O O
, O O
_num1 O O
. O O

in O O
a O O
number O O
of O O
young O O
and O O
severely O O
affected O O
patients O O
, O O
however O O
, O O
complete O O
methylation O O
of O O
these O O
restriction O O
sites O O
was O O
found O O
in O O
the O O
mutated O O
allele O O
. O O

hereditary B-Dis B-Dis
deficiency I-Dis I-Dis
of I-Dis I-Dis
the I-Dis I-Dis
fifth I-Dis I-Dis
component I-Dis I-Dis
of I-Dis I-Dis
complement I-Dis I-Dis
in O O
man O O
. O O

the O O
c6 O O
/ O O
c7 O O
marker O O
haplotypes O O
associated O O
with O O
most O O
c7 B-Dis B-Dis
defects I-Dis I-Dis
are O O
tabulated O O
. O O
. O O

in O O
edmd B-Dis B-Dis
, O O
the O O
additional O O
absence O O
of O O
lamin O O
b1 O O
from O O
heart O O
and O O
skeletal O O
muscle O O
nuclei O O
which O O
already O O
lack O O
emerin O O
may O O
offer O O
an O O
alternative O O
explanation O O
of O O
why O O
these O O
tissues O O
are O O
particularly O O
affected O O
. O O
. O O

the O O
resulting O O
amino-acid O O
substitutions O O
are O O
predicted O O
to O O
interfere O O
with O O
atp O O
binding O O
or O O
substrate O O
recognition O O
. O O

in O O
the O O
second O O
family O O
, O O
a O O
g279a O O
substitution O O
at O O
position O O
-1 O O
of O O
the O O
signal O O
peptide O O
was O O
observed O O
in O O
all O O
affected O O
individuals O O
. O O

the O O
hemochromatosis B-Dis O
_num3 O O
g O O
-- O O
> O O
a O O
and O O
_num3 O O
c O O
-- O O
> O O
g O O
mutations O O
: O O
prevalence O O
in O O
non-caucasian O O
populations O O
. O O

our O O
results O O
indicate O O
that O O
mutations O O
in O O
cardiac O O
ion-channel O O
genes O O
contribute O O
to O O
the O O
risk O O
of O O
developing O O
ivf B-Dis O
. O O
. O O

vhl-negative O O
786-0 O O
rcc B-Dis B-Dis
cells O O
are O O
tumorigenic O O
in O O
nude O O
mice O O
which O O
is O O
suppressed O O
by O O
the O O
reintroduction O O
of O O
vhl B-Dis B-Dis
. O O

because O O
ivf B-Dis B-Dis
causes O O
cardiac O B-Dis
rhythm O I-Dis
disturbance O I-Dis
, O O
we O O
investigated O O
whether O O
malfunction O O
of O O
ion O O
channels O O
could O O
cause O O
the O O
disorder O O
by O O
studying O O
mutations O O
in O O
the O O
cardiac O O
sodium O O
channel O O
gene O O
scn5a O O
. O O

variability O O
in O O
the O O
number O O
of O O
colorectal B-Dis B-Dis
adenomas I-Dis I-Dis
was O O
most O O
apparent O O
in O O
individuals O O
with O O
mutations O O
in O O
region O O
_num1 O O
, O O
and O O
upper-gastrointestinal O O
manifestations O O
were O O
more O O
severe O O
in O O
them O O
. O O

six O O
non-ashkenazi O O
individuals O O
shared O O
the O O
common O O
ashkenazi O O
haplotype O O
, O O
four O O
had O O
a O O
closely O O
related O O
pattern O O
, O O
and O O
the O O
rest O O
-lrb- O O
n O O
= O O
_num1 O O
-rrb- O O
displayed O O
a O O
distinct O O
brca1 O O
allelic O O
pattern O O
. O O

here O O
, O O
it O O
is O O
shown O O
that O O
mouse O O
embryonic O O
stem O O
cells O O
deficient B-Dis O
in I-Dis O
brca1 I-Dis O
are O O
defective O O
in O O
the O O
ability O O
to O O
carry O O
out O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
, O O
and O O
are O O
hypersensitive O O
to O O
ionizing O O
radiation O O
and O O
hydrogen O O
peroxide O O
. O O

the O O
analysis O O
of O O
tumors B-Dis B-Dis
from O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
_num2 O O
informative O O
patients O O
showed O O
loss O O
of O O
constitutional O O
heterozygosity O O
-lrb- O O
loh O O
-rrb- O O
at O O
intragenic O O
loci O O
. O O

_num2 O O
. O O

on O O
the O O
basis O O
of O O
the O O
present O O
study O O
, O O
the O O
mechanism O O
of O O
anhaptoglobinemia B-Dis O
and O O
the O O
mechanism O O
of O O
anomalous O O
inheritance O O
of O O
hp O B-Dis
phenotypes O I-Dis
were O O
well O O
explained O O
. O O

although O O
increasing O O
measured O O
allele O O
size O O
between O O
patients O O
clearly O O
correlates O O
with O O
an O O
increased O O
severity O O
of O O
symptoms O O
and O O
an O O
earlier O O
age O O
of O O
onset O O
, O O
this O O
correlation O O
is O O
not O O
precise O O
and O O
measured O O
allele O O
length O O
can O O
not O O
be O O
used O O
as O O
an O O
accurate O O
predictor O O
of O O
age O O
of O O
onset O O
. O O

the O O
first O O
was O O
an O O
association O O
noted O O
in O O
the O O
group O O
of O O
cd B-Dis O
families O O
with O O
breast B-Dis B-Dis
disease I-Dis I-Dis
. O O

it O O
is O O
not O O
clear O O
whether O O
such O O
mutants O O
really O O
behave O O
as O O
loss-of-function O O
mutants O O
as O O
predicted O O
by O O
haploinsufficiency O O
. O O

decreased O O
fertility O O
of O O
males O O
with O O
adult O O
onset O O
dm B-Dis B-Dis
and O O
contraction O O
of O O
the O O
repeat O O
upon O O
male O O
transmission O O
contribute O O
to O O
the O O
almost O O
absent O O
occurrence O O
of O O
paternal O O
transmission O O
of O O
congenital B-Dis O
dm I-Dis B-Dis
. O O

we O O
conclude O O
that O O
the O O
_num4 O O
g O O
-- O O
> O O
c O O
mutation O O
is O O
the O O
cause O O
of O O
hex B-Dis O
a I-Dis O
enzyme I-Dis O
deficiency I-Dis O
in O O
the O O
proband O O
. O O

this O O
study O O
provides O O
further O O
evidence O O
that O O
the O O
dm B-Dis B-Dis
expansion O O
tends O O
to O O
be O O
transmitted O O
preferentially O O
. O O

the O O
similarity O O
of O O
the O O
clinical O O
and O O
radiographic O O
findings O O
is O O
so O O
extensive O O
that O O
these O O
disorders O O
appear O O
to O O
be O O
a O O
single O O
entity O O
. O O

_num2 O O
-rrb- O O
, O O
as O O
well O O
as O O
a O O
younger O O
age O O
at O O
diagnosis O O
. O O

results O O
chain O O
terminating O O
signals O O
were O O
only O O
identified O O
in O O
patients O O
belonging O O
to O O
the O O
fap B-Dis B-Dis
group O O
-lrb- O O
_num3 O O
patients O O
-rrb- O O
. O O

these O O
mice O O
have O O
been O O
shown O O
to O O
reproduce O O
the O O
intergenerational O O
and O O
somatic O O
instability O O
of O O
the O O
_num2 O O
_ds O O
repeat O O
suggesting O O
that O O
surrounding O O
sequences O O
and O O
the O O
chromatin O O
environment O O
are O O
involved O O
in O O
instability O O
mechanisms O O
. O O

there O O
is O O
constitutive O O
methylation O O
in O O
intron O O
_num2 O O
at O O
restriction O O
sites O O
of O O
sacii O O
and O O
hhai O O
, O O
localized O O
_num1 O O
, O O
159-1 O O
, O O
_num3 O O
bp O O
upstream O O
of O O
the O O
_ds O O
repeat O O
, O O
whereas O O
most O O
, O O
if O O
not O O
all O O
, O O
of O O
the O O
other O O
sites O O
of O O
sacii O O
, O O
hhai O O
, O O
and O O
hpaii O O
in O O
this O O
region O O
are O O
unmethylated O O
, O O
in O O
normal O O
individuals O O
and O O
most O O
of O O
the O O
patients O O
. O O

we O O
conclude O O
that O O
paternal O O
transmission O O
of O O
congenital B-Dis B-Dis
dm I-Dis I-Dis
is O O
rare O O
and O O
preferentially O O
occurs O O
with O O
onset O O
of O O
dm B-Dis B-Dis
past O O
_num2 O O
years O O
in O O
the O O
father O O
. O O
. O O

the O O
others O O
were O O
minute O O
deletions O O
, O O
4649dela O O
in O O
exon O O
_num2 O O
and O O
7883del5 O O
in O O
exon O O
_num2 O O
. O O

to O O
determine O O
if O O
the O O
occurrence O O
of O O
4003deltc O O
in O O
these O O
unrelated O O
families O O
signifies O O
propagation O O
of O O
an O O
ancestral O O
allele O O
or O O
a O O
mutational O O
hot O O
spot O O
, O O
haplotypes O O
were O O
determined O O
for O O
polymorphisms O O
both O O
within O O
and O O
flanking O O
col17a1 O O
. O O

dysfunction O O
of O O
this O O
pathway O O
may O O
be O O
a O O
general O O
phenomenon O O
in O O
the O O
majority O O
of O O
cases O O
of O O
hereditary B-Dis B-Dis
breast I-Dis I-Dis
and I-Dis I-Dis
/ I-Dis I-Dis
or I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
. O O
. O O

the O O
average O O
age O O
of O O
disease O O
onset O O
in O O
those O O
families O O
harbouring O O
causative O O
mutations O O
was O O
between O O
_num2 O O
. O O

lamin O O
b1 O O
is O O
also O O
almost O O
completely O O
absent O O
from O O
skeletal O O
muscle O O
nuclei O O
. O O

we O O
also O O
demonstrate O O
that O O
soluble O O
tfr O O
and O O
hfe O O
bind O O
tightly O O
at O O
the O O
basic O O
ph O O
of O O
the O O
cell O O
surface O O
, O O
but O O
not O O
at O O
the O O
acidic O O
ph O O
of O O
intracellular O O
vesicles O O
. O O

complement B-Dis B-Dis
c7 I-Dis I-Dis
deficiency I-Dis I-Dis
: O O
seven O O
further O O
molecular O O
defects O O
and O O
their O O
associated O O
marker O O
haplotypes O O
. O O

a O O
distinct O O
group O O
of O O
ivf B-Dis B-Dis
patients O O
has O O
been O O
found O O
to O O
present O O
with O O
a O O
characteristic O O
electrocardiographic O O
pattern O O
. O O

this O O
demonstrated O O
-lrb- O O
_num1 O O
-rrb- O O
the O O
association O O
between O O
mutations O O
in O O
exons O O
_num1 O O
and O O
_num1 O O
and O O
dms B-Dis O
; O O
-lrb- O O
_num1 O O
-rrb- O O
among O O
patients O O
with O O
dms B-Dis O
, O O
a O O
higher O O
frequency O O
of O O
exon O O
_num1 O O
mutations O O
among O O
_num2 O O
, O O
xy O O
patients O O
with O O
female O O
phenotype O O
than O O
among O O
_num2 O O
, O O
xy O O
patients O O
with O O
sexual O O
ambiguity O O
or O O
male O O
phenotype O O
; O O
and O O
-lrb- O O
_num1 O O
-rrb- O O
statistically O O
significant O O
evidence O O
that O O
mutations O O
in O O
exons O O
_num1 O O
and O O
_num1 O O
preferentially O O
affect O O
amino O O
acids O O
with O O
different O O
functions O O
. O O
. O O

in O O
_num1 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
the O O
_num2 O O
patients O O
, O O
a O O
mutation O O
was O O
detected O O
in O O
constitutional O O
dna O O
, O O
and O O
_num1 O O
of O O
these O O
mutations O O
is O O
known O O
to O O
be O O
associated O O
with O O
reduced O O
expressivity O O
. O O

the O O
tumour B-Dis B-Dis
suppressor O O
gene O O
pten O O
, O O
which O O
maps O O
to O O
10q23 O O
. O O

in O O
contrast O O
, O O
no O O
mutations O O
were O O
detected O O
in O O
the O O
_an O O
gene O O
, O O
suggesting O O
that O O
this O O
tumour B-Dis B-Dis
suppressor O O
is O O
not O O
frequently O O
altered O O
in O O
this O O
leukaemia B-Dis O
. O O

low O O
levels O O
of O O
beta O O
hexosaminidase O O
a O O
in O O
healthy O O
individuals O O
with O O
apparent O O
deficiency O B-Dis
of O O
this O O
enzyme O O
. O O

pendred B-Dis O
patients O O
in O O
three O O
non-consanguineous O O
families O O
were O O
shown O O
to O O
be O O
compound O O
heterozygotes O O
for O O
l236p O O
and O O
t416p O O
. O O

colorectal B-Dis B-Dis
neoplasia I-Dis I-Dis
occurred O O
personally O O
or O O
in O O
the O O
families O O
of O O
_num2 O O
of O O
_num2 O O
ashkenazi O O
i1307k O O
carriers O O
, O O
_num1 O O
of O O
whom O O
also O O
had O O
a O O
personal O O
or O O
family O O
history O O
of O O
noncolonic O O
neoplasia B-Dis O
. O O

the O O
other O O
is O O
the O O
previously O O
described O O
i113f O O
that O O
produces O O
a O O
severe O O
phenotype O O
. O O

however O O
, O O
the O O
different O O
allelic O O
pattern O O
at O O
the O O
brca1 O O
locus O O
even O O
in O O
some O O
jewish O O
mutation O O
carriers O O
, O O
might O O
suggest O O
that O O
the O O
mutation O O
arose O O
independently O O
. O O
. O O

of O O
_num2 O O
informative O O
meioses O O
, O O
two O O
crossovers O O
were O O
noted O O
between O O
the O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
gene O O
and O O
the O O
hla-b O O
gene O O
, O O
with O O
a O O
recombinant O O
fraction O O
of O O
_num1 O O
. O O

our O O
results O O
demonstrate O O
that O O
in O O
certain O O
genetic O B-Dis
conditions O I-Dis
mld B-Dis I-Dis
like O O
arsa O O
and O O
gs O B-Dis
values O O
need O O
not O O
be O O
paralleled O O
by O O
clinical O O
disease O O
, O O
a O O
finding O O
with O O
serious O O
diagnostic O O
and O O
prognostic O O
implications O O
. O O

increased O O
mutation O O
in O O
the O O
homeodomain O O
is O O
accounted O O
for O O
by O O
the O O
hypermutable O O
cpg O O
dinucleotide O O
in O O
codon O O
_num3 O O
. O O

these O O
results O O
show O O
that O O
the O O
g2-phase O O
chromosomal O O
radiosensitivity O O
assay O O
can O O
be O O
used O O
for O O
the O O
detection O O
of O O
a-t B-Dis B-Dis
heterozygotes O O
. O O

analysis O O
of O O
all O O
family O O
members O O
demonstrated O O
that O O
the O O
missense O O
mutation O O
co-segregated O O
with O O
patients O O
with O O
tumors B-Dis B-Dis
or O O
who O O
, O O
as O O
a O O
result O O
of O O
linkage O O
analysis O O
had O O
been O O
predicted O O
to O O
carry O O
the O O
predisposing O O
mutation O O
. O O

the O O
_num1 O O
. O O

protein-truncation O O
testing O O
of O O
the O O
entire O O
atm O O
cdna O O
detected O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
truncating O O
mutations O O
in O O
_num3 O O
mutant O O
alleles O O
screened O O
. O O

these O O
assays O O
should O O
facilitate O O
screening O O
for O O
a-t B-Dis B-Dis
heterozygotes O O
in O O
the O O
populations O O
studied O O
. O O
. O O

the O O
gene O O
product O O
, O O
a O O
member O O
of O O
the O O
major O O
histocompatibility O O
complex O O
class O O
i-like O O
family O O
, O O
was O O
found O O
to O O
have O O
a O O
mutation O O
, O O
cys-282 O O
-- O O
> O O
tyr O O
-lrb- O O
c282y O O
-rrb- O O
, O O
in O O
_num2 O O
% O O
of O O
patient O O
chromosomes O O
. O O

the O O
two O O
clinically O O
unaffected O O
siblings O O
carried O O
the O O
maternal O O
mutation O O
_num3 O O
+ O O
1g O O
> O O
a O O
and O O
, O O
on O O
their O O
paternal O O
allele O O
, O O
a O O
novel O O
cytosine O O
to O O
thymidine O O
transition O O
at O O
nucleotide O O
_num4 O O
in O O
exon O O
_num1 O O
, O O
resulting O O
in O O
substitution O O
of O O
alanine O O
_num3 O O
by O O
valine O O
-lrb- O O
a464v O O
-rrb- O O
. O O

five O O
intragenic O O
polymorphisms O O
were O O
chosen O O
based O O
on O O
their O O
informativeness O O
. O O

the O O
ube3a O O
gene O O
encodes O O
the O O
e6-ap O O
ubiquitin-protein O O
ligase O O
and O O
has O O
recently O O
been O O
shown O O
to O O
be O O
mutated O O
in O O
angelman B-Dis B-Dis
syndrome I-Dis I-Dis
patients O O
who O O
lack O O
15q11-q13 O O
deletions O O
or O O
chromosome O O
_num2 O O
paternal O O
uniparental B-Dis O
disomy I-Dis O
. O O

however O O
, O O
since O O
these O O
patients O O
excrete O O
early O O
large O O
amounts O O
of O O
aspartylglucosamine O O
in O O
urine O O
, O O
biochemical O O
screening O O
is O O
easy O O
by O O
urine O O
chromatography O O
. O O
. O O

the O O
initial O O
mutation O O
was O O
shown O O
to O O
have O O
occurred O O
in O O
the O O
paternally O O
derived O O
rb1 O O
allele O O
. O O

in O O
contrast O O
, O O
lamin O O
b1 O O
was O O
absent O O
from O O
cardiomyocyte O O
nuclei O O
, O O
showing O O
that O O
lamin O O
b1 O O
is O O
not O O
essential O O
for O O
localization O O
of O O
emerin O O
to O O
the O O
nuclear O O
lamina O O
. O O

brca1 O O
required O O
for O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
. O O

eye B-Dis B-Dis
movement I-Dis I-Dis
abnormalities I-Dis I-Dis
correlate O O
with O O
genotype O O
in O O
autosomal O B-Dis
dominant O I-Dis
cerebellar B-Dis I-Dis
ataxia I-Dis I-Dis
type I-Dis I-Dis
i I-Dis I-Dis
. O O

this O O
mutation O O
may O O
be O O
valuable O O
for O O
developing O O
models O O
of O O
dominantly B-Dis O
inherited I-Dis O
neurodegeneration I-Dis B-Dis
, O O
as O O
the O O
early O O
age O O
of O O
onset O O
of O O
symptoms O O
suggests O O
that O O
this O O
mutation O O
may O O
be O O
particularly O O
deleterious O O
to O O
the O O
magnocellular O O
neuron O O
. O O
. O O

disruption O O
of O O
splicing O O
regulated O O
by O O
a O O
cug-binding O O
protein O O
in O O
myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
. O O

while O O
a O O
few O O
cases O O
of O O
isolated O B-Dis
acth B-Dis I-Dis
deficiency I-Dis I-Dis
have O O
been O O
reported O O
-lrb- O O
omim O O
_num6 O O
-rrb- O O
, O O
an O O
inherited O O
pomc O B-Dis
defect O I-Dis
has O O
not O O
been O O
described O O
so O O
far O O
. O O

this O O
mutation O O
eliminates O O
the O O
ability O O
of O O
hfe O O
to O O
associate O O
with O O
beta2-microglobulin O O
-lrb- O O
beta2m O O
-rrb- O O
and O O
prevents O O
cell-surface O O
expression O O
. O O

_num1 O O
-rrb- O O
with O O
simultaneous O O
maternal O O
meiotic O O
nondisjunction O O
for O O
chromosome O O
_num2 O O
. O O

saamis O O
-lrb- O O
_num1 O O
% O O
-rrb- O O
and O O
mordvinians O O
-lrb- O O
_num1 O O
. O O

a O O
novel O O
c O O
to O O
a O O
mutation O O
in O O
the O O
sterol O O
27-hydroxylase O O
gene O O
-lrb- O O
cyp27 O O
-rrb- O O
was O O
identified O O
by O O
sequencing O O
amplified O O
cyp27 O O
gene O O
products O O
from O O
a O O
patient O O
with O O
cerebrotendinous B-Dis B-Dis
xanthomatosis I-Dis I-Dis
-lrb- O O
ctx B-Dis B-Dis
-rrb- O O
. O O

the O O
hp2 O O
/ O O
hpdel O O
individuals O O
had O O
an O O
extremely O O
low O O
level O O
of O O
hp O O
-lrb- O O
mean O O
+ O O
/ O O
- O O
sd O O
= O O
_num1 O O
. O O

hla-b27 O O
and O O
_an O O
were O O
associated O O
with O O
the O O
disease O O
in O O
probands O O
, O O
and O O
the O O
rate O O
of O O
disease O O
concordance O O
was O O
significantly O O
increased O O
among O O
dz O O
twin O O
pairs O O
in O O
which O O
the O O
co-twin O O
was O O
positive O O
for O O
both O O
_an O O
and O O
dr1 O O
. O O

although O O
the O O
biochemical O O
properties O O
of O O
brca1 O O
polypeptides O O
are O O
not O O
understood O O
, O O
their O O
expression O O
pattern O O
and O O
subcellular O O
localization O O
suggest O O
a O O
role O O
in O O
cell-cycle O O
regulation O O
. O O

in O O
this O O
report O O
, O O
we O O
demonstrate O O
in O O
cultured O O
_num3 O O
cells O O
overexpressing O O
wild-type O O
or O O
mutant O O
hfe O O
proteins O O
that O O
both O O
the O O
wild-type O O
and O O
h63d O O
hfe O O
proteins O O
form O O
stable O O
complexes O O
with O O
the O O
transferrin O O
receptor O O
-lrb- O O
tfr O O
-rrb- O O
. O O

heteroduplex O O
analysis O O
complemented O O
by O O
direct O O
dna O O
sequencing O O
of O O
abnormally O O
migrating O O
bands O O
were O O
employed O O
. O O

also O O
the O O
fathers O O
of O O
the O O
reported O O
congenitally O O
affected O O
children O O
showed O O
, O O
on O O
average O O
, O O
shorter O O
_ds O O
repeat O O
lengths O O
and O O
hence O O
less O O
severe O O
clinical O O
symptoms O O
than O O
the O O
mothers O O
of O O
children O O
with O O
congenital B-Dis O
dm I-Dis B-Dis
. O O

polymerase O O
chain O O
reaction-single O O
strand O O
conformational O O
polymorphism O O
and O O
direct O O
sequence O O
analyses O O
demonstrated O O
a O O
c O O
to O O
t O O
substitution O O
in O O
exon O O
_num1 O O
of O O
the O O
cpo O O
gene O O
at O O
nucleotide O O
position O O
_num2 O O
, O O
which O O
lies O O
in O O
the O O
putative O O
presequence O O
for O O
targeting O O
to O O
mitochondria O O
. O O

_num1 O O
% O O
were O O
affected O O
. O O

immunohistochemical O O
staining O O
of O O
human O O
breast O O
specimens O O
also O O
revealed O O
brca1 O O
nuclear O O
foci O O
in O O
benign O B-Dis
breast O I-Dis
, O I-Dis
invasive B-Dis I-Dis
lobular I-Dis I-Dis
cancers I-Dis I-Dis
and O O
low-grade B-Dis B-Dis
ductal I-Dis I-Dis
carcinomas I-Dis I-Dis
. O O

we O O
have O O
identified O O
four O O
mutations O O
in O O
each O O
of O O
the O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
susceptibility O O
genes O O
, O O
brca1 O O
and O O
brca2 O O
, O O
in O O
french O O
canadian O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
and O O
breast B-Dis B-Dis
/ I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
families O O
from O O
quebec O O
. O O

we O O
extended O O
our O O
analysis O O
to O O
other O O
non-ashkenazi O O
subsets O O
_num3 O O
of O O
moroccan O O
origin O O
, O O
_num3 O O
yemenites O O
and O O
_num3 O O
iranian O O
jews O O
. O O

down-regulation O O
of O O
transmembrane O O
carbonic O O
anhydrases O O
in O O
renal B-Dis B-Dis
cell I-Dis I-Dis
carcinoma I-Dis I-Dis
cell O O
lines O O
by O O
wild-type O O
von B-Dis B-Dis
hippel-lindau I-Dis I-Dis
transgenes O I-Dis
. O O

among O O
these O O
were O O
one O O
frameshift O O
mutation O O
, O O
one O O
nonsense O O
mutation O O
, O O
one O O
novel O O
splice O O
site O O
mutation O O
, O O
and O O
one O O
missense O O
mutation O O
. O O

this O O
cell O O
cycle-dependent O O
colocalization O O
of O O
bard1 O O
and O O
brca1 O O
indicates O O
a O O
role O O
for O O
bard1 O O
in O O
brca1-mediated O O
tumor B-Dis B-Dis
suppression O O
. O O

if O O
untreated O O
, O O
hemochromatosis B-Dis B-Dis
can O O
cause O O
serious O O
illness O O
and O O
early B-Dis O
death I-Dis O
, O O
but O O
the O O
disease O O
is O O
still O O
substantially O O
under-diagnosed O O
. O O

_num2 O O
families O O
with O O
_num2 O O
informative O O
matings O O
for O O
both O O
properdin O O
factor O O
b O O
allotype O O
and O O
hla-b O O
were O O
found O O
. O O

the O O
clinical O O
diagnosis O O
of O O
agu B-Dis B-Dis
is O O
often O O
difficult O O
, O O
in O O
particular O O
early O O
in O O
the O O
course O O
of O O
the O O
disease O O
, O O
and O O
most O O
of O O
the O O
patients O O
are O O
diagnosed O O
after O O
the O O
age O O
of O O
_num1 O O
years O O
. O O

_num1 O O
% O O
of O O
all O O
control O O
individuals O O
, O O
and O O
in O O
one O O
control O O
individual O O
homozygous O O
for O O
this O O
glycine O O
substitution O O
. O O

we O O
mapped O O
ca12 O O
and O O
ca9 O O
loci O O
to O O
chromosome O O
bands O O
15q22 O O
and O O
17q21 O O
. O O

remarkably O O
, O O
this O O
occurs O O
without O O
affecting O O
the O O
growth O O
rate O O
and O O
cell O O
cycle O O
profile O O
of O O
these O O
cells O O
in O O
culture O O
. O O

lifetime O O
histories O O
of O O
oral-contraceptive O O
use O O
were O O
obtained O O
by O O
interview O O
or O O
by O O
written O O
questionnaire O O
and O O
were O O
compared O O
between O O
patients O O
and O O
control O O
women O O
, O O
after O O
adjustment O O
for O O
year O O
of O O
birth O O
and O O
parity O O
. O O

these O O
data O O
suggest O O
that O O
expansion O O
occurs O O
in O O
two O O
stages O O
, O O
the O O
first O O
during O O
meiosis O O
followed O O
by O O
a O O
second O O
mitotic O O
expansion O O
. O O

reintroduced O O
wild-type O O
vhl B-Dis B-Dis
strongly O O
inhibited O O
the O O
overexpression O O
of O O
the O O
ca12 O O
gene O O
in O O
the O O
parental O O
renal B-Dis B-Dis
cell I-Dis I-Dis
carcinoma I-Dis I-Dis
cell O O
lines O O
. O O

there O O
has O O
been O O
no O O
previous O O
finding O O
of O O
a O O
glycine O O
substitution O O
that O O
is O O
not O O
associated O O
with O O
any O O
obvious O O
phenotype O O
in O O
homozygous O O
individuals O O
. O O

in O O
conclusion O O
, O O
our O O
data O O
suggest O O
that O O
dmpk O O
is O O
involved O O
in O O
modulating O O
the O O
initial O O
events O O
of O O
excitation-contraction O O
coupling O O
in O O
skeletal O O
muscle O O
. O O
. O O

the O O
novel O O
single O O
nucleotide O O
deletion O O
, O O
2304delc O O
, O O
was O O
found O O
in O O
one O O
patient O O
. O O

we O O
review O O
the O O
sex O O
related O O
effects O O
on O O
transmission O O
of O O
congenital B-Dis O
dm I-Dis B-Dis
. O O

the O O
aim O O
of O O
this O O
study O O
was O O
to O O
assess O O
genotype-phenotype O O
correlations O O
in O O
aapc B-Dis B-Dis
families O O
. O O

mutations O O
were O O
detected O O
in O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
of O O
_num2 O O
tumors B-Dis B-Dis
with O O
loh O O
. O O

a O O
variety O O
of O O
phenotypes O O
were O O
observed O O
within O O
this O O
family O O
. O O

to O O
our O O
knowledge O O
, O O
this O O
is O O
the O O
first O O
report O O
regarding O O
effects O O
on O O
pre-mrna O O
splicing O O
of O O
a O O
mutation O O
at O O
the O O
-2 O O
position O O
of O O
a O O
_num1 O O
splice O O
site O O
. O O

myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
is O O
caused O O
by O O
a O O
_ds O O
expansion O O
in O O
the O O
_num1 O O
untranslated O O
region O O
of O O
the O O
dm B-Dis B-Dis
gene O O
. O O

the O O
risk O O
decreased O O
with O O
increasing O O
duration O O
of O O
use O O
-lrb- O O
p O O
for O O
trend O O
, O O
< O O
_num1 O O
. O O

pten O O
mutations O O
were O O
identified O O
in O O
_num2 O O
of O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
cd B-Dis O
families O O
, O O
including O O
missense O O
and O O
nonsense O O
point O O
mutations O O
, O O
deletions O O
, O O
insertions O O
, O O
a O O
deletion O O
/ O O
insertion O O
and O O
splice O O
site O O
mutations O O
. O O

hfe O O
is O O
an O O
mhc-related O O
protein O O
that O O
is O O
mutated O O
in O O
the O O
iron-overload B-Dis B-Dis
disease I-Dis I-Dis
hereditary I-Dis I-Dis
hemochromatosis I-Dis I-Dis
. O O

together O O
, O O
these O O
mutations O O
were O O
found O O
in O O
_num2 O O
of O O
_num2 O O
families O O
identified O O
to O O
have O O
a O O
mutation O O
. O O

skin B-Dis O
fragility I-Dis O
in O O
most O O
cases O O
is O O
due O O
to O O
mutations O O
in O O
the O O
gene O O
encoding O O
type O O
xvii O O
collagen O O
-lrb- O O
col17a1 O O
-rrb- O O
. O O

_num1 O O
; O O
_num2 O O
percent O O
confidence O O
interval O O
, O O
_num1 O O
. O O

mucopolysaccharidosis B-Dis B-Dis
iva I-Dis I-Dis
-lrb- O O
mps B-Dis B-Dis
iva I-Dis I-Dis
-rrb- O O
is O O
an O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
lysosomal I-Dis I-Dis
storage I-Dis I-Dis
disorder I-Dis I-Dis
caused O O
by O O
a O O
genetic B-Dis B-Dis
defect I-Dis I-Dis
in O O
n-acetylgalactosamine-6-sulfate O O
sulfatase O O
-lrb- O O
galns O O
-rrb- O O
. O O

mutations O O
in O O
a O O
novel O O
gene O O
-lrb- O O
wfs1 O O
-rrb- O O
encoding O O
a O O
putative O O
transmembrane O O
protein O O
were O O
found O O
in O O
all O O
affected O O
individuals O O
in O O
six O O
wfs B-Dis B-Dis
families O O
, O O
and O O
these O O
mutations O O
were O O
associated O O
with O O
the O O
disease O O
phenotype O O
. O O

we O O
report O O
the O O
spectrum O O
of O O
_num2 O O
atm O O
mutations O O
observed O O
in O O
ataxia-telangiectasia B-Dis B-Dis
-lrb- O O
a-t B-Dis B-Dis
-rrb- O O
patients O O
in O O
the O O
british O O
isles O O
. O O

very O O
nearly O O
all O O
mutations O O
appear O O
to O O
cause O O
loss O O
of O O
function O O
of O O
the O O
mutant O O
allele O O
, O O
and O O
more O O
than O O
_num2 O O
% O O
of O O
exonic O O
substitutions O O
result O O
in O O
nonsense O O
codons O O
. O O

autosomal B-Dis B-Dis
dominant I-Dis I-Dis
neurohypophyseal I-Dis I-Dis
diabetes I-Dis I-Dis
insipidus I-Dis I-Dis
associated O O
with O O
a O O
missense O O
mutation O O
encoding O O
gly23 O O
-- O O
> O O
val O O
in O O
neurophysin O O
ii O O
. O O

we O O
have O O
examined O O
the O O
sperm O O
dna O O
of O O
a O O
premutation O O
carrier O O
. O O

similar O O
results O O
were O O
obtained O O
with O O
ca9 O O
, O O
encoding O O
another O O
transmembrane O O
_ds O O
with O O
an O O
intact O O
catalytic O O
domain O O
. O O

classical O O
familial B-Dis B-Dis
adenomatous I-Dis I-Dis
polyposis I-Dis I-Dis
-lrb- O O
fap B-Dis B-Dis
-rrb- O O
is O O
a O O
high-penetrance O O
autosomal B-Dis B-Dis
dominant I-Dis I-Dis
disease I-Dis I-Dis
that O O
predisposes O O
to O O
hundreds O O
or O O
thousands O O
of O O
colorectal B-Dis B-Dis
adenomas I-Dis I-Dis
and I-Dis O
carcinoma I-Dis B-Dis
and O O
that O O
results O O
from O O
truncating O O
mutations O O
in O O
the O O
apc B-Dis B-Dis
gene O O
. O O

the O O
genomic O O
structure O O
was O O
determined O O
using O O
dna O O
from O O
several O O
sources O O
including O O
multiple O O
large-insert O O
libaries O O
and O O
genomic O O
dna O O
from O O
finnish O O
cld B-Dis O
patients O O
and O O
controls O O
. O O

here O O
we O O
describe O O
ube3a O O
coding-region O O
mutations O O
detected O O
by O O
sscp O O
analysis O O
in O O
_num2 O O
as B-Dis O
individuals O O
or O O
families O O
. O O

sporadic B-Dis O
prostate I-Dis B-Dis
carcinoma I-Dis I-Dis
is O O
the O O
most O O
common O O
male B-Dis B-Dis
cancer I-Dis I-Dis
in O O
the O O
western O O
world O O
, O O
yet O O
many O O
of O O
the O O
major O O
genetic O O
events O O
involved O O
in O O
the O O
progression O O
of O O
this O O
often O O
fatal O O
cancer B-Dis B-Dis
remain O O
to O O
be O O
elucidated O O
. O O

the O O
inactivation O O
of O O
the O O
von B-Dis B-Dis
hippel-lindau I-Dis I-Dis
-lrb- I-Dis I-Dis
vhl I-Dis I-Dis
-rrb- I-Dis O
tumor I-Dis B-Dis
suppressor O O
gene O O
predisposes O O
affected O O
individuals O O
to O O
the O O
human O O
vhl B-Dis B-Dis
cancer I-Dis I-Dis
syndrome I-Dis I-Dis
and O O
is O O
associated O O
with O O
sporadic B-Dis B-Dis
renal I-Dis I-Dis
cell I-Dis I-Dis
carcinomas I-Dis I-Dis
-lrb- O O
rcc B-Dis B-Dis
-rrb- O O
and O O
brain B-Dis O
hemangioblastomas I-Dis B-Dis
. O O

nevertheless O O
, O O
bard1 O O
polypeptides O O
are O O
found O O
exclusively O O
in O O
the O O
nuclear O O
fractions O O
of O O
both O O
g1 O O
- O O
and O O
s-phase O O
cells O O
. O O

in O O
addition O O
, O O
a O O
correlation O O
between O O
smooth O O
pursuit O O
gain O O
and O O
the O O
number O O
of O O
trinucleotide O O
repeats O O
was O O
found O O
. O O

fourteen O O
microsatellite O O
polymorphisms O O
were O O
selected O O
based O O
on O O
their O O
high O O
heterozygosity O O
and O O
their O O
location O O
within O O
10q23-q25 O O
near O O
col17a1 O O
. O O

one O O
of O O
the O O
principal O O
features O O
of O O
the O O
dm B-Dis B-Dis
mutation O O
is O O
an O O
extraordinarily O O
high O O
level O O
of O O
somatic O O
mosaicism O O
, O O
due O O
to O O
an O O
extremely O O
high O O
degree O O
of O O
somatic O O
instability O O
both O O
within O O
and O O
between O O
different O O
tissues O O
. O O

localization O O
of O O
human O O
brca1 O O
and O O
its O O
loss O O
in O O
high-grade O O
, O O
non-inherited B-Dis B-Dis
breast I-Dis I-Dis
carcinomas I-Dis I-Dis
. O O

in O O
a O O
south O O
african O O
girl O O
of O O
xhosa O O
stock O O
with O O
severe O O
piebaldism B-Dis B-Dis
and O O
profound O O
congenital O B-Dis
sensorineural B-Dis I-Dis
deafness I-Dis I-Dis
we O O
identified O O
a O O
novel O O
missense O O
substitution O O
at O O
a O O
highly O O
conserved O O
residue O O
in O O
the O O
intracellular O O
kinase O O
domain O O
of O O
the O O
kit O O
proto-oncogene O O
, O O
r796g O O
. O O

recently O O
, O O
the O O
r496h O O
mutation O O
of O O
arsa O O
was O O
proposed O O
to O O
be O O
a O O
cause O O
of O O
mld B-Dis B-Dis
-lrb- O O
draghia O O
et O O
al. O O
, O O
_num4 O O
-rrb- O O
. O O

the O O
most O O
frequently O O
found O O
mutation O O
, O O
identified O O
in O O
three O O
unrelated O O
turkish O O
a-t B-Dis B-Dis
individuals O O
, O O
was O O
previously O O
described O O
to O O
be O O
a O O
turkish O O
a-t B-Dis B-Dis
founder O O
mutation O O
. O O

we O O
screened O O
_num2 O O
prostate B-Dis B-Dis
tumors I-Dis I-Dis
by O O
microsatellite O O
analysis O O
and O O
found O O
chromosome O O
10q23 O O
to O O
be O O
deleted O O
in O O
_num2 O O
cases O O
. O O

in O O
ataxia-telangiectasia B-Dis B-Dis
-lrb- O O
a-t B-Dis B-Dis
-rrb- O O
patients O O
, O O
mutations O O
in O O
a O O
single O O
gene O O
, O O
atm O O
, O O
result O O
in O O
an O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
syndrome I-Dis I-Dis
that O O
embraces O O
a O O
variety O O
of O O
clinical O O
features O O
and O O
manifests O O
extreme O O
radiosensitivity O O
and O O
a O O
strong O O
pre-disposition O O
to O O
malignancy B-Dis O
. O O

clustering O O
of O O
missense O O
mutations O O
in O O
the O O
ataxia-telangiectasia B-Dis B-Dis
gene O O
in O O
a O O
sporadic B-Dis O
t-cell I-Dis O
leukaemia I-Dis O
. O O

nonsignificant O O
increases O O
in O O
similarity O O
with O O
regard O O
to O O
age O O
at O O
disease O O
onset O O
and O O
all O O
of O O
the O O
disease O O
severity O O
scores O O
assessed O O
were O O
noted O O
in O O
disease-concordant O O
mz O O
twins O O
compared O O
with O O
concordant O O
dz O O
twins O O
. O O

recently O O
, O O
we O O
reported O O
five O O
austrian O O
families O O
with O O
generalized O O
atrophic B-Dis B-Dis
benign I-Dis I-Dis
epidermolysis I-Dis I-Dis
bullosa I-Dis O
who O O
share O O
the O O
same O O
col17a1 O O
mutation O O
. O O

one O O
model O O
of O O
dm B-Dis B-Dis
pathogenesis O O
suggests O O
that O O
rnas O O
from O O
the O O
expanded O O
allele O O
create O O
a O O
gain-of-function O O
mutation O O
by O O
the O O
inappropriate O O
binding O O
of O O
proteins O O
to O O
the O O
cug O O
repeats O O
. O O

biochemical O O
studies O O
indicated O O
vlcad B-Dis B-Dis
deficiency I-Dis I-Dis
caused O O
by O O
a O O
stable O O
yet O O
inactive O O
enzyme O O
. O O

studies O O
on O O
meiotic O O
drive O O
in O O
dm B-Dis B-Dis
have O O
shown O O
increased O O
transmission O O
of O O
the O O
larger O O
allele O O
at O O
the O O
dm B-Dis B-Dis
locus O O
in O O
non-dm O O
heterozygotes O O
for O O
ctgn O O
. O O

_num1 O O
% O O
-rrb- O O
was O O
found O O
in O O
swedes O O
. O O

we O O
searched O O
for O O
such O O
germline O O
mutations O O
in O O
_num2 O O
french O O
melanoma B-Dis B-Dis
prone O O
families O O
selected O O
according O O
to O O
two O O
major O O
criteria O O
families O O
with O O
at O O
least O O
three O O
affected O O
members O O
-lrb- O O
n O O
= O O
_num2 O O
-rrb- O O
or O O
families O O
with O O
two O O
affected O O
members O O
, O O
one O O
of O O
them O O
affected O O
before O O
the O O
age O O
of O O
_num2 O O
-lrb- O O
n O O
= O O
_num2 O O
-rrb- O O
, O O
and O O
one O O
additional O O
minor O O
criterion O O
. O O

in O O
_num1 O O
patient O O
, O O
somatic O O
mosaicism O O
was O O
demonstrated O O
by O O
molecular O O
analysis O O
of O O
dna O O
and O O
rna O O
from O O
peripheral O O
blood O O
. O O

we O O
report O O
wt1 O O
heterozygous O O
mutations O O
in O O
_num2 O O
patients O O
, O O
_num1 O O
of O O
whom O O
presented O O
with O O
idms B-Dis O
. O O

patient O O
_num1 O O
was O O
found O O
to O O
be O O
a O O
compound O O
heterozygote O O
for O O
two O O
mutations O O
in O O
exon O O
_num1 O O
-lrb- O O
g7013t O O
, O O
c7133delta O O
-rrb- O O
which O O
interfere O O
with O O
appropriate O O
synthesis O O
of O O
acth O O
and O O
alpha-msh O O
. O O

deletion O O
mapping O O
studies O O
have O O
unambiguously O O
identified O O
a O O
region O O
of O O
chromosome O O
10q23 O O
to O O
be O O
the O O
minimal O O
area O O
of O O
loss O O
. O O

although O O
hemochromatosis B-Dis B-Dis
is O O
common O O
in O O
caucasians O O
, O O
affecting O O
> O O
= O O
1 O O
/ O O
300 O O
individuals O O
of O O
northern O O
european O O
origin O O
, O O
it O O
has O O
not O O
been O O
recognized O O
in O O
other O O
populations O O
. O O

crystal O O
structure O O
of O O
the O O
hemochromatosis B-Dis B-Dis
protein O O
hfe O O
and O O
characterization O O
of O O
its O O
interaction O O
with O O
transferrin O O
receptor O O
. O O

5-1 O O
. O O

previous O O
family O O
studies O O
suggested O O
that O O
these O O
individuals O O
may O O
be O O
compound O O
heterozygotes O O
for O O
the O O
common O O
mutant O O
tsd B-Dis B-Dis
gene O O
and O O
a O O
rare O O
-lrb- O O
allelic O O
-rrb- O O
mutant O O
gene O O
. O O

as O O
observed O O
in O O
some O O
of O O
the O O
tissues O O
of O O
dm B-Dis B-Dis
patients O O
, O O
there O O
is O O
a O O
tendency O O
for O O
repeat O O
length O O
and O O
somatic O O
mosaicism O O
to O O
increase O O
with O O
the O O
age O O
of O O
the O O
mouse O O
. O O

i. O O
clinical O O
, O O
immunochemical O O
, O O
and O O
family O O
studies O O
. O O

the O O
molecular O O
basis O O
of O O
c6 B-Dis B-Dis
deficiency I-Dis I-Dis
in O O
the O O
western O O
cape O O
, O O
south O O
africa O O
. O O

furthermore O O
, O O
the O O
precursor O O
level O O
of O O
the O O
w474c O O
alpha-subunit O O
was O O
found O O
to O O
accumulate O O
in O O
comparison O O
to O O
the O O
normal O O
alpha-subunit O O
precursor O O
levels O O
. O O

wfs1 O O
appears O O
to O O
function O O
in O O
survival O O
of O O
islet O O
beta-cells O O
and O O
neurons O O
. O O
. O O

recently O O
, O O
an O O
isoleucine O O
-- O O
> O O
lysine O O
polymorphism O O
at O O
codon O O
_num4 O O
-lrb- O O
i1307k O O
-rrb- O O
of O O
the O O
apc B-Dis B-Dis
gene O O
has O O
been O O
identified O O
in O O
_num1 O O
% O O
-7 O O
% O O
of O O
the O O
ashkenazi O O
jewish O O
population O O
. O O

transfection O O
of O O
constructed O O
minigenes O O
, O O
with O O
or O O
without O O
the O O
mutation O O
, O O
into O O
cos-1 O O
cells O O
confirmed O O
that O O
the O O
mutant O O
minigene O O
was O O
responsible O O
for O O
a O O
mrna O O
species O O
alternatively O O
spliced O O
at O O
an O O
activated O O
cryptic O O
_num1 O O
splice O O
site O O
_num2 O O
bp O O
upstream O O
from O O
the O O
_num1 O O
end O O
of O O
exon O O
_num1 O O
. O O

the O O
brca1 O O
c4446t O O
mutation O O
was O O
the O O
most O O
common O O
mutation O O
found O O
, O O
followed O O
by O O
the O O
brca2 O O
8765delag O O
mutation O O
. O O

there O O
is O O
increasing O O
evidence O O
that O O
there O O
exist O O
germ-line O O
variants O O
of O O
the O O
apc B-Dis O
gene O O
that O O
predispose O O
to O O
the O O
development O O
of O O
multiple O O
colorectal B-Dis B-Dis
adenomas I-Dis I-Dis
and I-Dis O
carcinoma I-Dis B-Dis
, O O
but O O
without O O
the O O
florid O O
phenotype O O
of O O
classical O B-Dis
fap B-Dis I-Dis
, O O
and O O
possibly O O
with O O
importance O O
for O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
risk O O
in O O
the O O
general O O
population O O
. O O
. O O

these O O
rapid O O
assays O O
detected O O
mutations O O
in O O
_num2 O O
% O O
of O O
costa O O
rican O O
patients O O
-lrb- O O
_num1 O O
-rrb- O O
, O O
_num2 O O
% O O
of O O
norwegian O O
patients O O
-lrb- O O
_num1 O O
-rrb- O O
, O O
_num2 O O
% O O
of O O
polish O O
patients O O
-lrb- O O
_num1 O O
-rrb- O O
, O O
and O O
_num2 O O
% O O
of O O
italian O O
patients O O
-lrb- O O
_num1 O O
-rrb- O O
, O O
as O O
well O O
as O O
in O O
patients O O
of O O
amish O O
/ O O
mennonite O O
and O O
irish O O
english O O
backgrounds O O
. O O

we O O
studied O O
somatic O O
instability O O
by O O
measuring O O
the O O
_ds O O
repeat O O
length O O
at O O
several O O
ages O O
in O O
various O O
tissues O O
of O O
transgenic O O
mice O O
carrying O O
a O O
-lrb- O O
_ds O O
-rrb- O O
55expansion O O
surrounded O O
by O O
_num2 O O
kb O O
of O O
the O O
human O O
dm B-Dis B-Dis
region O O
, O O
using O O
small-pool O O
pcr O O
. O O

we O O
have O O
found O O
strong O O
evidence O O
for O O
a O O
locus O O
on O O
chromosome O O
4p O O
at O O
d4s2949 O O
-lrb- O O
maximum O O
genehunter-plus O O
nonparametric O O
linkage O O
score O O
= O O
_num1 O O
. O O

_num3 O O
-rrb- O O
; O O
use O O
for O O
six O O
or O O
more O O
years O O
was O O
associated O O
with O O
a O O
_num2 O O
percent O O
reduction O O
in O O
risk O O
. O O

the O O
estimated O O
relative O O
risk O O
for O O
carriers O O
may O O
justify O O
specific O O
clinical O O
screening O O
for O O
the O O
_num3 O O
, O O
_num3 O O
americans O O
expected O O
to O O
harbor O O
this O O
allele O O
, O O
and O O
genetic O O
testing O O
in O O
the O O
setting O O
of O O
long-term-outcome O O
studies O O
may O O
impact O O
significantly O O
on O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
prevention O O
in O O
this O O
population O O
. O O

hereditary B-Dis B-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
clinical O O
study O O
group O O
. O O

most O O
mutations O O
in O O
dds B-Dis B-Dis
patients O O
lie O O
in O O
exon O O
_num1 O O
or O O
exon O O
_num1 O O
, O O
encoding O O
zinc O O
finger O O
_num1 O O
or O O
zinc O O
finger O O
_num1 O O
, O O
respectively O O
, O O
with O O
a O O
hot O O
spot O O
-lrb- O O
r394w O O
-rrb- O O
in O O
exon O O
_num1 O O
. O O

additive O O
genetic O O
effects O O
were O O
estimated O O
to O O
contribute O O
_num2 O O
% O O
of O O
the O O
population O O
variance O O
. O O

our O O
data O O
suggest O O
that O O
, O O
in O O
aapc B-Dis B-Dis
families O O
, O O
the O O
location O O
of O O
the O O
apc B-Dis B-Dis
mutation O O
may O O
partially O O
predict O O
specific O O
phenotypic O O
expression O O
. O O

his O O
sperm O O
showed O O
an O O
expanded O O
allele O O
in O O
a O O
tight O O
range O O
centering O O
on O O
a O O
size O O
of O O
approximately O O
_num3 O O
trinucleotide O O
repeats O O
. O O

for O O
six O O
such O O
individuals O O
, O O
there O O
was O O
significant O O
disparity O O
between O O
the O O
tests O O
. O O

mutations O O
in O O
pax6 O O
are O O
responsible O O
for O O
human O O
aniridia B-Dis B-Dis
and O O
have O O
also O O
been O O
found O O
in O O
patients O O
with O O
peters B-Dis B-Dis
anomaly I-Dis I-Dis
, O O
with O O
congenital B-Dis B-Dis
cataracts I-Dis I-Dis
, O O
with O O
autosomal B-Dis B-Dis
dominant I-Dis I-Dis
keratitis I-Dis I-Dis
, O O
and O O
with O O
isolated B-Dis O
foveal I-Dis B-Dis
hypoplasia I-Dis I-Dis
. O O

a O O
european O O
multicenter O O
study O O
of O O
phenylalanine B-Dis B-Dis
hydroxylase I-Dis I-Dis
deficiency I-Dis I-Dis
: O O
classification O O
of O O
_num3 O O
mutations O O
and O O
a O O
general O O
system O O
for O O
genotype-based O O
prediction O O
of O O
metabolic O O
phenotype O O
. O O

lorenzos O O
oil O O
should O O
be O O
given O O
in O O
the O O
early O O
stage O O
. O O
. O O

interestingly O O
, O O
the O O
i1307k O O
apc O O
polymorphism O O
, O O
associated O O
with O O
an O O
increased O O
risk O O
of O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
, O O
is O O
also O O
present O O
in O O
this O O
family O O
. O O

twenty-eight O O
percent O O
of O O
identified O O
pax6 O O
mutations O O
are O O
c-t O O
changes O O
at O O
cpg O O
dinucleotides O O
, O O
_num2 O O
% O O
are O O
splicing O O
errors O O
, O O
and O O
more O O
than O O
_num2 O O
% O O
are O O
deletion O O
or O O
insertion O O
events O O
. O O

_num1 O O
-rrb- O O
. O O

interestingly O O
, O O
none O O
of O O
these O O
mutations O O
was O O
observed O O
in O O
the O O
ptpase O O
core O O
motif O O
. O O

the O O
two O O
polymorphisms O O
were O O
localized O O
in O O
noncoding O O
part O O
of O O
the O O
gene O O
_num1 O O
-rrb- O O
a O O
c O O
/ O O
g O O
polymorphism O O
in O O
the O O
promotor O O
region O O
, O O
_num3 O O
bp O O
upstream O O
from O O
the O O
transcriptional O O
initiation O O
site O O
-lrb- O O
-142 O O
c O O
/ O O
g O O
-rrb- O O
, O O
and O O
_num1 O O
-rrb- O O
a O O
_num1 O O
bp O O
deletion O O
polymorphism O O
in O O
the O O
_num1 O O
noncoding O O
part O O
of O O
the O O
cpo O O
gene O O
, O O
_num3 O O
bp O O
downstream O O
of O O
the O O
last O O
base O O
of O O
the O O
normal O O
termination O O
codon O O
-lrb- O O
+ O O
_num3 O O
delattctt O O
-rrb- O O
. O O

molecular O O
genetic O O
analysis O O
of O O
her O O
vlcad O O
gene O O
revealed O O
a O O
t1372c O O
-lrb- O O
f458l O O
-rrb- O O
missense O O
mutation O O
and O O
a O O
_num4 O O
_ds O O
_num4 O O
splice O O
site O O
mutation O O
. O O

brca1 O O
associates O O
in O O
vivo O O
with O O
a O O
structurally O O
related O O
protein O O
termed O O
bard1 O O
. O O

an O O
allele-specific O O
polymerase O O
chain O O
reaction O O
system O O
designed O O
to O O
detect O O
exclusively O O
only O O
one O O
of O O
the O O
normal O O
and O O
mutant O O
alleles O O
indicated O O
that O O
all O O
the O O
four O O
patients O O
were O O
homozygous O O
for O O
the O O
mutation O O
in O O
exon O O
_num1 O O
and O O
that O O
the O O
parents O O
of O O
patient O O
_num1 O O
were O O
heterozygous O O
. O O

amino O O
acid O O
changes O O
were O O
identified O O
in O O
four O O
patients O O
, O O
three O O
of O O
whom O O
belonged O O
to O O
the O O
non-fap O O
group O O
of O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
patients O O
. O O

fluorescent O O
in O O
situ O O
hybridization O O
analysis O O
demonstrated O O
that O O
the O O
pws B-Dis B-Dis
critical O O
region O O
resided O O
on O O
the O O
derivative O O
chromosome O O
_num1 O O
and O O
that O O
there O O
was O O
no O O
deletion O O
of O O
the O O
pws B-Dis B-Dis
region O O
on O O
the O O
normal O O
pair O O
of O O
15s O O
present O O
in O O
j. O O
b. O O
methylation O O
analysis O O
at O O
exon O O
alpha O O
of O O
the O O
small O O
nuclear O O
ribonucleoprotein-associated O O
polypeptide O O
n O O
-lrb- O O
snrpn O O
-rrb- O O
gene O O
showed O O
a O O
pattern O O
characteristic O O
of O O
only O O
the O O
maternal O O
chromosome O O
_num2 O O
in O O
j. O O
b. O O
maternal B-Dis O
disomy I-Dis O
was O O
confirmed O O
by O O
polymerase O O
chain O O
reaction O O
analysis O O
of O O
microsatellite O O
repeats O O
at O O
the O O
gamma-aminobutyric O O
acid O O
receptor O O
beta3 O O
subunit O O
-lrb- O O
gabrb3 O O
-rrb- O O
locus O O
. O O

_num2 O O
-rrb- O O
. O O

_num1 O O
% O O
-rrb- O O
. O O

once O O
the O O
diagnosis O O
is O O
suspected O O
, O O
physicians O O
must O O
use O O
serum O O
ferritin O O
levels O O
and O O
hepatic O O
iron O O
stores O O
on O O
liver O O
biopsy O O
specimens O O
to O O
assess O O
patients O O
for O O
the O O
presence O O
of O O
iron B-Dis O
overload I-Dis O
. O O

moreover O O
, O O
further O O
arsa O O
alleles O O
functionally O O
similar O O
to O O
a464v O O
might O O
exist O O
which O O
, O O
together O O
with O O
0-type O O
mutations O O
, O O
may O O
cause O O
pathological O O
arsa O O
and O O
gs O O
levels O O
, O O
but O O
not O O
clinical O O
outbreak O O
of O O
the O O
disease O O
. O O
. O O

we O O
also O O
show O O
that O O
in O O
all O O
informative O O
carrier O O
father O O
to O O
affected O O
child O O
transmissions O O
, O O
with O O
the O O
notable O O
exception O O
of O O
the O O
premutation O O
carrier O O
, O O
the O O
expansion O O
size O O
decreases O O
. O O
. O O

x-linked B-Dis B-Dis
dilated I-Dis I-Dis
cardiomyopathy I-Dis I-Dis
-lrb- O O
xldcm B-Dis B-Dis
-rrb- O O
is O O
a O O
clinical O O
phenotype O O
of O O
dystrophinopathy B-Dis O
which O O
is O O
characterized O O
by O O
preferential O O
myocardial B-Dis O
involvement I-Dis O
without O O
any O O
overt O O
clinical O O
signs O O
of O O
skeletal B-Dis B-Dis
myopathy I-Dis I-Dis
. O O

this O O
mutation O O
-lrb- O O
7271t O O
-- O O
> O O
g O O
-rrb- O O
also O O
allows O O
expression O O
of O O
full-length O O
atm O O
protein O O
at O O
a O O
level O O
comparable O O
with O O
that O O
in O O
unaffected O O
individuals O O
. O O

both O O
human O O
and O O
mouse O O
lrp5 O O
cdnas O O
have O O
been O O
isolated O O
and O O
the O O
encoded O O
mature O O
proteins O O
are O O
_num2 O O
% O O
identical O O
, O O
indicating O O
a O O
high O O
degree O O
of O O
evolutionary O O
conservation O O
. O O
. O O

c5 O O
levels O O
of O O
other O O
family O O
members O O
were O O
either O O
normal O O
or O O
approximately O O
half-normal O O
, O O
consistent O O
with O O
autosomal O O
codominant O O
inheritance O O
of O O
the O O
gene O O
determining O O
c5 B-Dis B-Dis
deficiency I-Dis I-Dis
. O O

currently O O
, O O
the O O
most O O
useful O O
role O O
for O O
this O O
test O O
is O O
in O O
the O O
detection O O
of O O
hemochromatosis B-Dis B-Dis
in O O
the O O
family O O
members O O
of O O
patients O O
with O O
a O O
proven O O
case O O
of O O
the O O
disease O O
. O O

there O O
is O O
a O O
good O O
correlation O O
between O O
repeat O O
size O O
-lrb- O O
at O O
least O O
in O O
leucocytes O O
-rrb- O O
, O O
clinical O O
severity O O
and O O
age O O
of O O
onset O O
. O O

the O O
apci1307k O O
allele O O
and O O
cancer B-Dis O
risk O O
in O O
a O O
community-based O O
study O O
of O O
ashkenazi O O
jews O O
. O O

genetic O O
mapping O O
of O O
the O O
copper B-Dis O
toxicosis I-Dis O
locus O O
in O O
bedlington O O
terriers O O
to O O
dog O O
chromosome O O
_num2 O O
, O O
in O O
a O O
region O O
syntenic O O
to O O
human O O
chromosome O O
region O O
2p13-p16 O O
. O O

in O O
addition O O
, O O
pten O O
was O O
identified O O
as O O
the O O
susceptibility O O
gene O O
for O O
two O O
hamartoma B-Dis O
syndromes I-Dis O
cowden I-Dis B-Dis
disease I-Dis I-Dis
-lrb- O O
cd B-Dis O
; O O
mim O O
_num6 O O
-rrb- O O
and O O
bannayan-zonana B-Dis O
-lrb- I-Dis O
bzs I-Dis O
-rrb- I-Dis O
or I-Dis O
ruvalcaba-riley-smith I-Dis B-Dis
syndrome I-Dis I-Dis
-lrb- O O
mim O O
_num6 O O
-rrb- O O
. O O

nine O O
novel O O
and O O
three O O
recurrent O O
twist O O
mutations O O
were O O
found O O
in O O
_num2 O O
families O O
. O O

_num1 O O
% O O
of O O
the O O
alleles O O
in O O
this O O
study O O
. O O

phenylketonuria B-Dis B-Dis
-lrb- O O
pku B-Dis B-Dis
-rrb- O O
and O O
mild B-Dis B-Dis
hyperphenylalaninemia I-Dis I-Dis
-lrb- O O
mhp B-Dis B-Dis
-rrb- O O
are O O
allelic B-Dis O
disorders I-Dis O
caused O O
by O O
mutations O O
in O O
the O O
gene O O
encoding O O
phenylalanine O O
hydroxylase O O
-lrb- O O
pah O O
-rrb- O O
. O O

this O O
mans O O
leucocyte O O
dna O O
showed O O
one O O
normal O O
allele O O
and O O
one O O
allele O O
of O O
approximately O O
_num3 O O
repeats O O
. O O

_num1 O O
a O O
crystal O O
structure O O
of O O
hfe O O
reveals O O
the O O
locations O O
of O O
hemochromatosis B-Dis B-Dis
mutations O O
and O O
a O O
patch O O
of O O
histidines O O
that O O
could O O
be O O
involved O O
in O O
ph-dependent O O
interactions O O
. O O

two O O
mutations O O
associated O O
with O O
idms B-Dis O
are O O
different O O
from O O
those O O
described O O
in O O
dds B-Dis B-Dis
patients O O
. O O

_num1 O O
and O O
, O O
recently O O
, O O
found O O
to O O
encode O O
a O O
putative O O
sulfate O O
transporter O O
. O O

_num2 O O
+ O O
/ O O
-0 O O
. O O

_num2 O O
+ O O
/ O O
-1 O O
. O O

this O O
indicates O O
that O O
there O O
is O O
a O O
heavy O O
ascertainment O O
bias O O
in O O
the O O
selection O O
of O O
patients O O
for O O
pax6 O O
mutation O O
analysis O O
and O O
that O O
the O O
missing O O
pax6 O O
missense O O
mutations O O
frequently O O
may O O
underlie O O
phenotypes O O
distinct O O
from O O
textbook O O
aniridia B-Dis B-Dis
. O O

myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
protein O O
kinase O O
is O O
involved O O
in O O
the O O
modulation O O
of O O
the O O
ca2 O O
+ O O
homeostasis O O
in O O
skeletal O O
muscle O O
cells O O
. O O

we O O
studied O O
mutations O O
in O O
the O O
galns O O
gene O O
from O O
_num2 O O
additional O O
mps B-Dis B-Dis
iva I-Dis I-Dis
patients O O
-lrb- O O
_num2 O O
from O O
australia O O
, O O
_num1 O O
from O O
northern O O
ireland O O
-rrb- O O
, O O
with O O
various O O
clinical O O
phenotypes O O
-lrb- O O
severe O O
, O O
_num2 O O
cases O O
; O O
intermediate O O
, O O
_num1 O O
cases O O
; O O
mild O O
, O O
_num1 O O
cases O O
-rrb- O O
. O O

to O O
date O O
, O O
several O O
mutations O O
in O O
the O O
duchenne B-Dis B-Dis
muscular I-Dis I-Dis
dystrophy I-Dis I-Dis
gene O O
, O O
dmd O B-Dis
, O O
have O O
been O O
identified O O
in O O
patients O O
with O O
xldcm B-Dis O
, O O
but O O
a O O
pathogenic O O
correlation O O
of O O
these O O
cardiospecific O O
mutations O O
in O O
dmd O B-Dis
with O O
the O O
xldcm B-Dis B-Dis
phenotype O O
has O O
remained O O
to O O
be O O
elucidated O O
. O O

of O O
_num2 O O
atm O O
mutations O O
identified O O
in O O
families O O
native O O
to O O
the O O
british O O
isles O O
, O O
_num2 O O
were O O
founder O O
mutations O O
, O O
and O O
_num1 O O
of O O
these O O
_num2 O O
conferred O O
a O O
milder O O
clinical O O
phenotype O O
with O O
respect O O
to O O
both O O
cerebellar B-Dis B-Dis
degeneration I-Dis I-Dis
and O O
cellular O O
features O O
. O O

we O O
have O O
found O O
an O O
allelic O O
deletion O O
of O O
the O O
haptoglobin O O
-lrb- O O
hp O O
-rrb- O O
gene O O
from O O
an O O
individual O O
with O O
anhaptoglobinemia B-Dis O
. O O

patients O O
with O O
generalized O O
atrophic B-Dis B-Dis
benign I-Dis I-Dis
epidermolysis I-Dis I-Dis
bullosa I-Dis O
often O O
show O O
decreased O O
expression O O
of O O
type O O
xvii O O
collagen O O
, O O
a O O
transmembrane O O
hemidesmosomal O O
protein O O
encoded O O
by O O
col17a1 O O
. O O

further O O
studies O O
suggested O O
that O O
low O O
dilutions O O
of O O
c5d B-Dis B-Dis
serum O O
contain O O
a O O
factor O O
-lrb- O O
or O O
factors O O
-rrb- O O
interfering O O
at O O
some O O
step O O
in O O
the O O
hemolytic O O
assay O O
of O O
c5 O O
, O O
rather O O
than O O
a O O
true O O
c5 O O
inhibitor O O
or O O
inactivator O O
. O O

_num1 O O
and O O
encodes O O
a O O
_num3 O O
amino O O
acid O O
dual O O
specificity O O
phosphatase O O
-lrb- O O
protein O O
tyrosine O O
phosphatase O O
; O O
ptpase O O
-rrb- O O
, O O
was O O
shown O O
recently O O
to O O
play O O
a O O
broad O O
role O O
in O O
human O O
malignancy B-Dis O
. O O

pax6 O O
is O O
a O O
transcription O O
factor O O
with O O
two O O
dna-binding O O
domains O O
-lrb- O O
paired O O
box O O
and O O
homeobox O O
-rrb- O O
and O O
a O O
proline-serine-threonine O O
-lrb- O O
pst O O
-rrb- O O
- O O
rich O O
transactivation O O
domain O O
. O O

he O O
presented O O
with O O
respiratory O O
and O O
feeding O O
difficulties O O
at O O
birth O O
. O O

distribution O O
of O O
emerin O O
and O O
lamins O O
in O O
the O O
heart O O
and O O
implications O O
for O O
emery-dreifuss B-Dis B-Dis
muscular I-Dis I-Dis
dystrophy I-Dis I-Dis
. O O

we O O
describe O O
the O O
outcome O O
of O O
a O O
5-year-old O O
girl O O
with O O
vlcad B-Dis B-Dis
deficiency I-Dis I-Dis
who O O
was O O
first O O
seen O O
at O O
_num1 O O
months O O
of O O
age O O
with O O
severe O O
hypertrophic B-Dis B-Dis
cardiomyopathy I-Dis I-Dis
, O O
hepatomegaly B-Dis B-Dis
, O O
encephalopathy B-Dis O
, O O
and O O
hypotonia B-Dis B-Dis
. O O

atm O O
germline O O
mutations O O
in O O
classical O B-Dis
ataxia-telangiectasia B-Dis I-Dis
patients O O
in O O
the O O
dutch O O
population O O
. O O

the O O
haptoglobin-gene O O
deletion O O
responsible O O
for O O
anhaptoglobinemia B-Dis O
. O O

it O O
is O O
believed O O
that O O
the O O
mutated O O
allele O O
of O O
pax6 O O
produces O O
an O O
inactive O O
protein O O
and O O
aniridia B-Dis B-Dis
is O O
caused O O
due O O
to O O
genetic O B-Dis
haploinsufficiency O I-Dis
. O O

this O O
study O O
also O O
provided O O
evidence O O
for O O
the O O
pathological O O
nature O O
of O O
amino O O
acid O O
changes O O
in O O
apc O B-Dis
associated O O
with O O
both O O
fap B-Dis B-Dis
and O O
non-fap O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
patients O O
. O O
. O O

in O O
addition O O
, O O
we O O
observed O O
that O O
these O O
ca2 O O
+ O O
transients O O
partially O O
result O O
from O O
an O O
influx O O
of O O
extracellular O O
ca2 O O
+ O O
through O O
the O O
l-type O O
ca2 O O
+ O O
channel O O
. O O

patients O O
were O O
selected O O
because O O
they O O
were O O
heterozygous O O
or O O
homozygous O O
for O O
c2 B-Dis B-Dis
deficiency I-Dis I-Dis
. O O

overall O O
, O O
disease O O
was O O
linked O O
to O O
brca1 O O
in O O
an O O
estimated O O
_num2 O O
% O O
of O O
families O O
, O O
to O O
brca2 O O
in O O
_num2 O O
% O O
of O O
families O O
, O O
and O O
to O O
neither O O
gene O O
in O O
_num2 O O
% O O
-lrb- O O
_num2 O O
% O O
confidence O O
interval O O
-lsb- O O
ci O O
-rsb- O O
_num1 O O
% O O
-28 O O
% O O
-rrb- O O
, O O
suggesting O O
other O O
predisposition O O
genes O O
. O O

interestingly O O
, O O
the O O
presence O O
of O O
a O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
case O O
< O O
_num2 O O
years O O
of O O
age O O
was O O
strongly O O
predictive O O
of O O
the O O
presence O O
of O O
any O O
of O O
the O O
eight O O
mutations O O
screened O O
. O O

six O O
of O O
eight O O
mutations O O
were O O
observed O O
at O O
least O O
twice O O
. O O

a O O
novel O O
missense O O
mutation O O
in O O
patients O O
from O O
a O O
retinoblastoma B-Dis B-Dis
pedigree O O
showing O O
only O O
mild O O
expression O O
of O O
the O O
tumor B-Dis B-Dis
phenotype O O
. O O

complete O O
analysis O O
of O O
the O O
dystrophin O O
gene O O
was O O
performed O O
to O O
define O O
the O O
localization O O
of O O
deletions O O
and O O
duplications O O
in O O
relation O O
to O O
the O O
different O O
dmd B-Dis B-Dis
promoters O O
. O O

the O O
results O O
suggest O O
that O O
a O O
few O O
common O O
ancestral O O
mutations O O
in O O
both O O
caucasian O O
and O O
japanese O O
populations O O
have O O
originated O O
by O O
expansion O O
of O O
an O O
ancestral O O
n O O
= O O
_num1 O O
repeat O O
to O O
n O O
= O O
19-37 O O
copies O O
. O O

moreover O O
, O O
in O O
s O O
phase O O
cells O O
, O O
brca1 O O
polypeptides O O
are O O
hyperphosphorylated O O
and O O
accumulate O O
into O O
discrete O O
subnuclear O O
foci O O
termed O O
'' O O
brca1 O O
nuclear O O
dots O O
. O O
'' O O

_num1 O O
-rrb- O O
. O O

among O O
the O O
other O O
_num2 O O
unique O O
mutations O O
, O O
_num1 O O
were O O
small O O
deletions O O
or O O
insertions O O
predicted O O
to O O
cause O O
frameshifts O O
, O O
_num1 O O
was O O
a O O
mutation O O
to O O
a O O
stop O O
codon O O
, O O
_num1 O O
was O O
a O O
missense O O
mutation O O
, O O
and O O
_num1 O O
was O O
predicted O O
to O O
cause O O
insertion O O
of O O
an O O
isoleucine O O
in O O
the O O
hect O O
domain O O
of O O
the O O
ube3a O O
protein O O
, O O
which O O
functions O O
in O O
e2 O O
binding O O
and O O
ubiquitin O O
transfer O O
. O O

a O O
correlation O O
was O O
observed O O
between O O
the O O
presence O O
/ O O
absence O O
of O O
a O O
pten O O
mutation O O
and O O
the O O
type O O
of O O
breast O O
involvement O O
-lrb- O O
unaffected O O
versus O O
benign O O
versus O O
malignant O O
-rrb- O O
. O O

the O O
insertion O O
was O O
a O O
5-truncated O O
form O O
of O O
human O O
l1 O O
inversely O O
integrated O O
in O O
the O O
5-untranslated O O
region O O
in O O
the O O
muscle O O
exon O O
_num1 O O
, O O
which O O
affected O O
the O O
transcription O O
or O O
the O O
stability O O
of O O
the O O
muscle O O
form O O
of O O
dystrophin O O
transcripts O O
but O O
not O O
that O O
of O O
the O O
brain O O
or O O
purkinje O O
cell O O
form O O
, O O
probably O O
due O O
to O O
its O O
unique O O
site O O
of O O
integration O O
. O O

previous O O
ube3a O O
cdna O O
analysis O O
has O O
shown O O
a O O
coding O O
region O O
of O O
approximately O O
_num1 O O
. O O

the O O
disease O O
susceptibility O O
of O O
individuals O O
who O O
constitutionally O O
lack O O
both O O
wild-type O O
alleles O O
is O O
unknown O O
. O O

seven O O
of O O
_num2 O O
-lrb- O O
_num2 O O
% O O
-rrb- O O
were O O
within O O
the O O
core O O
motif O O
, O O
the O O
majority O O
-lrb- O O
five O O
of O O
seven O O
-rrb- O O
of O O
which O O
were O O
missense O O
mutations O O
, O O
possibly O O
pointing O O
to O O
the O O
functional O O
significance O O
of O O
this O O
region O O
. O O

identification O O
of O O
a O O
novel O O
nonsense O O
mutation O O
and O O
a O O
missense O O
substitution O O
in O O
the O O
vasopressin-neurophysin O O
ii O O
gene O O
in O O
two O O
spanish O O
kindreds O O
with O O
familial B-Dis B-Dis
neurohypophyseal I-Dis I-Dis
diabetes I-Dis I-Dis
insipidus I-Dis I-Dis
. O O

to O O
discover O O
genes O O
involved O O
in O O
von B-Dis B-Dis
hippel-lindau I-Dis I-Dis
-lrb- O I-Dis
vhl B-Dis I-Dis
-rrb- O O
- O O
mediated O O
carcinogenesis O O
, O O
we O O
used O O
renal B-Dis B-Dis
cell I-Dis I-Dis
carcinoma I-Dis I-Dis
cell O O
lines O O
stably O O
transfected O O
with O O
wild-type O O
vhl-expressing O O
transgenes O O
. O O

these O O
results O O
provide O O
a O O
new O O
insight O O
into O O
the O O
role O O
of O O
mutant O O
pax6 O O
in O O
causing O O
aniridia B-Dis B-Dis
. O O
. O O

in O O
most O O
of O O
these O O
patients O O
, O O
the O O
onset O O
of O O
the O O
disease O O
was O O
congenital O O
. O O

occasionally O O
, O O
a O O
fully O O
expanded O O
allele O O
has O O
been O O
found O O
to O O
arise O O
from O O
a O O
premutation O O
of O O
_num3 O O
or O O
less O O
triplet O O
repeats O O
. O O

the O O
germline O O
t-to-a O O
transversion O O
responsible O O
for O O
the O O
apc O B-Dis
i1307k O O
allele O O
converts O O
the O O
wild-type O O
sequence O O
to O O
a O O
homopolymer O O
tract O O
-lrb- O O
a8 O O
-rrb- O O
that O O
is O O
genetically O O
unstable O O
and O O
prone O O
to O O
somatic O O
mutation O O
. O O

on O O
the O O
second O O
maternally O O
inherited O O
allele O O
, O O
we O O
identified O O
the O O
common O O
infantile O O
disease-causing O O
4-bp O O
insertion O O
, O O
+ O O
_ds O O
_num4 O O
, O O
in O O
exon O O
_num2 O O
. O O

linkage O O
to O O
markers O O
on O O
chromosome O O
4p O O
was O O
confirmed O O
in O O
five O O
families O O
. O O

the O O
cornerstone O O
of O O
screening O O
and O O
case O O
detection O O
is O O
the O O
measurement O O
of O O
serum O O
transferrin O O
saturation O O
and O O
the O O
serum O O
ferritin O O
level O O
. O O

here O O
we O O
present O O
four O O
novel O O
pax6 O O
missense O O
mutations O O
, O O
two O O
in O O
association O O
with O O
atypical O B-Dis
phenotypes O O
ectopia B-Dis O
pupillae I-Dis O
-lrb- O O
displaced B-Dis O
pupils I-Dis O
-rrb- O O
and O O
congenital B-Dis B-Dis
nystagmus I-Dis I-Dis
-lrb- O O
searching B-Dis O
gaze I-Dis O
-rrb- O O
, O O
and O O
two O O
in O O
association O O
with O O
more O O
recognizable O O
aniridia B-Dis B-Dis
phenotypes O O
. O O

imprinting O O
in O O
the O O
15q11-q13 O O
region O O
involves O O
an O O
imprinting O O
centre O O
-lrb- O O
ic O O
-rrb- O O
, O O
mapping O O
in O O
part O O
to O O
the O O
promoter O O
and O O
first O O
exon O O
of O O
snrpn O O
. O O

we O O
have O O
created O O
two O O
deletion O O
mutations O O
in O O
mice O O
to O O
understand O O
pws B-Dis B-Dis
and O O
the O O
mechanism O O
of O O
this O O
ic O O
. O O

no O O
wt1 O O
mutations O O
were O O
detected O O
in O O
the O O
six O O
other O O
idms B-Dis O
patients O O
, O O
suggesting O O
genetic O O
heterogeneity O O
of O O
this O O
disease O O
. O O

_num1 O O
% O O
and O O
_num2 O O
. O O

both O O
mutations O O
result O O
in O O
premature O O
termination O O
codons O O
and O O
c6 O O
null O O
alleles O O
. O O

the O O
identification O O
of O O
two O O
frequent O O
pds B-Dis B-Dis
mutations O O
will O O
facilitate O O
the O O
molecular O O
diagnosis O O
of O O
pendred B-Dis B-Dis
syndrome I-Dis I-Dis
. O O

both O O
the O O
protein O O
truncation O O
test O O
-lrb- O O
ptt O O
-rrb- O O
and O O
the O O
restriction O O
endonuclease O O
fingerprinting O O
-lrb- O O
ref O O
-rrb- O O
method O O
were O O
used O O
and O O
compared O O
for O O
their O O
detection O O
efficiency O O
, O O
identifying O O
_num2 O O
% O O
and O O
_num2 O O
% O O
of O O
the O O
mutations O O
, O O
respectively O O
. O O

susceptibility O O
to O O
ankylosing B-Dis B-Dis
spondylitis I-Dis I-Dis
in O O
twins O O
: O O
the O O
role O O
of O O
genes O O
, O O
hla O O
, O O
and O O
the O O
environment O O
. O O

all O O
patients O O
manifested O O
classical O O
a-t B-Dis B-Dis
and O O
increased O O
cellular O O
radioresistant O O
dna O O
synthesis O O
. O O

here O O
, O O
it O O
is O O
shown O O
that O O
reintroduction O O
of O O
the O O
wild-type O O
vhl B-Dis B-Dis
gene O O
restores O O
the O O
ability O O
of O O
vhl-negative O B-Dis
rcc B-Dis I-Dis
cancer I-Dis O
cells O O
to O O
exit O O
the O O
cell O O
cycle O O
and O O
enter O O
g0 O O
/ O O
quiescence O O
in O O
low O O
serum O O
. O O

_num1 O O
% O O
of O O
the O O
offspring O O
were O O
affected O O
, O O
and O O
in O O
the O O
case O O
of O O
a O O
female O O
transmitting O O
parent O O
, O O
_num2 O O
. O O

stable O O
interaction O O
between O O
the O O
products O O
of O O
the O O
brca1 O O
and O O
brca2 O O
tumor B-Dis B-Dis
suppressor O O
genes O O
in O O
mitotic O O
and O O
meiotic O O
cells O O
. O O

we O O
performed O O
a O O
blind O O
chromosomal O O
analysis O O
on O O
g2-phase O O
lymphocytes O O
from O O
_num1 O O
unrelated O O
a-t B-Dis B-Dis
patients O O
, O O
_num2 O O
obligate O O
a-t B-Dis B-Dis
heterozygotes O O
-lrb- O O
parents O O
of O O
the O O
patients O O
-rrb- O O
, O O
and O O
_num2 O O
normal O O
controls O O
following O O
x-irradiation O O
with O O
_num1 O O
gy O O
in O O
order O O
to O O
evaluate O O
this O O
cytogenetic O O
method O O
as O O
a O O
tool O O
for O O
detection O O
of O O
atm O O
carriers O O
. O O

population O O
studies O O
of O O
this O O
polymorphism O O
are O O
facilitated O O
by O O
the O O
fact O O
that O O
the O O
cys282tyr O O
mutation O O
creates O O
a O O
rsal O O
restriction O O
site O O
. O O

all O O
were O O
found O O
in O O
compound O O
heterozygous O O
individuals O O
. O O

the O O
g301c O O
and O O
s162f O O
mutations O O
account O O
for O O
_num2 O O
. O O

the O O
786-0 O O
cell O O
line O O
, O O
like O O
many O O
cancer B-Dis B-Dis
cells O O
, O O
fails O O
to O O
exit O O
the O O
cell O O
cycle O O
upon O O
serum O O
withdrawal O O
. O O

_num3 O O
. O O

the O O
proband O O
is O O
a O O
_num2 O O
year O O
old O O
, O O
mentally B-Dis B-Dis
retarded I-Dis I-Dis
male O O
who O O
suffers O O
severe O O
muscular B-Dis B-Dis
weakness I-Dis I-Dis
. O O

growth B-Dis O
retardation I-Dis O
of O O
the O O
smad4-deficient O O
embryos O O
results O O
from O O
reduced O O
cell O O
proliferation O O
rather O O
than O O
increased O O
apoptosis O O
. O O

nonsense O O
mutation O O
in O O
exon O O
_num1 O O
of O O
human O O
complement O O
c9 O O
gene O O
is O O
the O O
major O O
cause O O
of O O
japanese O O
complement B-Dis B-Dis
c9 I-Dis I-Dis
deficiency I-Dis I-Dis
. O O

the O O
control O O
women O O
were O O
enrolled O O
regardless O O
of O O
whether O O
or O O
not O O
they O O
had O O
either O O
mutation O O
. O O

methods O O
dna O O
samples O O
from O O
_num3 O O
unrelated O O
jews O O
of O O
european O O
or O O
non-european O O
origin O O
, O O
with O O
or O O
without O O
a O O
personal O O
and O O
/ O O
or O O
family O O
history O O
of O O
neoplasia B-Dis B-Dis
, O O
were O O
examined O O
for O O
the O O
i1307k O O
variant O O
by O O
the O O
allele-specific O O
oligonucleotide O O
-lrb- O O
aso O O
-rrb- O O
method O O
. O O

these O O
estimates O O
were O O
not O O
substantially O O
affected O O
either O O
by O O
changing O O
the O O
assumed O O
penetrance O O
model O O
for O O
brca1 O O
or O O
by O O
including O O
or O O
excluding O O
brca1 O O
mutation O O
data O O
. O O

the O O
apc B-Dis O
variants O O
i1307k O O
and O O
e1317q O O
are O O
associated O O
with O O
colorectal B-Dis B-Dis
tumors I-Dis I-Dis
, O O
but O O
not O O
always O O
with O O
a O O
family O O
history O O
. O O

a O O
deletion O O
mutation O O
in O O
col17a1 O O
in O O
five O O
austrian O O
families O O
with O O
generalized O O
atrophic B-Dis B-Dis
benign I-Dis I-Dis
epidermolysis I-Dis I-Dis
bullosa I-Dis I-Dis
represents O O
propagation O O
of O O
an O O
ancestral O O
allele O O
. O O

the O O
haplotyping O O
of O O
patients O O
with O O
identical O O
mutations O O
indicates O O
that O O
almost O O
all O O
of O O
these O O
represent O O
common O O
ancestry O O
and O O
that O O
very O O
few O O
spontaneously O O
recurring O O
atm O O
mutations O O
exist O O
. O O

we O O
report O O
a O O
rare O O
case O O
of O O
paternally O O
transmitted O O
congenital B-Dis O
myotonic I-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
. O O

identification O O
of O O
constitutional O O
wt1 O O
mutations O O
, O O
in O O
patients O O
with O O
isolated O O
diffuse B-Dis B-Dis
mesangial I-Dis I-Dis
sclerosis I-Dis I-Dis
, O O
and O O
analysis O O
of O O
genotype O O
/ O O
phenotype O O
correlations O O
by O O
use O O
of O O
a O O
computerized O O
mutation O O
database O O
. O O

very-long-chain B-Dis O
acyl-coenzyme I-Dis O
a I-Dis O
dehydrogenase I-Dis O
-lrb- I-Dis O
vlcad I-Dis I-Dis
-rrb- I-Dis I-Dis
deficiency I-Dis I-Dis
is O O
a O O
disorder O O
of O O
fatty O O
acid O O
beta O O
oxidation O O
that O O
reportedly O O
has O O
high O O
rates O O
of O O
morbidity O O
and O O
mortality O O
. O O

_num1 O O
to O O
_num1 O O
. O O

though O O
auditory B-Dis B-Dis
anomalies I-Dis I-Dis
have O O
been O O
observed O O
in O O
mice O O
with O O
dominant O O
white O O
spotting O O
-lrb- O O
w O O
-rrb- O O
due O O
to O O
kit O O
mutations O O
, O O
deafness B-Dis B-Dis
is O O
not O O
typical O O
in O O
human O O
piebaldism B-Dis B-Dis
. O O

aapc B-Dis B-Dis
is O O
recognized O O
by O O
the O O
occurrence O O
of O O
< O O
_num3 O O
colonic B-Dis B-Dis
adenomas I-Dis I-Dis
and O O
a O O
later O O
onset O O
of O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
-lrb- O O
age O O
> O O
_num2 O O
years O O
-rrb- O O
. O O

products O O
of O O
steroidogenic O O
factor O O
_num1 O O
-lrb- O O
sf-1 O O
-rrb- O O
and O O
wilms B-Dis B-Dis
tumor I-Dis I-Dis
_num1 O O
-lrb- O O
wt1 O O
-rrb- O O
genes O O
are O O
essential O O
for O O
mammalian O O
gonadogenesis O O
prior O O
to O O
sexual O O
differentiation O O
. O O

we O O
have O O
investigated O O
the O O
r496h O O
mutation O O
and O O
found O O
this O O
mutation O O
at O O
a O O
relatively O O
high O O
frequency O O
in O O
an O O
african O O
american O O
population O O
-lrb- O O
f O O
= O O
_num1 O O
. O O

the O O
185delag O O
mutation O O
in O O
brca1 O O
is O O
detected O O
in O O
ashkenazi O O
jews O O
both O O
in O O
familial B-Dis B-Dis
breast I-Dis I-Dis
and I-Dis I-Dis
ovarian I-Dis I-Dis
cancer I-Dis I-Dis
and O O
in O O
the O O
general O O
population O O
. O O

the O O
hemochromatosis B-Dis B-Dis
gene O O
product O O
complexes O O
with O O
the O O
transferrin O O
receptor O O
and O O
lowers O O
its O O
affinity O O
for O O
ligand O O
binding O O
. O O

in O O
this O O
study O O
, O O
direct O O
mutation O O
analysis O O
of O O
the O O
apc B-Dis B-Dis
gene O O
was O O
performed O O
to O O
determine O O
genotype-phenotype O O
correlations O O
for O O
nine O O
extracolonic O O
manifestations O O
and O O
to O O
investigate O O
the O O
incidence O O
of O O
apc B-Dis B-Dis
mutations O O
in O O
non-fap O O
colorectal B-Dis B-Dis
cancer I-Dis I-Dis
. O O

on O O
the O O
basis O O
of O O
meiotic O O
recombinants O O
and O O
disease-associated O O
haplotypes O O
, O O
the O O
wfs B-Dis O
gene O O
was O O
localized O O
to O O
a O O
bac O O
/ O O
p1 O O
contig O O
of O O
less O O
than O O
_num3 O O
kb O O
. O O

paternal O O
transmission O O
of O O
congenital B-Dis B-Dis
myotonic I-Dis I-Dis
dystrophy I-Dis I-Dis
. O O

we O O
report O O
here O O
the O O
complete O O
characterization O O
of O O
the O O
_num2 O O
exons O O
of O O
the O O
col4a4 O O
gene O O
, O O
a O O
comprehensive O O
gene O O
screen O O
, O O
and O O
the O O
subsequent O O
detection O O
of O O
_num2 O O
novel O O
mutations O O
in O O
eight O O
patients O O
diagnosed O O
with O O
autosomal B-Dis B-Dis
recessive I-Dis I-Dis
alport I-Dis I-Dis
syndrome I-Dis I-Dis
. O O

we O O
examined O O
whether O O
the O O
wd B-Dis B-Dis
gene O O
atp7b O O
was O O
also O O
causative O O
for O O
_ds B-Dis O
by O O
investigating O O
the O O
chromosomal O O
co-localization O O
of O O
atp7b O O
and O O
_an O O
, O O
using O O
fluorescence O O
in O O
situ O O
hybridization O O
-lrb- O O
fish O O
-rrb- O O
. O O

we O O
have O O
now O O
identified O O
a O O
missense O O
mutation O O
, O O
a O O
splice-donor O O
mutation O O
, O O
and O O
a O O
frameshift O O
mutation O O
in O O
the O O
coding O O
region O O
of O O
scn5a O O
in O O
three O O
ivf B-Dis B-Dis
families O O
. O O

based O O
on O O
our O O
recent O O
finding O O
that O O
cycloheximide O O
stabilized O O
mutant O O
col17a1 O O
transcripts O O
in O O
keratinocytes O O
homozygous O O
for O O
a O O
frameshift O O
mutation O O
, O O
the O O
effects O O
of O O
the O O
splice-site O O
mutation O O
on O O
splicing O O
of O O
col17a1 O O
transcripts O O
were O O
determined O O
using O O
reverse O O
transcriptase O O
polymerase O O
chain O O
reaction O O
of O O
total O O
rna O O
from O O
keratinocytes O O
incubated O O
for O O
_num1 O O
. O O

_num1 O O
has O O
recently O O
been O O
identified O O
as O O
the O O
gene O O
responsible O O
for O O
the O O
human O O
recessive B-Dis B-Dis
disease I-Dis I-Dis
ataxia-telangiectasia I-Dis I-Dis
-lrb- O O
a-t B-Dis B-Dis
-rrb- O O
. O O

five O O
intragenic O O
dimorphisms O O
are O O
now O O
well O O
characterized O O
and O O
the O O
high O O
degree O O
of O O
allelic O O
heterogeneity O O
in O O
hc B-Dis O
is O O
demonstrated O O
with O O
seven O O
new O O
different O O
mutations O O
making O O
a O O
total O O
of O O
nineteen O O
cpo O B-Dis
gene B-Dis O
defects I-Dis O
reported O O
so O O
far O O
. O O
. O O

sixteen O O
different O O
_an O O
germline O O
mutations O O
were O O
found O O
in O O
_num2 O O
families O O
, O O
while O O
one O O
germline O O
mutation O O
, O O
arg24his O O
, O O
was O O
detected O O
in O O
the O O
cdk4 O O
gene O O
. O O

by O O
using O O
exon-specific O O
polymerase O O
chain O O
reaction O O
-lrb- O O
pcr O O
-rrb- O O
/ O O
single-strand O O
conformation O O
polymorphism O O
as O O
a O O
screening O O
step O O
and O O
nucleotide O O
sequencing O O
of O O
target O O
exons O O
, O O
we O O
determined O O
that O O
the O O
proband O O
was O O
a O O
compound O O
heterozygote O O
for O O
two O O
c6 O O
gene O O
mutations O O
. O O

this O O
study O O
reports O O
on O O
six O O
cases O O
of O O
deficiency B-Dis B-Dis
in I-Dis O
the I-Dis O
human I-Dis O
complement I-Dis O
regulatory I-Dis O
protein I-Dis O
factor I-Dis O
h I-Dis O
-lrb- O O
fh O O
-rrb- O O
in O O
the O O
context O O
of O O
an O O
acute B-Dis O
renal I-Dis B-Dis
disease I-Dis I-Dis
. O O

sperm O O
dna O O
analysis O O
in O O
a O O
friedreich B-Dis B-Dis
ataxia I-Dis I-Dis
premutation O O
carrier O O
suggests O O
both O O
meiotic O O
and O O
mitotic O O
expansion O O
in O O
the O O
frda B-Dis B-Dis
gene O O
. O O

neuropsychological O O
analysis O O
assessed O O
verbal O O
and O O
visuospatial O O
intelligence O O
, O O
verbal O O
memory O O
, O O
and O O
reading O O
skills O O
. O O

myotonic B-Dis B-Dis
dystrophy I-Dis I-Dis
-lrb- O O
dm B-Dis B-Dis
-rrb- O O
is O O
an O O
autosomal B-Dis O
dominant I-Dis O
disease I-Dis O
which O O
, O O
in O O
the O O
typical O O
pedigree O O
, O O
shows O O
a O O
three O O
generation O O
anticipation O O
cascade O O
. O O

another O O
missense O O
mutation O O
-lrb- O O
t416p O O
-rrb- O O
was O O
found O O
in O O
a O O
homozygous O O
state O O
in O O
one O O
family O O
and O O
in O O
a O O
heterozygous O O
state O O
in O O
four O O
families O O
. O O

2-22 O O
. O O

we O O
recently O O
reported O O
the O O
positional O O
cloning O O
of O O
a O O
candidate O O
gene O O
for O O
hereditary B-Dis B-Dis
hemochromatosis I-Dis I-Dis
called O O
hfe O O
. O O

the O O
newly O O
described O O
hfe O O
marker O O
provides O O
a O O
new O O
approach O O
to O O
the O O
screening O O
of O O
hh B-Dis O
as O O
well O O
as O O
studies O O
of O O
the O O
relationship O O
between O O
the O O
hfe O O
tyr O O
allele O O
and O O
different O O
disorders O O
including O O
cancer B-Dis B-Dis
risk O O
reversals O O
in O O
predictive O O
testing O O
for O O
huntington B-Dis B-Dis
disease I-Dis I-Dis
. O O

mutant O O
embryos O O
have O O
reduced O O
size O O
, O O
fail O O
to O O
gastrulate O O
or O O
express O O
a O O
mesodermal O O
marker O O
, O O
and O O
show O O
abnormal O O
visceral O O
endoderm O O
development O O
. O O

mutational O O
analysis O O
of O O
col17a1 O O
identified O O
a O O
maternally O O
inherited O O
g-to-t O O
transversion O O
at O O
the O O
-1 O O
position O O
of O O
exon O O
_num2 O O
. O O

the O O
french O O
familial B-Dis B-Dis
melanoma I-Dis I-Dis
study O O
group O O
. O O

mutation O O
screening O O
and O O
sequence O O
analysis O O
disclosed O O
the O O
involvement O O
of O O
three O O
different O O
arsa O O
mutations O O
being O O
the O O
molecular O O
basis O O
of O O
intrafamilial O O
phenotypic O O
heterogeneity O O
. O O

bipolar B-Dis B-Dis
affective I-Dis I-Dis
disorder I-Dis I-Dis
-lrb- O O
bpad B-Dis B-Dis
; O O
manic-depressive B-Dis O
illness I-Dis O
-rrb- O O
is O O
characterized O O
by O O
episodes O O
of O O
mania B-Dis O
and O O
/ O O
or O O
hypomania B-Dis O
interspersed O O
with O O
periods O O
of O O
depression B-Dis O
. O O

seven O O
novel O O
mutations O O
and O O
two O O
new O O
polymorphisms O O
were O O
detected O O
. O O

atm O O
mutations O O
and O O
phenotypes O O
in O O
ataxia-telangiectasia B-Dis B-Dis
families O O
in O O
the O O
british O O
isles O O
: O O
expression O O
of O O
mutant O O
atm O O
and O O
the O O
risk O O
of O O
leukemia B-Dis B-Dis
, O O
lymphoma B-Dis B-Dis
, O O
and O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
. O O

we O O
show O O
that O O
sodium O O
channels O O
with O O
the O O
missense O O
mutation O O
recover O O
from O O
inactivation O O
more O O
rapidly O O
than O O
normal O O
and O O
that O O
the O O
frameshift O O
mutation O O
causes O O
the O O
sodium O O
channel O O
to O O
be O O
non-functional O O
. O O

_num1 O O
% O O
of O O
the O O
normal O O
level O O
. O O

previous O O
studies O O
of O O
patients O O
from O O
a O O
british-irish O O
population O O
showed O O
that O O
the O O
i113f O O
mutation O O
is O O
the O O
most O O
common O O
single O O
mutation O O
among O O
mps B-Dis B-Dis
iva I-Dis I-Dis
patients O O
and O O
produces O O
a O O
severe O O
clinical O O
phenotype O O
. O O

a O O
gene O O
encoding O O
a O O
novel O O
transmembrane O O
protein O O
was O O
identified O O
by O O
dna O O
sequence O O
analysis O O
within O O
the O O
insulin-dependent B-Dis B-Dis
diabetes I-Dis I-Dis
mellitus I-Dis I-Dis
-lrb- O O
iddm B-Dis B-Dis
-rrb- O O
locus O O
iddm4 O O
on O O
chromosome O O
11q13 O O
. O O

_num2 O O
, O O
p O O
= O O
_num1 O O
. O O

we O O
have O O
analyzed O O
additional O O
cdna O O
clones O O
and O O
provide O O
evidence O O
for O O
an O O
additional O O
_num1 O O
. O O

the O O
observed O O
genetic O O
heterogeneity O O
including O O
the O O
relative O O
high O O
percentage O O
of O O
splice-site O O
mutations O O
had O O
no O O
reflection O O
on O O
the O O
phenotype O O
. O O

genetic O O
heterogeneity O O
and O O
penetrance O O
analysis O O
of O O
the O O
brca1 O O
and O O
brca2 O O
genes O O
in O O
breast B-Dis B-Dis
cancer I-Dis I-Dis
families O O
. O O

with O O
direct O O
tests O O
for O O
the O O
hd B-Dis B-Dis
mutation O O
, O O
we O O
have O O
assessed O O
the O O
accuracy O O
of O O
results O O
obtained O O
by O O
linkage O O
approaches O O
when O O
requested O O
to O O
do O O
so O O
by O O
the O O
test O O
individuals O O
. O O

genetic O O
and O O
environmental O O
variance O O
components O O
were O O
assessed O O
with O O
the O O
program O O
mx O O
, O O
using O O
data O O
from O O
this O O
and O O
previous O O
studies O O
of O O
twins O O
with O O
as B-Dis O
. O O

to O O
date O O
, O O
our O O
detection O O
rate O O
for O O
twist O O
or O O
fgfr O O
mutations O O
is O O
_num2 O O
% O O
in O O
our O O
saethre-chotzen B-Dis B-Dis
syndrome I-Dis I-Dis
patients O O
, O O
including O O
our O O
five O O
patients O O
elsewhere O O
reported O O
with O O
twist O O
mutations O O
. O O

frequent O O
inactivation O O
of O O
pten O O
/ O O
mmac1 O O
in O O
primary O B-Dis
prostate B-Dis I-Dis
cancer I-Dis I-Dis
. O O

brca1 O O
mutations O O
are O O
rare O O
in O O
sporadic B-Dis B-Dis
cancers I-Dis I-Dis
, O O
but O O
loss O O
of O O
brca1 O O
resulting O O
from O O
reduced O O
expression O O
or O O
incorrect O O
subcellular O O
localization O O
is O O
postulated O O
to O O
be O O
important O O
in O O
non-familial B-Dis B-Dis
breast I-Dis I-Dis
and I-Dis I-Dis
ovarian I-Dis I-Dis
cancers I-Dis I-Dis
. O O

_num1 O O
% O O
-rrb- O O
and O O
none O O
of O O
the O O
yemenites O O
or O O
iranians O O
was O O
a O O
carrier O O
of O O
the O O
185delag O O
mutation O O
. O O

splicing O O
of O O
ctnt O O
was O O
disrupted O O
in O O
dm B-Dis B-Dis
striated O O
muscle O O
and O O
in O O
normal O O
cells O O
expressing O O
transcripts O O
that O O
contain O O
cug O O
repeats O O
. O O

other O O
observations O O
indicate O O
that O O
the O O
c5d B-Dis B-Dis
state O O
is O O
compatible O O
with O O
normal O O
coagulation O O
function O O
and O O
the O O
capacity O O
to O O
mount O O
a O O
neutrophilic O O
leukocytosis O O
during O O
pyogenic B-Dis B-Dis
infection I-Dis I-Dis
. O O
. O O

in O O
our O O
study O O
, O O
we O O
have O O
determined O O
the O O
atm O O
mutation O O
spectrum O O
in O O
_num2 O O
classical O O
a-t B-Dis B-Dis
patients O O
, O O
including O O
some O O
immigrant O O
populations O O
, O O
as O O
well O O
as O O
_num2 O O
of O O
dutch O O
ethnic O O
origin O O
. O O

we O O
identified O O
a O O
_num4 O O
g O O
-- O O
> O O
c O O
-lrb- O O
amino O O
acid O O
w474c O O
-rrb- O O
substitution O O
in O O
the O O
first O O
position O O
of O O
exon O O
_num2 O O
of O O
hexa O O
of O O
a O O
non-jewish O O
proband O O
who O O
manifested O O
a O O
subacute O O
variant O O
of O O
g B-Dis O
-lrb- I-Dis O
m2 I-Dis O
-rrb- I-Dis O
gangliosidosis I-Dis O
. O O

in O O
total O O
, O O
one O O
or O O
both O O
of O O
these O O
mutations O O
were O O
found O O
in O O
nine O O
of O O
the O O
_num2 O O
families O O
analyzed O O
. O O

deficiency B-Dis O
of I-Dis O
arylsulfatase I-Dis O
a I-Dis O
-lrb- O O
arsa O O
-rrb- O O
enzyme O O
activity O O
causes O O
metachromatic B-Dis B-Dis
leukodystrophy I-Dis I-Dis
-lrb- O O
mld B-Dis B-Dis
-rrb- O O
. O O

this O O
results O O
in O O
infertility B-Dis B-Dis
and O O
congenital B-Dis B-Dis
myotonic I-Dis I-Dis
dystrophy I-Dis I-Dis
-lrb- O O
cdm B-Dis O
-rrb- O O
with O O
the O O
disappearance O O
of O O
dm B-Dis B-Dis
in O O
that O O
pedigree O O
. O O

seven O O
further O O
molecular O O
bases O O
of O O
c7 B-Dis B-Dis
deficiency I-Dis I-Dis
are O O
described O O
. O O

wilms B-Dis B-Dis
tumor I-Dis I-Dis
_num1 O O
and O O
dax-1 O O
modulate O O
the O O
orphan O O
nuclear O O
receptor O O
sf-1 O O
in O O
sex-specific O O
gene O O
expression O O
. O O

_num2 O O
x O O
_num2 O O
-lrb- O O
-4 O O
-rrb- O O
; O O
sibpal O O
pempirical O O
value O O
< O O
_num1 O O
x O O
_num2 O O
-lrb- O O
-5 O O
-rrb- O O
-rrb- O O
and O O
suggestive O O
evidence O O
for O O
a O O
locus O O
on O O
chromosome O O
4q O O
at O O
d4s397 O O
-lrb- O O
maximum O O
genehunter-plus O O
nonparametric O O
linkage O O
score O O
= O O
_num1 O O
. O O

contrary O O
to O O
this O O
theory O O
, O O
our O O
data O O
showed O O
that O O
these O O
mutants O O
are O O
dominant-negative O O
in O O
transient O O
transfection O O
assays O O
when O O
they O O
are O O
coexpressed O O
with O O
wild-type O O
pax6 O O
. O O

investigation O O
of O O
the O O
genetic O O
background O O
by O O
means O O
of O O
mtdna O O
lineages O O
indicate O O
that O O
all O O
our O O
patients O O
are O O
probably O O
of O O
native O O
american O O
descent O O
w474c O O
amino O O
acid O O
substitution O O
affects O O
early O O
processing O O
of O O
the O O
alpha-subunit O O
of O O
beta-hexosaminidase O O
a O O
and O O
is O O
associated O O
with O O
subacute O O
g B-Dis O
-lrb- I-Dis O
m2 I-Dis O
-rrb- I-Dis O
gangliosidosis I-Dis O
. O O

results O O
the O O
adjusted O O
odds O O
ratio O O
for O O
ovarian B-Dis B-Dis
cancer I-Dis I-Dis
associated O O
with O O
any O O
past O O
use O O
of O O
oral O O
contraceptives O O
was O O
_num1 O O
. O O

these O O
modules O O
include O O
a O O
putative O O
signal O O
peptide O O
for O O
protein O O
export O O
, O O
four O O
epidermal O O
growth O O
factor O O
-lrb- O O
egf O O
-rrb- O O
repeats O O
with O O
associated O O
spacer O O
domains O O
, O O
three O O
ldl-receptor O O
-lrb- O O
ldlr O O
-rrb- O O
repeats O O
, O O
a O O
single O O
transmembrane O O
spanning O O
domain O O
, O O
and O O
a O O
cytoplasmic O O
domain O O
. O O

_num1 O O
; O O
_num2 O O
percent O O
confidence O O
interval O O
, O O
_num1 O O
. O O

the O O
overexpressed O O
h63d O O
protein O O
does O O
not O O
have O O
this O O
effect O O
, O O
providing O O
the O O
first O O
direct O O
evidence O O
for O O
a O O
functional O O
consequence O O
of O O
the O O
h63d O O
mutation O O
. O O

hereditary B-Dis B-Dis
coproporphyria I-Dis I-Dis
-lrb- O O
hcp B-Dis O
-rrb- O O
is O O
an O O
autosomal B-Dis B-Dis
dominant I-Dis I-Dis
disease I-Dis I-Dis
characterized O O
by O O
a O O
deficiency B-Dis B-Dis
of I-Dis I-Dis
coproporphyrinogen I-Dis I-Dis
oxidase I-Dis O
-lrb- O O
cpo O O
-rrb- O O
caused O O
by O O
a O O
mutation O O
in O O
the O O
cpo O O
gene O O
. O O

complement B-Dis B-Dis
component I-Dis I-Dis
c6 I-Dis I-Dis
deficiency I-Dis I-Dis
-lrb- O O
c6d B-Dis O
-rrb- O O
was O O
diagnosed O O
in O O
a O O
16-year-old O O
african-american O O
male O O
with O O
meningococcal B-Dis B-Dis
meningitis I-Dis I-Dis
. O O

